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Molecular biological approaches were used to study and interfere with the life
cycle of infectious hematopoietic necrosis virus (IHNV). These included the control
of IHN disease in rainbow trout by genetic immimi7ation or interference in vitro by
synthesis of sense and antisense expression of the viral nucleocapsid (N) gene, and in
situ localization of the virus in infected fish.
The design of DNA vaccines was based upon the fording that fish skeletal
muscle cells could express transgenes delivered by direct injection using a needle and
syringe. Optimum transgene expression occurred seven days post injection with 25
ug of plasmid DNA. The cytomegalovirus immediate early promoter enhancer was
the strongest promoter tested. Transgene expression lasted for at least 115 days post
injection. The DNA persisted as an unintegrated and non-replicated plasmid.
Vaccination of fish with the IHNV glycoprotein (G) encoding plasmid, pCMV4-G,
resulted in a protective immune response. Fish vaccinated with pCMV4-G and an
IHNV N encoding plasmid, pCMV4-N, produced a stronger anti-G specific immune
response than did fish vaccinated with pCMV4-G. However, the percent survival of
fish vaccinated either in combination or with pCMV4-G alone was the same, 86%,
still well above the 25-35 % survival of fish vaccinated with pCMV4-N or mock
vaccinated.
A temporal state of intracellular immunity was induced in cells expressing the
IHNV N gene in the sense or antisense orientation. The cells were completely
resistant to IHNV 3 months after transfection. However, five months after
transfection the antisense transfected cells were 99 % less susceptible to IHNV
Redacted for Privacyplaque formation than control cells, the sense transfected cells were 33% less 
susceptible. 
The sites of IHNV infection during the height of a viral epizootic were 
determined by in situ hybridization using an oligonucleotide complementary to the 
IHNV N gene. A number of parameters were optimized, the most critical being the 
amount of probe used and the washing and hybridization stringency.  The virus was 
found systemically. The most conspicuous site of IHNV infection was found in the 
hematopoietic tissues of the kidney. Copyright by Eric D. Anderson
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CHAPTER 1
 
THESIS INTRODUCTION
 
The rhabdovirus infectious hematopoietic necrosis virus (1HNV) is a pathogen 
of certain salmonid fish native to the Pacific Rim Countries. Due to the severity, 
prevalence, and economic cost of the IHN disease, considerable efforts have been 
made to control the virus. These efforts can be divided into two broad categories: 
improving animal health practices, and the development of safe and effective 
chemotherapeutics and vaccines. Both of these are based upon a wealth of 
information gathered since the viruses identification in the 1950's (Rucker et al., 1953; 
Watson et al., 1954; Guenther et al., 1959). The work presented in this thesis was 
conducted to provide a basic understanding of the cytopathic mechanisms of IHNV in 
vivo and in vitro. The information, and techniques developed, should be useful both 
in the applied field of vaccine design, and the basic fields of virology and immunology. 
Genetic Immunization 
Genetic immunization, or the use of plasmid DNA to vaccinate, is one of the 
newest approaches in vaccine design. This approach was developed following the 
discovery that naked DNA could be delivered to somatic tissues in vivo, using a 
needle and syringe, and the encoded proteins could be expressed (Wolff et al., 1990). 
Ulmer et al. (1993) were the first to use this technique to vaccinate against a viral 
pathogen. Since these original reports, numerous groups have developed DNA 
vaccines for a number of different pathogens (see Table 2.1). Genetic immunization 
can be applied using any gene which is appropriate. The vaccine can not revert to a 
virulent phenotype, involves a broad spectrum immune responses, and is easy to 
prepare. Because of these virtues, we decided to test DNA vaccines for their ability 
to immunize fish against HINV. 2 
Prior to the use of DNA vaccines an understanding of the basic principles 
underlying gene expression following direct DNA injection was undertaken (Chapter 
3). In these studies strong promoters were identified, the sites and duration of gene 
expression, the dose response (amount of plasmid delivered-level of gene expression), 
and the nature of the DNA in vivo was determined. These studies established that 
genetic immunization is a feasible method of immunization of fish against IHNV. 
In chapter 4, DNA vaccines containing the IHNV nucleocapsid (N) gene or the 
glycoprotein (G) gene were designed. Previous studies using attenuated IHNV(Fryer 
et al., 1976; Tebbit, 1976), killed IHNV(Amend, 1976; Nishimura et al., 1985; 
Naganawa et al., 1993), subunit (Gilmore et al., 1988; Oberg et al., 1991) and purified 
viral protein (Engelking and Leong, 1989a; Engelking and Leong, 1989b) vaccines have 
demonstrated that fish could be immunized against IHNV. Based upon the previous 
work and that in Chapter 3, DNA vaccines were tested for their ability to evoke a 
protective immune response in fish. Both the specificity of the antibody response 
and the ability to protect fish from an II-INV challenge were measured. 
The DNA vaccines proved efficacious and allowed dissection of the viral proteins (N 
or G) necessary for a protective immune response in fish. 
Intracellular Immunity 
The control of cellular gene expression and protein synthesis by 
complementary RNA has been well characterized in prokaryotes (reviewed in: 
Inouye, 1988; van der Krol et al, 1988; Helene and Toulme, 1990; Takayama and 
Inouye, 1990). The control is believed to be the result of hybridization of the 
complementary RNA with a target sequence followed by degradation of the duplex, or 
blockage of mRNA translation. In eukaryotes, expression of complementary RNA has 
also been used to interfere with cellular and viral gene expression. Izant and Weintraub 
(1984) were the first group to demonstrate that such an approach was feasible in 
eukaryotes. Since this initial report, antisense and sense expression of viral genes have 
been used to induce a state of intracellular immunity in a variety of plants and animal 
models (in vivo and in vitro). The mechanism(s) by which interfering RNAs inhibit 
viruses in eukaryotes are for the most part not understood; published reports have relied 
on biological assays to assess the degree of intracellular immunity. 3 
In chapter 5, sense and antisense expression of the IHNV N gene was used to 
examine the ability of the N gene to interfere with cellular life-cycle of IHNV. This 
work was based upon the finding that oligodeoxyribonucleotides complementary to the 
N gene of the rhabdovirus vesicular stomatitis virus (VSV) could interfere with VSV 
replication. Both orientations of the N gene were found to impart a partial state of 
intracellular immunity in fish cells. The mechanisms underlying the immunity were not 
investigated but the results do suggest that the N protein plays an integral role in 
regulation of the IHNV life cycle. 
Localization of IHNV In Vivo 
An understanding of the life cycle of IHNV is critical to the development of 
methods for the control of IHNV. Amend (1975) was the first to experimentally show 
that IHNV could be isolated from mature fish infected with IHNV when they were fry. 
Until recently, there have not been any other reports confirming the work of Amend. 
However, recently Drolet et al. (1995) used immunohistochemical analysis to 
demonstrate that IHNV could be detected in mature fish which had survived a viral 
epizootic as fry. This work showed that IHNV can persist as defective interfering 
particles in mature fish. However, though the fish were harboring the virus, infectious 
IHNV could not be isolated. 
Chapter 5 deals with the development of in situ hybridization as a tool to 
localize IHNV in infected fish. This technique was developed as a complementary 
approach to the immunocytochemical analysis developed by Drolet et al. (1994a, 
1994b, and 1995). A number of parameters were optimized to improve the sensitivity 
of viral localization in fish tissue. The most critical were identified to be the 
hybridization and washing stringencies. Using in situ hybridization, the virus was 
found to be systemic. The most conspicuous site of infection was the kidney. This 
technique should provide a powerful tool for the study of the life cycle of IHNV. In 
situ may be a particularly well suited, in combination with polymerase chain reaction 
and immunocytochemistry, for determining the site(s) of replication of the defective 
interfering viral particles described by Drolet et al. (1995) 4 
CHAPTER 2
 
LITERATURE REVIEW
 
Infectious Hematopoietic Necrosis Virus 
Classification 
Infectious hematopoietic necrosis virus (IENV), a viral pathogen of salmon 
and trout, is a member of the family Rhabdoviridae and has been assigned to the genus 
Lyssavirus (Shope and Tesh, 1987). This classification is based upon the similarities 
of the IHN virion morphology (Amend and Chambers, 1970), the RNA genome 
(McCain et al., 1974) and the protein molecular weights (McAllister and Wagner, 
1975; Hill et al., 1975; Hsu et al., 1986) with the prototypic Lyssavirus, rabies virus. 
A feature that distinguishes IHNV and two other fish lyssaviruses, hirame 
rhabdovirus, and viral hemorrhagic septicemia virus, from all other Rhabdoviridae 
including fish vesiculoviruses, is the possession of a sixth gene termed the non-virion 
gene (Kurath et al., 1985; Kurath et al., 1994). The non-virion gene is located near the 
5' end of the viral genome between the glycoprotein and polymerase gene (Kurath et 
al., 1985). 
Historical perspective 
The written history of IHNV is entwined with the advent of intensive salmon 
fanning in the Pacific Northwest of the United States. As fish hatcheries were 
developed, good animal husbandry was required to maintain and enhance the health of 
the farmed fish. Accordingly, fish health specialists identified pathogens that 
occurred in fish, and documented their findings. 
The first reports of IHNV infecting fish occurred during the 1950's and early 
1960's from hatcheries in Washington (Rucker et al., 1953), Oregon (Wingfield et al., 
1969) and California (Ross et al., 1960). These reports distinguished the disease by a 
rapid onset and high moralities in juvenile sockeye salmon (Oncorhynchus nerka) 5 
(Rucker et al., 1953; Watson et al., 1954). The viral etiology of the disease was 
confirmed by its transmission with cell-free filtrates from infected fish to uninfected 
fish which subsequently showed signs of viral infection (Watson et al., 1954). 
Initially, the disease was described as highly species-specific; infecting only 
sockeye salmon (Guenther et al. 1959). However, in 1960 a viral epizootic similar to 
the sockeye salmon disease outbreaks reported in the decade of the fifties occurred in 
chinook salmon (Oncorhynchus tshawytscha) fry (Ross et al., 1960). In 1969, Amend 
reported a similar viral disease causing high mortalities in rainbow trout 
(Oncorhynchus mykiss) fry. Amend and Chambers (1970a; 1970b) found that the 
viruses causing disease in sockeye and chinook salmon and rainbow trout had a 
similar, cytopathic effects on cell culture, pathology exhibited in fish, and appearance 
when viewed my electron microscopy. As will be described later, the documented 
distribution and host range of IHNV have expanded considerably in the past 30 years. 
IHNV acquired its name from the microscopic pathology it produced in fish 
(Amend et al., 1969). Necrosis of the hematopoietic tissues of the anterior kidney is 
the primary internal histological manifestation of the virus. A recent 
immunohistochemical study of the route of entry and progression of IHNV infection 
in fish demonstrated that the virus eventually reaches and infects most organs (Drolet 
et al., 1994). 
Currently IHNV is considered to be the most costly viral fish pathogen in the 
Pacific Northwest of the U.S.A in lost fisheries resources and revenues to sport and 
commercial fisherman (Leong, 1993). Thus, considerable efforts have been made to 
control IHNV. These control methods include improving fish husbandry and 
hatchery management practices, identifying and using chemotherapeutics, and the 
development and use of efficacious vaccines against IHNV. The successes and 
failures of these efforts will be reviewed here. 
The control of IHNV is based on a wealth of information gathered since the 
1950s concerning IHNV geographic distribution, host range, host susceptibility, life 
cycle, pathogenesis, molecular biology, and basic fish biology. The development of 
fish cell culture in the 1950's, enabling virus propagation, was a landmark in the study 
of IHNV (Wolf, 1988). The application of molecular biological techniques has 
provided one of the most important leaps in our understanding of IHNV in the past 
20 years. Clearly, a combination of disciplines will be required to eventually control 
IHNV. 6 
Geographic distribution 
Since the first IHNV isolations in the 1950's and 1960's, the virus has been 
identified in numerous areas around the world. The virus is considered to be enzootic 
in the Pacific Northwest of the U.S.A. and Canada. This is likewise true for 
Hokkaido and Honshu Islands of Japan (Sano et al. 1977). IHNV has also been 
reported in fish located in Minnesota (Plumb, 1972), Montana (Holoway and Smith, 
1973), South Dakota (unpublished, cited in Wolf et al. 1973), and West Virginia (Wolf 
et al. 1973). In Europe, IHNV has been isolated from fish in France (Laurencin, 
1987), Italy (Bovo et al., 1987), and Belgium (Hill, 1992). Recently, IHNV was 
isolated from several species of salmon in Korea (Park et al., 1994). The spread of 
IHNV is believed to be the result of shipment of contaminated eggs and fry from the 
Pacific Northwest of the U.S.A. and Canada around the world. 
The isolation of IHNV from feral fish populations was first reported by 
Williams and Amend (1976) in sockeye salmon in British Columbia. Traxler (1986) 
reported an epizootic in feral kokanee salmon (Oncorhynchus nerka) in Lake 
Cowichan, British Columbia. The Oregon Department of Fish and Wildlife (1992 and 
1993) reported that a natural IHNV epizootic occurred in pre-adult kokanee in Lake 
Billy Chinook, Oregon (Engelking and Kaufman, 1994). However, in general, the 
majority of IHNV epizootics have occurred in fish reared in intensive aquaculture 
operations (Leong, 1993). 
Host range and susceptibility 
The host range of IHNV is relatively broad. IHNV has been found to 
naturally infect rainbow and steelhead trout, sockeye salmon , Atlantic salmon (Salmo 
salar), pink salmon (Oncorhynchus gorbuscha), chum salmon (Oncorhynchus keta), 
cutthroat trout (Salmo trutta), coho salmon (Oncorhynchus kisutch), amago salmon 
(Oncorhynchus rhodurus), and yamame salmon (Oncorhynchus masou; reviewed in 
Lapatra, 1989). 
Recently Bootland et al. (1994) demonstrated that bull trout (Salvelinus 
confluentus) and mountain whitefish (Prosopium williamsoni) could be experimentally 
infected with IHNV. The marine fish, seabream (Archosargus rhomboidalis) and 7 
turbot (Scopthablzus maximus) have also been experimentally infected with IHNV 
(Castric and Jeffroy, 1991). IHNV has also been isolated from leeches (Piscicola 
salmositica; Mulcahy et al. 1990) and mayflies (Callibaetis sp.; Shors and Winston, 
1989). 
The majority of IHNV epizootics have occurred in very young fry (a few 
months old; Pilcher and Fryer, 1980). However, IHNV epizootics have been reported 
in year old sockeye (Yasutake, 1978; Burke and Grischowsky 1984), two-year-old 
kokanee (Traxler, 1986), and year old-rainbow trout (Roberts, 1986). Thus, it 
appears that age is not the only factor influencing fish susceptibility to IHNV. 
Variations in salmonid susceptibility to IHNV have been observed. Virus 
isolated from sockeye salmon and rainbow trout have reduced virulence for other 
salmonid species compared to the host from which they were isolated (Pilcher and 
Fryer, 1980; Wingfield et al., 1969). Lapatra et al. (1989) and Chen (1983) 
demonstrated that there are IHNV strains which are more virulent for particular 
species of salmonids. The electropherotype type 1 IHNV is more virulent for 
kokanee and the type 2 IHNV is more virulent for rainbow trout (Lapatra et al. 1989) 
Coho salmon have been considered relatively resistant to IHN. This occurs by an 
unknown mechanism. However, IHNV has been isolated from naturally infected coho 
(Lapatra et al. 1987) and experimentally infected coho (Lapatra et al. 1989). Various 
salmonid hybrids generated by genetic manipulation have been shown to be less 
susceptible to IHNV (Lapatra et al. 1993). The use of hybrid fish has great promise 
for the production of IHNV resistant stocks, however it may be costly to produce 
hybrid fish, and may require continued crosses to ensure that the viral resistance is 
not lost. 
IHNV life cycle 
The nature of the life cycle of IHNV remains controversial. Amend (1975) 
reported those rainbow trout fry infected with IHNV become life-long carriers as 
evidenced by recovery of IHNV from their reporductive fluids at maturity. Since this 
observation, numerous studies at Oregon State University has been conducted to 
confirm this finding, none of which have been successful. However, recently IHNV 
has been identified in mature rainbow trout experimentally exposed to IHNV as fry. 
This was shown by a combination of immunohistochemistry using G and N-specific 8 
monoclonal antibodies and N-specific PCR (Drolet et al., 1995), all of which 
positively identified IHNV in fish tissues. These last results give credence to the 
possibility of a life long carrier state. 
Fish to fish waterborne transmission of IHNV was first reported by Rucker 
(1953). Mulcahy et al. (1983) demonstrated that IHNV titers in river water taken 
near spawning fish held at high density contained sufficient virus to infect yearling 
sockeye salmon held downstream. These and other studies (Wedemeyer et al. 1978) 
demonstrated that IHNV remains infective in water for several months. IHNV has 
been recovered from the feces and urine of infected fish (Nishimura et al. 1988). It has 
been inferred that this may be the source of IHNV transmission in water. There have 
not been any defmitive reports of transmission of IHNV to fish by virus in water 
sediments. Thus, these studies suggested that maintenance of IHNV in fish 
populations is due to waterborne transmission of IHNV from infected to uninfected 
fish, fry, and developing embryos. 
Indirect evidence of vertical transmission of IHNV has been demonstrated in 
several studies. Mulcahy and Pascho (1985) isolated infectious IHNV from dead eggs 
and fry obtained from IHNV positive parental fish. IHNV can be detected in ovarian 
fluid collected from spawning salmon (Lapatra et al. 1990). Mulcahy and Batts 
(1987) found that cells collected from ovarian fluid could be cultured in vitro and 
release IHNV into the culture media. Mulcahy and Pascho (1984) showed that IHNV 
strongly absorbed to fish sperm. However, Yoshimizu et al. (1989) demonstrated 
that salmon eggs or sperm incubated with IHNV, or eggs injected with IHNV, did not 
result in mortalities in the progeny. Yoshimizu et al. (1989) did show that eyed 
embryos injected with IHNV resulted in 90% mortality after hatching. Thus, it 
appears that vertical transmission remains an open question. 
Several studies have been undertaken to identify a reservoir of IHNV. It has 
been suggested that resident non-salmonid fish populations may serve as IHNV 
reservoirs. However, no reports have been published concerning this possibility. As 
noted previously, IHNV has been recovered from leeches and mayflies. However, 
while tissue culture infective virus could be recovered from mayflies and leeches it 
was unclear whether the virus replicates in the invertebrate host or that there was 
virus transmission from the host to fish. 
A part of the work described in this thesis was directed at developing in situ 
hybridization to localize IHNV in whole fish for the purpose of understanding the life 
cycle of IHNV. 9 
Progression and pathogenesis 
Yasutake (1970) has reviewed the microscopic histopathology of IHNV. The 
virus causes severe necrosis of the head kidney (hematopoietic cells).  Necrosis, to a 
lesser degree, also occurs in the posterior kidney, stomach, and pancreas. 
Additionally, there is localized necrosis of the kidney during the latter stages of IHNV 
infection. 
A detailed study of the route of entry and progression of IHNV in rainbow 
trout has recently been described (Drolet et al., 1994).  This study revealed that 
IHNV infection progresses from two major sites: the gills and the gastrointestinal 
tract. It appears that both routes of infection eventually result in systemic viremia 
and that connective tissue is the major site of replication. 
Young fish experimentally infected with IHNV typically have external signs of 
infection 3-5 days post exposure (dpe). Mortalities typically begin 4-5 dpe, peak 
approximately 10 dpe, and decline thereafter so that by 40-50 dpe there are no more 
mortalities. Infectious virus can be isolated from fish surviving a viral challengefor 
approximately 40-50 dpe; after this time infectious virus can not be isolated. 
Recently, Drolet et al. (1995) demonstrated that IHNV can persistent in fish as 
defective particles for at least two years post infection. 
Biology of IHNV in cells culture 
There are numerous cell lines both salmonid and non-salmonid, in which IHNV 
can replicate (Lannan et al., 1984; Wolf and Mann, 1980). A characteristic 
manifestation of IHNV in fish cells is the formation of a plaque when the cells are 
overlaid with semi-solid media. The cytopathic effect is a result of both inhibition of 
cellular transcription and translation.  11-LNV has also been shown to grow to high 
titers in mosquito cells and the harvested virus is infectious for fish (Scott et al., 
1980). However, unlike fish cells, mosquito cells do not show cytopathic effects due 
to IHNV. 
A multitude of factors influence the rate of growth of IHNV in fish cells. 
These include, among others, the virus isolate, cell type, incubation temperature, and 
cell density (Mulcahy et al., 1984). In general IHNV grows optimally at a 10 
temperature of 16 -18° C and does not replicate in fish cells at temperatures much 
above 24° C. Replication of IHNV at temperatures of 5 -10° C is isolate specific 
(Mulcahy et al., 1984). Following infection of cells, there is a lag period of 
approximately ten hours in which no infectious virus can be recovered, and maximum 
viral production is 30-90 hours post infection (Mulcahy et al., 1984; Fendrick et al., 
1982). Hsu et al. (1985) demonstrated that the IHNV nucleocapsid protein appeared 
2-3 hours post infection, the matrix proteins appeared 6-7 hours post infection, and 
the glycoprotein appeared 9-10 hours post infection. They also found that the 
polymerase could be detected 30-31 hours post; however, this time is probably 
indicative of the low levels of polymerase synthesized and not necessarily the actual 
time of appearance. 
Persistent infection of fish cells with IHNV has been reported and has been 
used as a method for the production of attenuated live IHNV vaccines (Fryer et al., 
1976; Fukuda et al., 1989). Engelking and Leong (1981) demonstrated that 
persistently infected cells were resistant to superinfection by homologous but not 
heterologous strains of IHNV. They also suggested that persistence was not mediated 
by interferon. In addition, persistent infection of cells with a temperature sensitive 
mutant of IHNV resulted in no cytopathicity at 20° C. However, when the cells were 
shifted to 15° C there was a rapid cytopathicity. 
Control of IHNV 
Overview 
Currently there are no licensed vaccines or chemotherapeutics available for the 
control of IHNV. Avoidance of IHNV is the most practical and practiced method of 
control (Wolf, 1988). To this end, hatchery reared eggs, fry, and spawning fish are 
rigorously monitored for IHNV in both private and government facilities. IHNV 
positive animals are quarantined and, when practical, eliminated. Despite such 
methods, IHNV remains the most costly of viral pathogens in the Pacific Northwest 
of the USA. 11 
Chemical control of IHNV Addition of low concentration of iodine to water 
has been shown to produce a 99.9% reduction in infectious IHNV titers after a 7.5 
second exposure (Amend and Pietsch, 1972; Batts et al. 1991). A result of the 
sensitivity of IHNV to iodine is that now newly fertilized eggs are routinely treated in 
a dilute solution of iodine to reduce the risk of vertical transmission of IHNV. 
However, iodine treatment is not foolproof; fry hatched from iodine treated eggs and 
reared in virus free water can still succumb to IHNV infection, presumably by virus 
resident within the egg (Mulcahy and Pascho, 1985). 
A number of investigators in Japan have reported isolation of anti-IHNV 
substances from naturally occurring aquatic microbes. Yoshimizu et al. (1991) found 
that a peptide isolated from Psuedomonas fluorescens had a strong antiviral effect on 
IHNV. Hasobe and Saneyoshi (1985) reported that (S)-DHPA ( 9-(S)-(2,3­
dihydroxypropyl) adenine), Chloroquine, and Virazole had significant anti-IHNV 
activity using an in vitro cell culture assay. 
Control of IHNV by water treatment 
The elevation of water temperature has been suggested as a means of 
controling IHNV (Amend, 1970; Wingfield and Chen, 1970). Amend (1970) reported 
that infection of sockeye salmon with IHNV was prevented when fish were held in 
18° C water following infection at 150 C. However, it was also found that if infection 
was allowed to progress at 15° C for several days, followed by the transfer of the fish 
to 18° C water, the disease was exacerbated. Hetrick et al. (1979), also investigated 
the effect of temperature on IRN disease in fish, but they held the fish at the same 
temperature throughout the experiment. From these studies the authors concluded 
that there was not a significant benefit to elevated water temperature and pointed out 
that elevated water temperatures could potentiate pathogenic bacterial growth, and 
further, that elevating water temperatures in hatcheries is not economically feasible. 
Ozone and U.V. treatment of water has been shown to be an effective method 
of control of IHNV in vitro ( Wedemeyer et al., 1976). Yoshimizu et al. (1991) 
demonstrated that U.V. irradiation of river water resulted in a 95% decrease of 
cumulative mortality in IHNV-infected fish compared to control groups. However, 
irradiation of water has not been widely used due to the prohibitive cost. 12 
Vaccines 
Four types of vaccines have been developed to combat IHNV: Attenuated 
live virus (Fryer et al., 1976; Tebbit, 1976; Rohovec et al., 1981), killed virus (Amend, 
1976; Nishimura et al., 1985), subunit (Gilmore et al., 1988; Oberg et al., 1991), and 
purified IHNV glycoproteins ( Engelking and Leong, 1989a; Engelking and Leong. 
1989b). All of the vaccines types have been at least partially successful in conferring 
a protective immune response to vaccinated fish. 
Attenuated viral vaccine Fryer et al. (1976) reported the first attenuated viral 
vaccine developed for the control of IHNV. The attenuated virus was prepared by 
continual passage (34 or 41 serial passages) of virulent IHNV, obtained from rainbow 
trout, on steelhead trout embryo cells (STE 114). The serially passed virus had a 
100-fold reduction in virulence compared to the parental isolate. Either immersion or 
injection of sockeye and kokanee salmon fry with the vaccine resulted in greater than 
90% protection from a challenge with high doses of live virus. The vaccinated fish 
were shown to be protected from subsequent IHNV challenge for at least 110 days 
post injection (Tebbit, 1976). However, when rainbow trout fry were exposed to the 
attenuated vaccine approximately 20% of the fry died from the vaccine. Fryer et al. 
suspended further testing of the vaccine due to a lack of commercial interest and 
safety concerns. 
Killed viral vaccine There have been three reports of the use of inactivated 
IHNV as a vaccine (Amend, 1976; Nishimura et al., 1985; Naganawa et al., 1993). 
The report by Naganawa et al. (1993) is interesting in that it appears that formalin­
inactivated IHNV administered 24 hours prior to a viral challenge protects fish from 
IHNV. This finding is indicative of some form of nonspecific protective immune 
response. 
Amend et al. (1976) demonstrated that a 13propiolactone inactivated IHNV 
vaccine injected intraperitoneally into fish was extremely effective, conferring 
approximately 94% relative percent protection compared to the control unvaccinated 
fish. Nishimura et al. (1985) reported a similar result with a formalin inactivated 
IHNV vaccine injected intraperitoneally into fish. However, fish challenged with 13 
virus following immersion in formalin-inactivated IHNV resulted in 33% greater 
mortalities than the intraperitoneally vaccinated fish. While inactivated viral vaccines 
have proven efficacious, they have not been used, primarily due to the cost of the 
preparation and the possibility that viable, virulent virus remains in the preparation. 
Purified glycoprotein vaccine Engelking and Leong (1989a) demonstrated that 
vaccination of kokanee salmon and rainbow trout by inoculation or immersion with 
purified IHNV glycoprotein conferred up to as 84% relative percent survival 
following challenge with a homologous strain of IHNV. The same authors expanded 
on these studies by demonstrating that vaccination of fish with the IHNV type 1 
glycoprotein confers protection to five heterologous strains of IHNV (Engelking and 
Leong 1989b). 
Engelking and Leong (1989a) showed that virus neutralizing antiserum was 
generated in rabbits receiving the IEINV glycoprotein. Rabbits injected with gel 
purified IHNV nucleoprotein, or the matrix proteins, generated binding but not 
neutralizing antibodies to the respective proteins. Both Ristow et al. (1993) and 
LaPatra et al. (1993) have demonstrated that the humoral immune response of fish to 
IHNV is relatively restricted; the majority of anti -IHNV antibodies are against the 
glycoprotein and the matrix proteins. Thus, the purified IHNV glycoprotein is both 
an effective vaccine and possibly the only viral protein necessary for strong cross-
protective immune responses in fish against IHNV. 
Subunit vaccines Gilmore et al. (1988) developed an IHNV subunit vaccine by 
fusing a 329 base pair fragment from the IHNV glycoprotein cDNA with a trp-E 
bacterial expression vector. Immunization of rainbow trout and Chinook salmon by 
immersion in a crude bacterial lysate containing the trp -E glycoprotein fusion protein 
resulted in high degree of protection from a subsequent challenge with IHNV. Oberg 
et al. (1991) demonstrated that a bacterially expressed nucleoprotein subunit vaccine 
used in conjunction with the glycoprotein subunit vaccine resulted in an augmented 
protective immune response in fish. However, the nucleoprotein subunit vaccine used 
alone did not protect fish from a subsequent IHNV challenge. Currently, large scale 
preparation of the subunit vaccines are being undertaken and the efficacy of the 
vaccines is being tested in field trials. 14 
IHNV Molecular Biology 
Virion Morphology and composition 
Electron microscopic analysis of tissues of IHNV infected fish (Amend and 
Chambers, 1970a; Yamamoto and Clermont, 1990) and tissue culture cells (Amend 
and Chambers, 1970b), has revealed a bullet-shaped viral particle approximately 90 
nm in width and 160 nm in length. 
Features of the viral particle include a dense, ether-sensitive lipid and protein 
coat, protruding glycoprotein spikes, and an inner ribonucleoprotein complex 
composed of the viral RNA bound intimately with the nucleoprotein, matrix proteins, 
and RNA-dependent RNA polymerase. Hsu et al. (1985) have estimated that IHNV 
virions are composed of 43 polymerase, 166 glycoprotein, 766 nucleoprotein, 270 
matrix 1 protein, and 192 matrix 2 protein molecules. 
Genome and viral mRNA characteristics 
The nucleic acid of IHNV is a contiguous, single-stranded RNA of negative 
polarity (McCain et al., 1974; McCallister et al., 1974; Hill et al., 1975; Kurath and 
Leong, 1985). The genome molecular weight has been estimated to be 3.7 X 106 
daltons by electrophoretic separation on glyoxal gels (Kurath and Leong, 1985). The 
gene order, determined by R-loop mapping, is 3' N-M1-M2-G-NV-L 5' (Kurath et al, 
1985). The complete nucleotide sequence has been determined for the 1609 base 
glycoprotein gene (Koener et al, 1987) and the 1359 base nucleocapsid gene (Gilmore 
and Leong, 1988). 
Six viral mRNAs are synthesized in tissue culture infected cells as determined 
by glyoxal gel electrophoretic separation of 3 H- uridine- labeled polyadenylated viral 
mRNA (Kurath et al., 1985). The molecular weights of the mRNAs are: glycoprotein 
(G) mRNA, 5.6 X 105; nucleoprotein (N) mRNA, 4.8 X 105; matrix proteins one and 
two (M1, M2) mRNA, 3.0 X 105; and the non-virion (NV) mRNA, 1.9 X 105. The 
in vitro synthesis of mRNA from purified IHNV resulted in mRNA species which co­
migrated with viral mRNA isolated from tissue culture cells (Kurath and Leong, 1987) 15 
The molar ratio of the mRNAs produced intracellularly in tissue culture cells, 
normalized to the N mRNA are as follows: (G) mRNA, 0.49; (N) mRNA, 1.0; 
Mland M2 mRNA's, 2.52; and NV mRNA, 0.41 (Kurath and Leong, 1985). 
Proteins 
The virion of IHNV is composed of five virally encoded proteins (McCallister 
and Wagner, 1975, Hill, 1975). In tissue culture cells, there is an additional non-virion 
protein synthesized with a molecular weight of 12 kilodaltons (kd; Leong and Kurath, 
1985). The role of the NV protein is presently unknown. 
The virion-associated protein molecular weights are as follows: polymerase 
(L), 150 kd; G, 66-70 kd; N, 40-44 kd; Ml, 25 kd; and M2, 21 kd (Hsu et al., 1986). 
Hsu and colleges (1986) have classified IHNV into five types according to the 
electrophoretic profiles of the virion proteins. The typing has been valuable in 
analyzing the geographic distribution and virulence of IHNV. 
The 150 kd L protein is believed to be the primary component of the virion-
associated RNA-dependent RNA polymerase that replicates the viral genome, and 
transcribes the six mRNAs. 
The 66-70 kd G protrudes from the external lipid layer of the virion (Drolet et 
al., manuscript submitted). The protein is believed to be the protein responsible for 
attachment of the virion to an unidentified receptor on the cell. The G has been 
shown to be a glycoprotein by incorporation of 3 H- labeled glucosamine (McAllister 
and Wagner, 1975) and by enzymatic digestion (Engelking and Leong, 1989). The 
protein has a putative 20 amino acid signal sequence at its N terminus (Koener et al., 
1987). There is a hydrophobic segment at the carboxy terminus suggesting its 
association with the virion lipid membrane (Koener et al., 1987). 
Recently, four IHNV neutralization-resistant variants, that had been selected 
with a G-specific monoclonal antibody (Roberti et al., 1991), were analyzed for their 
virulence and pathogenicity in rainbow trout (Kim et al., 1994) in relation to the G 
amino acid (a.a.) sequence. Kim and colleagues (1994) showed that the variant RB-1 
was highly attenuated and predominately infected brain tissues. The analysis of the 
deduced a.a. sequence of RB-1's G showed a change of threonine to an isoluecine at 
a.a. 78 and glutamic acid to glycine at a.a. 218. The three other moderately attenuated 
viruses had an important change in the G a.a. sequence at position 276, glutamic acid 16 
to aspartic acid. Thus, there is a strong correlation of the primary structure of G with 
tissue tropism and virulence. 
The 40-44 kd N protein is believed to encapsulate the RNA genome. The 
carboxy terminal 57 amino acids are highly hydrophilic and contains a large number of 
arginines (Gilmore and Leong, 1988). This finding has been suggested as evidence that 
the carboxy terminus of N is involved in RNA binding. The N along with the M1 
protein were found to be phosphoproteins by the incorporation of 32P­
orthophosphate (McCallister and Wagner, 1975). The intracellular concentration of 
the N protein of VSV is postulated to play an important role in signaling the switch 
from transcription to replication of the viral genome (Banerjee 1983). 
Biochemical analysis of the IHNV 25 kd M1 and 21 kd M2 has not been 
reported for IHNV. It is believed that they play similar roles to their homologues in 
VSV and rabies virus. These include virus assembly and budding of the maturing 
virion from the cell as well as interacting with the RNA-dependent RNA polymerase. 
Recently, the matrix protein of VSV has also been found to mediate many of the 
cytotoxic effects induced by the virus including down regulation of cellular 
transcription and translation (Black et al., 1994). 
Genetic Immunization 
Overview 
Genetic immunization, or the use of antigen-encoding DNAs to vaccinate, is 
one of the newest approaches for the development of vaccines (Ulmer et al., 1993; 
Cox et al. 1993; Xiang et al., 1993; Montgomery et al., 1993; Fynan et al., 1993; Raz 
et al., 1994; Segedah et al., 1994). In essence, DNA transfection of somatic cells and 
resultant antigen expression approximates what the immune system sees following 
infection with a live virus. The result is that genetic immunization activates both a 
protective cellular and humoral immune response in vaccinated organisms. The 
cellular immune response is attributed to the capacity of endogenously synthesized 
antigens 
(viral or DNA encoded) processed through the cytoplasmic and endoplasmic 
reticulum to associate with major histocompatability class 1 molecules which in turn 17 
can be recognized by cytotoxic T lymphocytes (CTL) (Germain and Margulies, 
1993). Presumably, the humoral immune response is activated as a result of shedding 
of the DNA encoded antigen from the transfected cells or by lysis and release of the 
antigen by CTLs (Ulmer et al., 1993; Xiang et al. 1993). The free antigen is then able 
to activate MHC class 2-bearing cells (including B cells) that, in turn, produce antigen 
specific antibodies. 
A number of replicating and non-replicating viral vectors have been utilized for 
DNA vaccination including retroviruses (Brown et al., 1992; Irwin et al., 1994; Hunt 
et al., 1988), vaccinia virus (reviewed in Hruby, 1993), adenoviurses (Prevec et al., 
1991; Graham and Prevec, 1992), fowlpox virus (Baxby and Paoletti, 1992) and 
adeno-associated virus (Muzyczka, 1992). Drawbacks to these viral vectors are the 
risk of associated pathology due to the viral component of the vaccine, and more 
specifically the fact that none of the vectors mentioned have been shown to infect or 
replicate in fish. The alternative to viral vectors is the use of naked plasmid DNA for 
genetic immunization. Plasmid DNA as a vaccine has the benefit of being non­
infectious agent, requires no assembly of virus particles and very importantly, 
expression of genes contained in plasmid DNA has been observed following direct 
injection into fish (Hansen et al., 1991; Rahman and McClean, 1992). 
The use of plasmid DNA-based vaccines requires an understanding of gene 
expression following the direct introduction of DNA into somatic cells. This includes 
identifying efficient DNA delivery methods, strong promoters, the duration of gene 
expression, the fate of the injected DNA, and the sites of gene expression. The 
following section will deal with factors that govern gene expression by direct DNA 
injection and a review of current DNA vaccines. 
Transgene expression in somatic cells 
DNA delivery Two general methods have been used to introduce DNA into 
somatic cells for vaccination: direct injection using a needle and syringe (Wolf et al., 
1990), and DNA bombardment using a gene gun (Tang et al., 1992). A third method 
which has been proposed but has yet to be used for vaccination is DNA encapsulated 
in liposomes delivered either by injection or aerosol delivery (Feigner et al., 1987). Of 
the three methods the simplest and most commonly used for DNA vaccination is the 
direct injection DNA into striated muscle tissue. 18 
DNA entry into somatic cells The mode of DNA entry into somatic cells 
following DNA particle bombardment and DNA/liposomes inoculation is relatively 
straight forward. The gene gun delivery method transfers DNA directly into somatic 
cells by passing "DNA bullets" through the cell membranes (Cheng et al., 1993; Yang 
et al., 1993). The entry of DNA/lipid complex is believed to be mediated by fusion of 
the lipid/DNA vesicle with the cellular membrane followed by release ofthe DNA 
into the cytoplasm (Feigner et al., 1987; Zhu et al., 1993). 
The mechanism of DNA entry into muscle cells following injection with a 
needle and syringe is unclear. Wolf et al. (1990) suggested that the injected DNA may 
enter muscle cells by combining with calcium ions which influx when muscle cells 
contract. However, Wolff et al. (1991) demonstrated that including calcium chelators 
along with the injected DNA solution, electrically stimulating muscle contraction, and 
denervation of muscle cells, had a minimal impact on gene expression. Physical 
disruption of cell membranes by needle penetration, uptake of the injected DNA, and 
subsequent patching of the damaged membrane has also been suggested as method of 
DNA entry into muscle cells (Wolf et al., 1991). However, Davis et al. (1993) found 
that muscle cells damaged by the needle during injection did not express the transgene 
DNA. Thus, the mode of entry into muscle cells remains unknown. 
Sites of gene expression Striated muscle cells have been considered the only 
tissues capable of taking up and expressing genes that are transferred by direct 
injection of plasmid DNA (Davis et al. 1993). However, Fynan et al. (1993) have 
shown that mice vaccinated with an influenza virus hemagglutinin plasmid by topical 
administration intranasally, or by intravenous, intradermal, and subcutaneous 
injection, resulted in significant protection from viral challenge. Thus it appears that 
many tissues can take up and express plasmid DNA. Unfortunately, Fynan et al. 
(1993) did not show any data on the levels of gene expression in the various tissues 
following delivery. Raz et al. (1994) clearly demonstrated that plasmid DNA injected 
into mice intradermally resulted in expression in keratinocytes, fibroblasts, and 
dendritic cells. In rats, intraperitoneal injection of calcium phosphate-precipitated 
DNA results in rapid uptake and expression of the genes in the intestine, lung, spleen, 
kidney, and heart (Bevenisty and Reshef, 1986). Injection of DNA directly into rat 
hearts has also been shown to result in efficient gene expression (Kitis et al., 1991). 
Thus, numerous tissues can efficiently be transfected following direct DNA injection 19 
and the notion that striated muscle are the only tissues capable of taking up and 
expressing DNA should be dismissed. 
Transgene expression in numerous tissues has been reported following DNA 
bombardment with a gene gun (Cheng et al., 1993; Yang et al., 1993). The only 
limitation of the sites of gene expression following particle bombardment appears to 
be those tissues which cannot be exposed to the gene gun by surgery. 
Intravenous injection of lipid/DNA complexes into mice results in transfection 
of virtually all tissues (Zhu et al., 1993). Aerosol delivery of DNA/lipid complexes to 
the lungs may be a powerful tool for vaccination against pathogens such as influenza 
virus which enter organisms via the lungs; however, no reports have been published 
on this approach to date. 
Promoter analysis A wide variety of promoters have been used to express 
genes following the direct injection of naked DNA and DNA/lipid complexes or gene 
gun delivery of DNA: these include 1) viral promoters, 2) hormone, heavy metal, and 
virus inducible promoters, 3) and constitutive cellular promoters, from both mammals 
and fish. A review of the current literature indicates that the cytomegalovirus 
immediate early enhancer/promoter (CMV MP) consistently provides the greatest 
level of reporter gene expression in all tissues examined. It is important to note that 
the expression of transgenes in striated muscle cells following direct DNA injection is 
promoter dependent. For instance, the mouse mammary tumor virus LTR promoter 
expresses poorly in muscle tissue (Yang et al., 1993). 
Duration of gene expression and fate of the DNA A suprising feature of 
transgene expression following delivery to somatic cells by direct DNA injection, 
DNA/lipid complex injection, and DNA particle bombardment, is the long-lived gene 
expression. Wolf et al. (1990) showed that high levels of gene expression were 
recovered from injected mouse muscle tissues for two months. In addition the same 
authors found that the half-life of the reporter mRNA (luciferase) and protein in 
mouse muscle was less than 24 hours. Thus, the long-lived reporter protein activity 
in mouse muscle tissue was the result of continuous gene expression from the injected 
plasmid DNA. Zhu et al. (1993) found that a single intravenous injection of a 
DNA/lipid complex resulted in high reporter gene expression in multiple tissues for at 20 
least 9 weeks. Cheng et al. (1993) reported sustained gene expression in mouse 
dermis for 1.5 years following gene gun delivery of reporter transgenes. However, in 
tilapia fish injected intramuscularly with a reporter transgene plasmid, reporter 
protein activity could be detected only two days post injection (Rahman and 
McClean, 1992). This is not the case for carp, in which reporter protein activity 
could be detected at least four days after plasmid DNA injection (the last time tested; 
Hansen et al., 1991). 
Wolff et al. (1990) found that DNA recovered from injected muscle tissues 
two months post injection persisted as a circular, unreplicated plasmid. However, 
during the first three days post injection, the DNA was heavily degraded, and then 
degradation ceased (Wolff et al., 1991). Liposome-encapsulated DNA delivered 
intravenously into mice also persists as a circular, unreplicated plasmid for at least 21 
days post administration. There have not been any reports of the fate of transgene 
DNA following delivery with a gene gun. 
DNA vaccines 
Overview The use of vaccines composed of antigen-encoding naked plasmid 
DNA and antigen-encoding-retroviral vectors is summarized in Table 2.1. Tang et al. 
(1992) was the first group to show that naked DNA encoding an antigen (human 
growth hormone), when introduced into mouse somatic cells, could express the 
encoded antigen and subsequently evoke an immune response. Ulmer et al. (1993) 
was the first group to report that DNA vaccines could be used to protect animals 
(mice) from a subsequent challenge with a pathogen (influenza virus). To date, naked 
DNA vaccines have been employed to combat the disease produced by, influenza 
virus (Fynan et al., 1993 a, b; Montgomery et al., 1993; Ulmer et al., 1993; 
Yankauckas et al., 1993; Raz et al., 1994), rabies virus, (Xiang et al., 1994), human 
immunodeficiency virus (HIV) (Wang et al., 1993 a, b), bovine herpesvirus (Cox et al., 
1993), and malaria (Sedegah et al., 1994). 
Although numerous DNA vaccines have been developed, they all share some 
common properties. All of the DNA based vaccines reported to date elicit both 
cellular and humoral immune responses. The magnitude of the immune response to 
the expressed antigen is dependent on the amount of the DNA injected. The route of 
vaccine delivery has a profound effect on the extent of the immune response Table 2.1  Compilation of results concerning genetic immunization 
Pathogen  Animal  Deliveryl 
DNA Vaccine 
Gene2  Promoter3 
immune Response 
Humoral  Cellular  Protection  Reiff 
Influenza 
Influenza 
Influenza 
Influenza 
mouse 
mouse 
mouse 
chicken 
IM 
ID 
IM 
IM 
NP 
NP 
NP 
NP 
CMV 
CMV 
RSV 
RSV 
ALV 
+ + 
+ + + + 
+ + + 
+ + + + 
+ 
+ + + + 
+ + + + 
n.d. 
+ + + + 
n.d. 
+ + + 
+ + 
n.d. 
n.d 
0 
1 
2 
3 
4 
Influenza 
Influenza 
Influenza 
Influenza 
mouse 
mouse 
chicken 
chickens 
IM 
IM 
IV 
IN 
SC 
IP 
gene gun 
IM 
IT 
IB 
I0 
IM 
NP 
HA 
HA 
HA 
HA 
CMV 
CMV 
CMV 
ALV 
n.d 
n.d. 
0 
0 
+ 
n.d. 
n.d. 
+ 
n.d. 
n.d. 
n.d. 
n.d. 
+ 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
+ + + 
+ + + + 
+ + + + 
+ + + 
+ + 
+ + 
0 
+ + + + 
+ + 
+ + 
+ 
+ 
++++ 
5 
6 
6 
7 
HIV 
HIV 
HIV 
mice 
macaques 
mice 
IM 
1M 
IM 
gp160 
tat 
rev 
gp41 
env/rev 
MMTV 
MMTV 
CMV 
+ + + 
+ + + 
+ + + 
+ + + + 
+ + + + 
n.d. 
n.d. 
n.d. 
n.d. 
+ + + + 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
8 
8 
9 Table 2.1 (Continued) 
DNA Vaccine  Immune Response 
Pathogen  Animal  Delivery 1  Genet  Promoter3  Humoral  Cellular  Protection  Ref' 
HIV  baboon  IM  env/rev  CMV  + + + +  + + + +  n.d.  9 
Rabies  mouse  IM  G  SV40  + + + +  + + + +  + + + +  10 
Bovine  mouse  IM  G  RSV  + + + +  n.d.  n.d.  11 
Herpes 
Bovine  cow  IM  G  RSV  + + +  + ++  11 
Herpes 
+ + Malaria  mouse  IM  G  CMV  + + +  + +  12 
1IM, intramuscular; ID, intradermal; IV, intravenous; IN, intranasal; SC, subcutaneous; IT, intratracheal IB, intrabursal
 
2 NP, nucleoprotein; HA, hemagluttinin; G, glycoprotein
 
3 CMV, cytomegalovirus; RSV, rous sarcoma virus; ALV, avian leukosis virus; MMTV, mouse mammary tumor virus
 
4 1-(Ulmer et al., 1993); 2-(Raz et al., 1994); 3-(Yankauckas et al., 1993); 4-(Brown et al., 1988); 5-(Montgomery et al., 1993);
 
6-(Fynan et al., 1993); 7-(Hunt et al., 1988); 8-(Wang et al., 1993); 9-(Irwin et al., 1994); 10-(Xiang et al., 1994);
 
11-(Cox et al., 1993); 12 (Sedegah et al., 1994)
 
n.d., not done
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generated, and the amount of DNA vaccine required. Those DNA vaccines which 
have been tested for their ability to protect animals from a viral challenge have proven 
efficacious: protection has ranged from 50-100% compared to negative control 
groups. 
Protection conferred by DNA vaccines Immunization of mice with a influenza 
nucleoprotein (inf vNP)-encoding plasmid DNA vaccine (pDNAv) resulted in 50% 
(intradermal injection; Raz et al., 1994) to 100% (intramuscular injection; Ulmer et al., 
1993) protection from a lethal dose of influenza virus. Mice vaccinated 
intramuscularly with the inf vNP pDNAv were also protected from heterologous 
strains of influenza virus (Ulmer et al., 1993, Montgomery et al., 1994). 
Intramuscular immunization of mice (Montgomery et al., 1993; Fynan et al, 1993) and 
chickens (Fynan et al., 1993) with an influenza virus hemagglutinin (inf vHA) 
encoding pDNAv resulted in 95-100% and 63% protection respectively, against a 
lethal dose of influenza virus. Fynan et al. (1993) demonstrated that the site of 
delivery of the injected inf vHA pDNAv influenced the degree of relative protection 
from a challenge with influenza virus (see Table 1.). 
Immunization of mice with a rabies virus glycoprotein (rvG)-encoding 
pDNAv conferred 100% protection from a challenge with lethal dose of rabies virus 
(Xiang et al., 1993). A bovine herpesvirus glycoprotein (bhv G)-encoding pDNAv 
successfully protected cows from a subsequent bovine herpesvirus viral challenge 
(Cox et al., 1993). Immunization of mice with a malaria glycoprotein (G) encoding 
pDNAv resulted in a 84.5% reduction of shizonts in the liver (Segedah et al., 1994). 
In addition, the malaria G pDNAv protected 54% of the immunized mice from blood 
stage sporozoite infection. 
Cellular immune response The first report of genetic immunization by Ulmer 
et al. (1993) demonstrated that mice vaccinated intramuscularly with an inf v NP 
pDNAv generated both an inf vNP specific humoral and cellular immune response. 
While the vaccinated mice had high concentrations of anti-inf vNP antibodies, the 
antibodies were not neutralizing. The authors suggested that protection from 
influenza virus was mediated by a cellular immune response. This result is similar to 
that of Segedah et al. (1994) who used a malaria G pDNAv for which a CD8+ CTL 24 
response was found to be the primary protective immune response induced by 
intramuscular pDNAv immunization (Segedah et al., 1994). A CD8+ restricted 
cytotoxic immune response has also been reported following intramuscular 
immunization with rvG pDNAv, but the contribution of the cellular immune response 
in relation to the protective immunity was not determined (Xiang et al., 1993). 
Additionally, Xiang et al. (1994) found that the rvG pDNAv DNA  vaccine generated 
a T-helper type 1(Thi ) immune response in mice and that the Th2 subset did not 
contribute to the protective immune response. 
In general, the cellular immune response can be enhanced by increasing the 
dose and the number of boosts of the pDNAv. Xiang et al. (1994) found that 
generation of a T-cytotoxic immune response in mice following intramuscular 
immunization with a rvG pDNAv required a minimum of two 10 p.g boosts. Xiang et 
al. (1994) also found that increasing the dose of the ry G pDNAv from 10 lig to 250 
pg resulted in a three-fold increase in CTL activity.  Interestingly, mice immunized 
intramuscularly with as little as 10 pg of a inf v NP pDNAv generated anti-NP CD8+ 
CTL activity roughly equal to mice immunized with 600 p.g of inf v NP pDNAv 
when measured one year after vaccination (Yankauckas et al., 1993). However, 
increasing the dose of the inf v NP pDNAv  (10 lig to 60014) increased the number of 
mice which had high levels of inf v NP-specific CTL activity one year post­
vaccination (Yankauckas et al., 1993). Yankauckas et al. (1994) was the first group to 
show that the cellular immune response was long-lasting (13 months) following 
pDNAv immunization; they also found that the NP-specific CTL response one year 
post inoculation was similar to the levels reached by three weeks post inoculation. 
It is clear that increasing the dose and number of boost ofpDNAv enhances 
the cellular immune response. However, even a single low dose of pDNAv results in 
a long lasting immune response. What is not clear is whether or not increasing the 
cellular immune response by inoculating high doses ofpDNAv and increasing the 
number of boosts of pDNAv is  necessary to generate a protective immune response. 
It may be that a single low dose inoculation of pDNAv is sufficient to induce long 
lasting protective cellular immunity. 
Humoral immune response Like the cellular immune response, the humoral 
immune response is dependent upon the dose and number of boosts of the pDNAv. 
However, it generally requires less pDNAvto generate a humoral immune response 25 
than it does a cellular immune response. The humoral immune response has also been 
found to be dependent on the site of vaccine delivery. Unfortunately, the effect of the 
site of delivery of DNA vaccines on the cellular immune response has not been 
reported. 
Wang et al.(1993) found that an inoculation of 4 boosts consisting of 100 lig 
each of a HIV gp160 (membrane bound-envelope glycoprotein) pDNAv was required 
to seroconvert 90% of mice receiving the pDNAv. Xiang et al. (1994) found that the 
induction of rabies-virus-neutralizing antibodies increased proportionally to the 
number of boost (one to three) of 150 gig of ry G pDNAv. Segedah et al. (1994) also 
found a similar increase in malaria-neutralizing antibodies following boosting of mice 
with a malaria G pDNAv. They also found that increasing the number of malaria G 
pDNAv boosts from three to four resulted in a decrease in mouse-malaria-specific 
antibodies. This last finding is the first report of the potential induction of 
immunotolerance by repeated boosting with a pDNAv. Cox et al. (1993) found that 
there was no correlation between the level of neutralizing antibodies induced by 
inoculation of cows with a bhv G pDNAv and the generation of a protective immune 
response. This finding suggests that the cellular immune response to the bhv G 
pDNAv  plays an important role in neutralizing the herpes virus. 
Raz et al (1994) were the first group to report that the site of pDNAv 
delivery by direct injection has a profound effect on the quantity of vaccine required 
to elicit a long term immune response. Intradermal immunization with as little as 0.3 
lig of infvNP pDNAv  generated a specific NP antibody response for 70 weeks post 
vaccination. Immunohistochemical analysis with anti-NP antibodies revealed that 
intradermal vaccination results in gene expression in keratinocytes, fibroblasts, and 
dendritic cells of the skin. In addition the immune response was dependent on the 
promoter driving expression of the infvNP protein; plasmids containing the inf vNP 
downstream of the CMV IEP resulted in the strongest immune response (Raz et al. 
1994; Montgomery et al., 1993). Gene-gun particle bombardment of mouse dermal 
cells with as little as 0.1 pg of human growth hormone also generates a strong humoral 
immune response (Tang et al., 1992; Eisenbraun et al, 1993). Gene-gun immunization 
of mice with an inf vHA pDNAv required 2500 times less pDNAv to generate a 
humoral response compared to direct intramuscular DNA injection (Fynan et al., 
1993). Thus, the site and method of pDNAv delivery has a dramatic impact on the 
immune response. Further investigations should lead to more efficient and practical 
methods of immunization using pDNAv, making possible the large scale vaccination 
of fish in farming facilities. 26 
Intracellular Immunization 
Overview 
Cellular expression of endogenously synthesized (genetically engineered) viral 
RNA in either the sense or antisense orientation can interfere with the life cycle of 
viruses (reviewed in: Inouye, 1988; van der Krol et al, 1988; Helene and Toulme, 
1990; Takayama and Inouye, 1990) . Interference can occur at a number of steps 
during the virus life cycle, thus defining a broad unifying mode of action of the 
interfering RNA is not possible. There have been reports of transgene interference 
occurring at the level of replication, transcription, translation, RNA processing 
(reviewed in Takayama and Inouye, 1990), virion uncoating, (Register and Beachy, 
1988; Reimann- Phillip and Beachy, 1993; Okuno et al., 1993), virus spread 
(Wisniewski et al., 1990), cell binding (Federspiel et al., 1989), and trans-dominant 
viral protein interference (Malim et al., 1989; Trono et al., 1989; Bevec et al., 1992; 
Meiluer et al., 1990; Bahner et al., 1993,). Viral RNA can be degraded by 
endogenously synthesized ribozymes (Ojwang et al., 1992; Taylor et al., 1992; Chen 
et al., 1992; Dropulic et al., 1992; Xing et al., 1992; Dropulic and Jeang, 1993; Xing et 
al., 1993). In addition, transgene RNA can serve as decoy sequences acting as a viral 
protein sponge (Sullenger et al., 1991; Lee et al., 1992; Lisziewicz et al., 1993). 
Finally, nucleic acid oligonucleotides can be targeted to specific viral nucleic acid 
sequences disrupting replication, transcription, translation, or RNA processing 
(Reviewed in Stein and Cohen, 1988; Crooke, 1992). Therapies based upon the sense 
and antisense strategy have been broadly categorized as inducing a state of 
intracellular immunity (Baltimore, 1988). 
In this review, inhibition of the life cycle of animal viruses, and in specific 
instances plant viruses, by endogenously synthesized RNA will be addressed.  Also, 
reports concerning the inhibition of the rhabdovirus vesicular stomatitis virus by 
oligonucleotides will be included. 27 
Mechanisms of sense and antisense RNA interference 
The multiple modes of action of natural antisense RNAs in prokaryotes have 
been demonstrated to be due to hybridization between the antisense RNA and its 
target nucleic acid sequence (RNA or DNA; reviewed in Inouye, 1988; Takayama and 
Inouye, 1990). In eukaryotes it has also been hypothesized that the mode of action 
of artificial antisense RNA upon cellular and viral gene expression involves in vivo 
hybridization between the antisense RNA and its target sequence. But, other than the 
nuclease degradation of duplex RNA (which will be reviewed), there have not been 
any reports concerning the precise mechanism of action of interfering RNAs with 
animal viruses in vivo. Recently, Helene and Toulme (1990) summarized the current 
information available concerning interference of cellular (eukaryotic) genes by 
antisense RNA. Inhibition begins with putative duplex formation. The duplexes are 
then either degraded by nucleases, chemically inactivated by "unwindases" (which 
have not been characterized), trapped in the nucleus or, unable to be translated by 
ribosomes. Presumably, any one, or combination of these mechanisms, is involved in 
viral interference. 
There have been only two reports which have identified duplex formation 
between an antisense RNA and its target in eukaryotic cells (Kim and Wold, 1985; 
Yokoyama and Imamoto, 1987). The authors showed, using an RNAase protection 
assay, that at least 95% of the RNA duplexes between an antisense thymidine kinase 
(TK) RNA and its complementary sense target are confined to the nucleus. Kim and 
Wold (1985) suggested that the duplexes formed in the nucleus inhibited export of the 
mRNA to the cytoplasm, accounting for the 90% reduction in cellular TK activity 
observed. 
Indirect evidence of hybrid formation has been reported (Crowley et al., 1985; 
Kasid et al. 1989). In these studies, interference by the transgene RNA could be 
detected by a biological assay (measuring the effects of discoidin or Myc gene 
expression on cell morphology or growth, respectively) but the interfering RNA could 
not be detected by Northern blotting. The authors concluded that duplexes between 
the interfering RNA and the target sequence were formed in the nucleus and were then 
rapidly degraded by specific double-stranded RNAases. Chatterjee et al. (1992) 
found that HIV type 1 mRNA was not detectable by Northern blotting in HIV-
infected cells expressing antisense RNA complementary to the viral LTR. However, 
in this case, prior to HIV infection the antisense RNA could be detected by Northern 28 
blotting. Again, it was concluded that a duplex formed between the mRNA and the 
antisense RNA was targeted for degradation by cellular RNAases. 
The extent to which viral gene expression can be inhibited by a particular 
antisense or sense sequence is believed to ultimately depend upon the length and 
accessibility of the interfering RNA, the availability of the target mRNA, and the 
ability of the interfering RNA and its target to form duplexes (Shierczinger and 
Knecht, 1993). Systematic analyses of antisense RNA inhibition of gene expression 
dependent upon the target site (Kim and Wold, 1985; Chang and Stoltzfus, 1985; 
Izant and Weintraub, 1985; Rhodes and James, 1990; Rittner and Sczakiel, 1991; 
Shierczinger and Knecht, 1993 ) and hybridization kinetics (Rittner et al., 1993) have 
been reported. The result of these studies are contradictory. For instance, Izant and 
Weintraub (1985) found that the greatest inhibition of thymidine kinase (TK) 
expression occurred with antisense RNA complementary to the 5'-untranslated region 
of the TK mRNA. In contrast, Shierczinger and Knecht (1993) found that myosin 
heavy-chain (MHC) gene expression was inhibited to the greatest extent by antisense 
RNA complementary to the 3'-portion of the MHC gene; 5c-complementary antisense 
RNA did not inhibit MHC gene expression. Rittner and Sczakiel (1991) found that of 
ten antisense RNAs complementary to HIV mRNA, two interfering RNAs 
complementary to distinct viral mRNAs most effectively inhibited HIV replication. 
Rittner et al. (1993) found that three of three fast-hybridizing antisense-RNAs 
specific to the HIV tat and rev coding regions inhibited viral replication. However, the 
authors also found that one of three slow-hybridizing, antisense-RNAs 
complementary to the same HIV sequence inhibited viral replication to the same 
degree as the fast-hybridizing RNA. Thus, it may be that the choice of target sites 
and hybridization kinetics of an antisense RNA is particular to the system being 
evaluated. 
The quantity of endogenously synthesized antisense RNA necessary to 
inhibit viral or cellular genes is a controversial issue. It has been suggested that, in 
general, antisense or sense RNA must be present in excess of the target mRNA to 
exert an effect (van der Kroll et al., 1988; Helene and Toulme, 1990). This is 
illustrated by Kim and Wold (1985) who found that antisense TK RNA only 
inhibited TK activity when the antisense expressing plasmid (containing the 
dihydrofolate reductase gene) was amplified by increasing concentrations of 
methotrexate, which concomitantly increased the quantity of cellular antisense RNA 
300-fold. On the other hand, Rhodes and James (1990) found that there was no 
correlation between the abundance of a HIV antisense RNA in the cell and the degree 29 
of HIV inhibition. The strongest evidence against the need for a large excess of 
interfering sense or antisense RNA comes from studies using plant viruses (reviewed 
in Lindbo et al., 1993). Dougherty et al. (1994) compared the amount of =translated 
potyvirus coat protein (CP) RNA levels in CP expressing transgenic plants with the 
degree of plant viral resistance. The authors found that plants expressing relatively 
low levels of cytoplasmic CP RNA were consistently more resistant to the virus than 
plants with high levels of CP RNA expression. However, the authors found that 
nuclear levels of the interfering RNA in the resistant plants was relatively high. 
Again, this is an example of the complexity of sense and antisense RNA interference 
with viruses and cellular genes, and suggest that each virus or cellular gene may 
respond to the interfering RNA differently. 
Antisense and sense RNAs and have been shown to suppress viral protein 
synthesis (Chaterjee et al., 1992; Rhodes and James 1990;Sczalciel et al., 1990; 
Sczakiel et al., 1992; Joshi et al., 1991; Rittner et al., 1991; plant viruses are reviewed 
in Beachy, 1993). Studies demonstrating that oligonucleotides complementary to the 
rhabdovirus vesicular stomatitis virus (VSV) mRNAs down-regulate viral protein 
synthesis. Agris et al. (1986) found that oligodeoxyribonucleoside 
methylphosphonates complementary to the initiation codon regions of the VSV N, 
NS, and G mRNAs inhibited viral protein synthesis in mouse L cells. Synthesis of all 
five viral proteins were inhibited by the oligonucleotides; the G oligonucleotide 
inhibited total viral protein synthesis by 90%, the N oligonucleotide by 70%, and the 
NS oligonucleotide by 40%. Interestingly, the oligonucleotides did not inhibit protein 
synthesis corresponding to there specificity to for a specific mRNA sequence. The 
complete inhibition of viral protein synthesis was attributed to duplex formation of a 
viral mRNA with a complementary oligo resulting in blockage of translation of the 
duplex, causing a viral protein deficit which, assuming each protein has an 
interconnected function, abrogated further viral protein synthesis. Leonetti et al. 
(1987) showed that poly-(L-lysine)-conjugated oligos complementary to the 
initiation codon of N mRNA, inhibited N protein synthesis by 90%. Leonetti et al. 
also found that oligos complementary to internal sequences of the N gene did not 
inhibit viral synthesis, demonstrating the importance of choosing the appropriate 
target site. 30 
Protein interference 
Intracellular expression of functional viral proteins can inhibit virus 
replication. The majority of reports of protein mediated interference for animal 
viruses come from studies using HIV (Malim et al., 1989; Trono et al., 1989; Mermer 
et al., 1990; Sczakiel et al., 1990; Bevec et al., 1992; Bahner et al., 1993). In these 
studies, expression of mutant Tat or Rev proteins interfered with the wild-type 
protein resulting in interference with HIV replication. This type of interference 
requires that the mutant protein be trans-dominant and be either oligomeric or capable 
of saturating the target site, presumably so that it can interfere with the wild-type 
protein functions. Balmer et al. (1993) culminated the work with the trans-dominant 
Tat and Rev-mediated inhibition of HIV replication by side-by-side comparison of the 
two mutant proteins inhibitory effect on HIV replication. The mutant Rev protein 
consistently inhibited HIV infection while the mutant Tat protein actually produced 
mild trans-activation. Interestingly, intracellular expression of both Tat and Rev 
mutant proteins inhibited reporter gene activity (the reporter gene was linked to a Tat 
or Rev responsive sequence) in a transient assay. This last point is another example 
of the variable conclusions which can be drawn regarding the effectiveness of 
strategies of intracellular immunization according to the system being utilized. 
Federspiel et al. (1989) found that the expression of avian reticuloedotheliosis 
virus envelope protein (which serves as a receptor for cell attachment) protected the 
cells from a subsequent viral challenge. The authors hypothesized that the envelope 
protein blocked cell surface receptors inhibiting virus entry into the cell. However, 
there was not direct evidence to support the hypothesis. 
Carr and Zaitlin (1993) has reviewed reports concerning the viral resistance of 
transgenic plants expressing replicases of plant viruses. It is hypothesized that the 
transgene replicase interferes with the wild-type viral replicase. However, the precise 
mechanism of interference is unknown. Further, it is not certain whether the replicase 
protein of mRNA causes viral interference since in a few cases the interfering protein 
could not be detected in viral resistant transgenic (replicase) plants (Braun and 
Hemenway, 1992; Golemboski et al., 1990). 
Transgenic plants expressing CP genes have been shown to be resistant to viral 
infection (reviewed in Reimarm-Phillip and Beachy, 1993; Lindbo et al., 1993; 
Gonsalves and Slightom, 1993). The CP is believed to inhibit an early step in the viral 
life cycle, such as virion uncoating. However, as is the case for replicase-mediated 31 
viral resistance, it is not clear whether the CP mRNA or protein mediates viral 
resistance. Powell et al. (1990) found that transgenic tobacco plants which synthesize 
an untranslatable tobacco mosaic virus (TMV) CP mRNA are not resistant to TMV 
infection; viral resistance required expression of the TMV CP. On the other hand, it 
has been shown that transgenic plants synthesizing both translated and untranslated 
tobacco etch (TEV) virus CP mRNA are resistant to viral infection (Lindbo and 
Dougherty, 1992a; Lindbo and Dougherty 1992b). In this case, the authors 
hypothesized that the TEV RNA caused viral resistance by duplex formation with 
viral RNA or, alternatively, induction of an undefined plant mediated immunity. 
Intracellular immunity to viruses 
A list of eukaryotic cellular and viral genes inhibited by artificial sense and 
antisense genes for which expression data were available showed inhibitionranging 
from 0 to 99% (van der Kroll et al., 1988). The variability of inhibition is likely due 
to different assay systems, gene target sequences, and the type of interfering RNA, all 
of which complicate comparison between studies. An example of this comesfrom 
studies by Sczakiel et a1.(1990) and Sczakiel and Pawlita (1990). Sczakiel et al. 
(1990) found that microinjection of epitheleiod cells with plasmid DNA encoding a 
410 by HIV leader-gag sequence in the sense or antisense orientation along with an 
infectious HIV clone (at a ratio of 5:1, respectively) reduced the load of HIV antigen 
produced by 70%. However, when the same HIV sense and antisense plasmids were 
stably introduced into human T cells and subsequently challenged with HIV, the cell 
lines containing plasmid DNA in the sense orientation produced the same HIV antigen 
levels as the control cells. The cell lines containing the antisense plasmid were HIV 
resistant. The differential behavior of the sense-encoding plasmid was attributed to 
the different test assays employed. 
Degree of intracellular immunity A recurrent theme, using animal virus model 
systems, is the incomplete inhibition of viral replication by interfering sense and 
antisense RNA, proteins and oligonucleotides (Chang et al., 1985; Agris et al., 1986; 
Lemaitre et al., 1987; Leonetti et al., 1988; Rhodes and James, 1990; Sczakiel et al., 
1990; Joshi et al., 1991; Rittner and Sczakiel, 1991; Sczakiel and Pawlita, 1991; 32 
Sczakiel et al., 1992; Lisziewicz et al., 1992; Sullivan et al., 1992; Rittner et al., 1993; 
Junker et al., 1994). One explanation for incomplete inhibition of viral replication is 
that the interfering RNA or protein is eventually overwhelmed (saturated) by its 
complementary viral RNA. This is supported by the fact that interfering RNA and 
trans-dominant proteins have been found to nearly abolish HIV replication for a 
period of 10-14 days post infection but thereafter HIV replication rises to the same 
levels as it does in control cells (Rhodes and James, 1990; Sczakiel and Pawlita, 1991; 
Sczakiel et al., 1992; Balmer et al., 1993). Further, the level of interfering RNA in 
cells in which HIV had escaped inhibition remained unchanged, indicating that the viral 
escape did not result from an inhibition of synthesis of the interfering RNA (Sczakiel 
and Pawlita, 1991). Finally, a number of reports have shown that when a high 
infective doses of virus is used to infect otherwise intracellular immune cells (when 
using a low virus infective doses), viral replication is not inhibited (Beachy, 1993) 
Another explanation for incomplete viral interference is that not all cells, even 
though in many cases they are clonal cell lines, express the interfering RNA or 
protein. Federspiel et al. (1989), found that D17 cell lines (canine cells) expressing 
the reticuloedotheliosis virus (REV) envelope protein were 25,000-fold more resistant 
to REV infection than control cells. The authors found that the high degree of REV 
resistance was dependent upon the uniformity of expression of the REV envelope 
protein by the cells, but not dependent upon the overall expression level of the 
envelope protein by the cells. Other than the report by Federspiel et al. (1989), there 
have not been any reports characterizing the uniformity of expression of interfering 
RNA or proteins in animal cell culture. 
Oligonucleotides complementary to VSV mRNA inhibit but do not completely 
abolish VSV replication. Further, the degree of inhibition appears temporal and is 
target dependent. Agris et al. (1986) found that oligodeoxyribonucleoside 
methylphosphonates complementary to VSV N, NS, and G mRNA reduced the titer 
of VSV in infected cells by 1.08, 0.52, and 1.18 logs, respectively, six hours post 
infection. However, by 24 hours post infection the oligonucleotides reduced VSV 
titers by a half that found at the 6 hour time point. Both Lemaitre et al. (1987) and 
Leonetti et al. (1988) found that poly(L-lysine)-conjugated oligodeoxyribonucleotides 
complementary to the initiation codon of the VSV N mRNA reduced VSV titers in 
infected cells by roughly 21/2 logs compared to a non-specific oligonucleotide. Both 
groups also found that oligonucleotides complementary to internal regions of the VSV 
N mRNA did not inhibit viral titers in VSV infected cells. Leonetti et al. (1988) also 33 
found that an oligonucleotide complementary to a conserved intergenic sequence of 
the VSV viral genome inhibited viral titers in VSV infected cells by 2 logs. 34 
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Abstract 
Expression of the firefly luciferease gene under the control of viral or fish 
promoters were observed in fish tissue after direct DNA injection of plasmid DNA. 
Plasmid DNA containing the firefly luciferase gene was injected into the skeletal 
muscle of rainbow trout (Oncorhynchus mykiss) and levels of luciferase activity were 
found to be dependent on the controlling promoter and the amount of injected DNA. 
Plasmids using the cytomegalovirus immediate early enhancer/promoter (CMV-IEP) 
consistently produced the highest levels of luciferase activity. Maximal activity was 
observed 5-7 days postinjection with 50 gg of DNA. This activity persisted in the 
tissues for as long as 115 days postinjection. When the DNA was examined up to 
two months postinjection, the predominant form was unreplicated, unintegrated DNA 
in linear or relaxed circular conformation. Expression of injected DNA was 
predominately found within muscle cells along the injection path and in scattered 
muscle cells anterior to the injection site. 
Introduction 
Direct injection of DNA into the somatic tissues of animals is a powerful 
strategy for immunization (Ulmer et al., 1993; Xiang et al., 1991) and gene therapy 
(Raz et al., 1993). The technique also provides an attractive alternative to the creation 
of transgenic animals that have the transgene incorporated into the genome. Not only 
is direct injection technologically simple since it can be carried out with a hypodermic 
needle and syringe, but the biological effects of the gene transfer are relatively 
immediate. Expression of transgenes such as the cytokines 11-2, IL-4, and TGF-131 
(Raz et al., 1993); human dystrophin (Ascadi et al., 1991), the NP gene of influenza 
(Raz et al., 1994) and the reporter genes [3-galactosidase, firefly luciferase, and 
chloramphenicol acetyl transferase (CAT) has been demonstrated in animals after 
direct DNA injection (Wolff et al., 1990). The technique bypasses the time 
consuming selection of transgene germline carriers over several generations and its 
potential for effecting measureable phenotypic changes in farmed animals being 
examined. 36 
In fish, biologically active foreign genes have been delivered by electroporation 
and microinjection of developing embryos (for review, see Fletcher and Davies, 1991) 
and sperm (Symonds et al., 1994). These studies have demonstrated that both 
mammalian and fish promoters/enhancers are effective in promoting the expression of 
foreign genes in fish. Furthermore, the tissue specificity of expression in fish by these 
promoters is often similar to that observed in mammalian species (Michard-Vanhee et 
al., 1994). Direct injection of DNA in the muscle of tilapia fish (Oreochromis 
niloticus) has resulted in the expression of the reporter gene, chloramphenicol acetyl 
transferase (CAT), driven by the carp I3-actin promoter (Rahman and Maclean, 1992). 
Maximal CAT activity was seen at 48 hours postinjection and declined thereafter, so 
that by 7 days postinjection, there was essentially no activity in the samples. In carp 
(Cyprinus carpio), expression was higher in small, faster growing fish than in larger 
fish (Hansen et al., 1991). All of these studies suggest that direct DNA injection in 
fish may provide a viable strategy for immunizing animals with specific viral and 
bacterial genes or providing animals with genes for growth enhancement or disease 
resistance. 
As part of an effort to develop practical technologies for immunizing fish 
against viral pathogens, the parameters that govern gene expression by direct DNA 
injection in fish were examined. In this report, the firefly luciferase gene was used as 
the reporter gene for examining expression promoters/enhancers, sites of gene 
expression, duration and level of gene expression, and the persistence of the plasmid 
DNA in rainbow trout (Oncorhynchus mykiss). The information provided by the 
analysis will be important for future work in developing vaccines and other products 
for fish. 
Results 
Determination of the amount and volume of DNA for maximum gene expression 
To determine the amount of injected DNA required for maximum luciferase 
activity, fish (50 g average weight) were injected with 10, 25, or 501.ig of DNA and 
luciferase activity was measured at 36 hours post injection (Figure 3.1). The 
promoter/enhancers examined included the glucocorticoid responsive mouse mammary 37 
Figure 3.1	  Luciferase activity with increasing quantities of injected DNA. The 
luciferase activity in muscle tissue from 50 g fish was determined at 36 
h postinjection. Each bar represents the average of three fish and the 
standard error is shown for each data set indicated by the T bars. Four 
expression vectors were examined at 10, 25, and 50 lig of injected 
DNA. (A) Luciferase activity recovered from fish injected with 
pMMTVLuc, pFV4EAL , or PBS. (B) Luciferase activity recovered 
from fish injected with pCMV4EAL or pCMVL . 38 
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tumor virus (MMTV) promoter/enhancer, the CMV-IEP + translational enhancer, 
CMV-IEP enhancer alone, and the carp (3 -actin promoter. At 25 lig of injected DNA, 
the maximum luciferase activity was observed for all ofthe test DNAs. No 
substantial increase in activity was observed when the amount of DNA injected was 
increased two-fold to 50 pg. 
Tissues from fish injected with the pMMTV-Luc plasmid did not contain 
much luciferase activity (15,000-19,000 cpm). However, the other plasmids, 
particularly pCMVL, promoted the expression of large amounts of luciferase activity 
with 3.2 million relative light units (RLU) at 25 .tg DNA and 3.9 million RLU at 50 
pg DNA. The fish promoter/enhancer, FV4, for the carp 13-actin gene produced 
intermediate luciferase activity at 124,000 RLU for 2514 DNA and 269,000 RLU at 
50 lig DNA. Luciferase expression from pMMTV was not detectable after 36 hours 
postinjection. 
The effect of the volume of the injected material on the reproducibility of each 
assay was also examined (Table 3.1). Inthis study, fish at 1 and 50 g were injected 
with 25 gg of DNA in 100 and 200 .tl volumes. For the fish that received 25 pg of 
DNA in 100 ul of solution, there was considerable variability in luciferase activity/mg 
fish tissue. When the volume was increased to 200  reproducible measurements in 
luciferase activity/mg fish tissue were observed. Thus, the standard conditions for 
DNA injections was 25 p,g of DNA/200 tl of PBS. 
Table 3.1  Analysis of gene expression as a function of the volume of injected 
material. Luciferase activity in lg and 50 g fish injected with 100 pi or 
200 pi of PBS containing 25 p.g pCMVL. Luciferase activity was 
measured 48 hrs post injection. The RLU is the mean of luciferase 
activity recovered from five individual fish for each measurement. 
Luciferase activity 
Weight (g)  Volume (g1)  RLU x 104  Standard Error x 104 
50  100  1710  579 
50  200  1207  119 
100  1466  446 
1  200  1318  44 
1 40 
Comparison of the different promoters/enhancers in fish 
A comparison of the strengths of the different promoter/enhancers to express 
luciferase activity in fish was made with 25 p.g of DNA injected into 50 gfish.. The 
luciferase activity was examined at 1, 2, 3, 5, and 7 days postinjection (Figure 3.2). 
Luciferase activity was observed for all of the plasmid constructs except in pMMTV­
luc injected fish which showed low levels of luciferase activity only after seven days. 
The fish injected with pCMVL and pFV4EAL produced maximum luciferase activity 
after five days and fish injected with pCMV4EAL showed maximum expression at 
seven days postinjection. On day 7, luciferase activity for the pCMV4EAL and 
pCMVL injected fish was approximately 4500-fold greater than the activity found in 
the tissues of the pFV4EAL injected fish. 
The function of the pMMTV-luc plasmid was tested in fish tissue culture 
cells in transient expression assays. Luciferase activity was increased five-fold over 
background by dexamethasone treatment (data not shown). When pCMVEAL and 
pCMVL were tested in transient expression assays in fish tissue culture cells, these 
plasmids produced a thousand-fold greater luciferase activity than the pMMTV-Luc­
transfected cells after dexamethasone induction. Thus, the low expression of 
pMMTVLuc in vitro, is correlated with the low expression of luciferase produced by 
pMMTV-Luc in fish skeletal muscle tissue in vivo. 
Duration of luciferase activity in DNA-injected fish 
Previous reports on the injection of DNA into tilapia suggested that the DNA 
may be expressed only for 48 hours (Rhaman et al. 1992). If genetic immunization 
and gene therapy are to be used successfully in fish, the gene must be expressed at 
relatively high levels for a reasonably prolonged period. Injected fish were monitored 
for luciferase activity for up to 63 days postinjection (Fig. 3.3) in 50 g fish injected 
with 25 p.g of pCMV4EAL DNA (Figure 3.3 a) and up to 115 days postinjection in 1 
g fish injected with 10 pg of the DNA (Figure 3.3 b). Maximum luciferase activity 
was reached by day 7 for both groups. In the 50 g fish, the activity remained near 
80% of this maximum throughout the experiment. 41 
Figure 3.2	  Promoter comparison. Fish at 50 g size were injected with 25 tg of 
plasmid DNA in 200 pl PBS and assayed for luciferase expression 1, 2, 
3, 5, and 7 days post injection. The luciferase activity is shown in 
RLU and is the mean of the activity obtained for three different fish. 
The standard error is represented by the T bars. (A) Luciferase 
activity recovered from fish injected with pMMTV, pFV4EAL, or 
PBS. (B) Luciferase activity recovered from fish injected with 
pCMV4EAL or pCMVL 
Figure 3.3	  Duration of expression of luciferase activity. (A) Fish at 50 g size were 
injected with 25 gg of pCMVEAL DNA in 200 p.1 PBS. Individual 
fish were sampled at the indicated days and the luciferase activity in 
each sample was determined. (B) Fish at 1 g size were injected with 
10 p.g of DNA in 200 .t1 PBS and individual fish were sampled to 115 
days post injection. For each measurement 3-5 fish were assayed, the 
standard error is indicated by the T bars. 42 
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In the study with small fish (1 g), luciferase activity declined over time, and by 
15 weeks postinjection luciferase activity had diminished to approximately 10% of 
the maximum. Although the luciferase activity was comparatively low by day 115, it 
was still approximately one hundred-fold above background. It is unclear whether the 
DNA was slowly degraded over time or whether the growth of the tissue at the 
injection was "diluting" the DNA expression/µg tissue. 
Southern blotting and hybridization 
The fate of the injected DNA was examined in 50 g fish injected with 
pCMV4EAL by southern blot analysis. DNA was extracted from fish tissue and 
digested with the restriction endonuclease Hindln. This enzyme cuts at a single site 
in the luciferase gene of pCMV4EAL to yield a DNA band of 6.7 kb. When the 
Southern blots were developed with a radioactively labeled probe to the luciferase 
gene, a hybridization band at 6.7 kb was observed in samples taken from the injected 
fish at 2, 14, 28, and 63 days postinjection ( Figure 3.4 a) . Undigested DNA was 
also analyzed and migrated as linear and relaxed circular DNA on days 2, 14 , and 28 
days postinjection (Figure 3.4 b). At 63 days postinjection, the DNA migrated as a 
single band of approximately 7.0 kb . This change in mobility was more than likely 
due to differences in the salt concentration of the DNA solution since similar changes 
in migration patterns can be reproduced by altering the salt concentration of the 
plasmid DNA solution. 
To assess the possibility that the change in DNA at day 63 was the result of 
DNA replication and/or integration, the DNA taken on day 28 and 63 was digested 
with HindIll followed by digestion with restriction enzyme isoschizomers Dpnl or 
MboI (Figure 3.4 c). These enzymes recognize the sequence -GATC- and differ in 
their ability to cut methylated DNA (Lavitrano et al., 1989). Plasmid DNA prepared 
in Escherichia coli, DH5a, is methylated at the N6 position of adenine. The 
restriction enzyme DpnI requires N6-methylated adenine for activity and the enzyme 
MboI will not cut DNA with methylated adenines. A Southern blot hybridization of 
the HindIII-digested DNA showed that the injected DNA was insensitive to MboI 
digestion and senstivie to DpnI digestion. Thus, it appears that the injected DNA 
remains in the tissue as unreplicated, unintegrated DNA. 45 
Figure 3.4	  Southern blot analysis of DNA isolated from muscle of fish injected 
with pCMVEAL DNA 2, 14, 28, and 63 days post injection. 
(A) Approximatley 15 pz of DNA injected muscle was linearized with 
Hind 111. The linearized DNA comigrates with control plasmid DNA 
at 6.7 kb. (B) Approximatley 15 pg of undigested DNA was analyzed. 
Open circular (OC, 7.2 kb), linear (L, 6.7 kb), and supercoiled 
(SC, 2.3 kb) DNA were identified. (C) Approximatley 15 pg of DNA 
injected muscle was linearized with Hind 111. The linearized DNA 
was then digested with Dpn 1 or Mbol indicated by the (+) symbol or 
not digested which is indicated by the (-) symbol. 46 
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Sites of DNA expression 
The sites of expression for the injected DNA were determined at 3-5 days 
postinjection when maximum luciferase acitivity was observed. In these studies, the 
reported gene, 13-galactosidase, was used in the plasmid construct, pCMV-f3gal, and 
this plasmid was injected into the fish muscle tissue. Histochemical analysis of 13­
galactosidase expression revealed that the active enzyme was synthesized in 1 g fish 
along the path of injection and in muscle cells at a distance of 5 mmanterior to the 
path of injection. Because there was a significant amount of13-galactosidase 
expression throughout the digestive tract in control fish, further analyses were 
performed using luciferase as the reporter gene. 
In 50 g fish luciferase activity remained localized to muscle tissue. In 1 gram 
fish luciferase activity was recovered from numerous tissues (Figure 3.5 a and 3.5 b). 
The highest level of luciferase activity in the 1 gram fish was recovered from skeletal 
muscle along the path of injection. There was also luciferase activityrecovered from 
anterior and posterior kidney, muscle (taken 5 mm from and on the opposite side of 
the path of injection), heart, liver, spleen, and gill. The luciferase activity in these 
tissues was variable and was roughly 1000-fold less than that obtained from muscle 
tissue along the path of injection. 
Discussion 
A study of a number of the parameters that govern gene expression following 
the intramuscular injection of DNA into rainbow trout was conducted to determine 
the feasibility of using this technology for genetic immunization and gene therapy in 
fish. The results of this study show that the luciferase gene under the control of 
CMV-IEP is expressed at high levels for extended periods of time after direct DNA 
injection into the skeletal muscle of rainbow trout. Gene expression occurs in the cells 
of skeletal muscle and several other organs and the injected DNA persists as an 
unintegrated, non-replicated plasmid DNA. 
The level of gene expression following the direct injection of DNA was found 
to be dependent on the the quantity of the injected DNA and the promoter used to 
drive the foreign gene expression. This finding is consistent with other reports of 48 
Figure 3.5  Sites of gene expression. Fish (1 g) injected with 10 p.g of 
pCMV4EAL in 200 µl of PBS. Tissue from five individual fish were 
assayed for luciferase activity 5 days post injection. The luciferase 
activity is reported as RLU-0.1 mg/ tissue. (A) Luciferase activity 
recovered from the cardiac stomach (c. stomach), pyloric stomach (p. 
stomach), large intesitine (L. intestine), small intesitne (s. intestine), 
muscle (distant from the sight of injection), kidney, heart, spleen, liver, 
and gill. (B) Luciferase activity recovered from muscle tissue along the 
path of injection. 49 
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direct introduction of DNA either by injection in mice (Wolff et al., 1990) and carp 
(Hansen et al., 1991) or particle bombardment of mice (Cheng et al., 1993). Rainbow 
trout injected with 10, 25 or 50 gg of the pCMV4EAL produced luciferase activity 
that reached near maximum activity at 25 pg with a slight increase (1.2-fold increase) 
when 50 pg of plasmid was injected. Also, like the mammalian studies, rainbow trout 
cells responded to different promoter/enhancers with differing levels of expression. 
The MMTV promoter was not a strong promoter in trout tissue and similarly, it is 
not a strong promoter in mice (Yang et al., 1990). Thus, the direct injection of DNA 
into fish should provide a powerful and simple approach for functional analysis of 
untested promoters prior to the creation of transgenic animals. 
In carp, the transient expression of the CAT gene after direct DNA injection 
has been shown to be dependent upon the size of injected fish (Hansen et al., 1991). 
Expression levels were higher in small, faster growing fish (10 cm in length) compared 
to larger, slower growing fish (20 cm in length). This was not the case for luciferase 
expression in rainbow trout where very little difference was observed between the 
levels of luciferase activity /µg tissue in 1 or 50 g rainbow trout injected with 25 pg of 
DNA. A significant variability in luciferase expression was observed in fish that were 
injected with the same amount of DNA in different volumes. Fish that received the 
larger volume (200 gl) as opposed to the smaller volume (100 gl) showed less 
variability in expression. Presumably, the larger volume produces changes in tissue 
turgor and osmotic environment that might lead to greater tissue damage and better 
uptake of DNA (Davis et al., 1993). Moreover, the larger volumes may disperse the 
DNA throughout the body cavity. 
If genetic immunzation, and particularly gene therapies for growth 
enhancement and induction of maturation, are going to be developed succesfully for 
fish, the expression of the introduced DNA must be relatively long-lived. In rainbow 
trout, luciferase activity was detected for at least 115 days postinjection. The 
possibility that the luciferase protein or mRNA is stable and is, therefore, responsible 
for the prolonged activity seems unlikely. The half-life of luciferase has been 
estimated to be less than 24 h in murine skeletal muscle cells (Wolff et al., 1990). In 
contrast, the duration of CAT activity from DNA injected in tilapia was limited to a 
few days (Rhaman et al., 1992). In mice, DNA expression can last as long as several 
months following injection or intravenous administration of DNA/lipid complexes 
(Wolff et al., 1990; Zhu et al., 1993), and 1.5 years following ballistic bombardment 
(Cheng et al. 1993). The long-lived expression of reporter genes is remarkable since 
muscle cells expressing foreign proteins should be recognized and attacked in an MHC 51 
Class I restricted manner. This should result in the eventual recognition and 
elimination of transfected muscle cells by responding lymphocytes (Xiang et al., 
1993). Apparently this does not happen and leads one to speculate that not all 
proteins expressed following DNA injection will be immunogenic, or alternatively, 
that the predominant cells, muscle cells, which express the reporter gene may not 
elicit a strong immune response. This long-lived expression also suggests thatdirect 
DNA injection with reasonable booster schemes could be used for genes encoding 
pathogen resistance and growth enhancers (Raz et al., 1991), genes that require 
continuous production for effectiveness. Also, because the DNA persists, promoters 
sensitive to stress ( hormone inducible promoters; Kitis et al., 1991) or environmental 
contaminants (heavy metal inducible promoters) (Cheng et al., 1993) may be used for 
the analysis of inducible gene expression. 
Because a portion of the injected DNA must ultimately find its way into the 
nucleus, there is the possibility of DNA integration into the host genome.  The 
studies reported here confirm the work of others (Wolff et al., 1990; Zhu et al., 1993), 
that most of the DNA is not integrated or replicated in vivo. The injected DNA 
appears to be stable; there was very little plasmid degradation that was detected by 
Southern blotting. This result is unlike the findings in mice where degradation of the 
DNA begins within a few hours of injection (Wolff et al., 1991). In this report, the 
blotting detection limit was approximately 1340 copies of pCMV4EAL. This limit 
was determined by estimating a detect limit of 1 pg of homologous DNA in 10 mg of 
genomic DNA. Within these detection limits, we were unable to detect replicated or 
integrated plasmid DNA. 
The sites of DNA expression following intramuscular DNA injection were 
determined in small (1 g) and large fish (50 g). In the large fish, luciferase activity was 
confined exclusively to the muscle tissue along or near the path of injection. In the 
smaller fish, there was detectable expression in numerous tissue of some of the fish. 
The gene expression in the different tissues was confirmed by histochemical 
identification of p-galactosidase expressing cells. This result may be explained by the 
fact that an injection volume as small as 100 IA caused a significant extension of the 
peritoneal cavity and dorsal fm in the small fish. Thus, the injected DNA may have 
been distributed throughout the entire fish. The expression of DNA in small fish at a 
distance from the injection site demonstrates that needle damage is not the only 
method of DNA entry into cells. A similar finding has been reported for rats injected 
intraperitoneally with calcium phospate-precipitated DNA (Benvenistry and Reshef, 52 
1986). If the rats were injected with naked DNA, degradation of DNA and 
accumulation of the degraded DNA in the bladder was observed. 
In summary, a study of the parameters which govern gene expression 
following the intramuscular injection of DNA into rainbow trout was conducted. The 
results suggest that genetic immunization and gene therapy should be feasible in fish. 
The direct injection of DNA could be used as an alternative to the production of 
transgenic fish. 
Material and Methods 
Rearing of Fish 
Specific pathogen-free rainbow trout (Shasta strain) at 0.5 g were provided by 
the Center for Marine and Freshwater Biomedical Research, Food Toxicology and 
Nutrition Laboratory, at Oregon State University. The fish were reared at the Center 
for Salmon Disease Research, Salmon Disease Laboratory, in well water at 12° C at a 
flow rate of 0.5 gal/min. All fish were acclimated at the site for at least one week 
before any experimental procedures were conducted on the animals. 
Construction of the Expression Plasmids 
Four vectors which expressed the firefly luciferase gene (de Wet et.al., 1987) 
under the regulatory control of one of three mammalian viral promoters or one fish 
promoter were used in the study. The plasmid, pMMTV -Luc (Clontech, Inc.), 
contained the luciferase gene under the control of the glucocorticoid responsive mouse 
mammary tumor virus promoter (Lee et al., 1981). The entire luciferase gene in this 
plasmid is flanked on the 5' and 3' ends by Smal restriction enzyme sites. The 
plasmid, pCMV4EAL, contained the cytomegalovirus immediate early promoter 
(CMV-IEP) and a translational enhancer fused to the luciferase gene. This plasmid 
was made by inserting the entire 1.9 kb luciferase Smal fragment from MMTV-Luc, 
into the Smal site of pCMV4 (Andersson et.al., 1989). The plasmid, pCMVL, 53 
contained the CMV-IEP fused to the luciferase gene (P.D.L. Gibbs, 1992). The 
plasmid, pFV4EAL, contained the carp 13-actin promoter fused to the luc gene and 
was made by inserting the 1.9 kb luc gene Smal fragment from MMTV-Luc into the 
SmaI site of pFV4 (Liu et.al., 1990). In addition, pCMV13gal, which contains the 
CMV-IEP fused to the P-galactosidase gene was created by inserting the 
HindIEUBamHII3-galactosidase gene from pSV-P-galactosidase (Promega) into the 
HindIII/BamHI site of pCDNA-3 (Invitrogen). 
Preparation of DNA and DNA delivery 
The quantity of plasmid DNA that had been purified by affinity 
chromatography (Qiagen, Inc. Chatsworth, Calif.) was determined by 
spectrophotometric measurements at 260 and 280 nm. The DNA in aliquots 
equivalent to 10, 25, and 50 p.g was suspended in 100 or 200 ills of phosphate 
buffered saline solution ( PBS, 0.14M NaCI, 10mM sodium phosphate, pH 7.4). For 
DNA delivery, a 27-gauge needle and a 1-ml tuberculin syringe were used. Fish were 
anesthetized by immersion in 100 pg/ml concentration of tricaine methane sulfonate 
(MS-222; Argent Chemical Laboratories) for 1-2 min. and then the DNA was injected 
immediately rostro-ventral to the dorsal fin at a 300 degree angle to a depth of 38 mm. 
Great care was taken to ensure that each fish was injected identically. To eliminate 
the possible variability due to DNA preparation (Wolff et al., 1991) each experiment 
was performed with the same preparation of plasmid DNA. 
Luciferase assays 
Luciferase assays were performed as described for the enhanced luciferase 
detection system manufactured by Analytical Luminescence Laboratory. The entire 
fish, in the case of 1 g fish, or individual dissected tissues from 5 g fish were 
homogenized in 5 volumes of lysis buffer (wt/vol) using a polytron homogenizer 
(Brinkman) at 13,000 rpm for 20 seconds. For 50 gram fish, 5 g muscle plugs were 
carefully dissected from the injection site, the skin was removed and discarded, and 
the tissue was homogenized as previously described. The homogenates were clarified 54 
by centrifugation at 10,000 x g for 10 min. Aliquots of 10 p.1 of the supernatant 
material were diluted in lysis buffer and luciferase activity was measured in a 
Beckman LS 8000 liquid scintillation counter on single photon mode (Nguyen et al., 
1988). The resultant counts per minute (cpm) were integrated over a 30 seconds 
period. Luciferase activity is reported as the mean relative light units (RLU) in 
cpm/10 p1 for three fish. Standardized assays containing 0.01 and 1 pg of purified 
luciferase routinely measured 70,000 cpm (three-fold above background) and 5 
million cpm respectively. The maximum reliable count was considered 5 million cpm. 
Samples from non-injected control fish were usually measured at 15,000 to 20,000 
cpm and all measurements below 40,000 cpm (two-fold above background) were 
considered to be negative for luciferase activity. In this study, cpm is actually a 
measure of relative light units or RLU since all assays were performed with samples 
containing 1 mg/ml of tissue unless otherwise indicated. 
Southern blotting and hybridization 
DNA was extracted from the tissues as described (Maniatis et.al., 1982). 
Restriction digestions of 10 p.g of genomic DNA from mock or DNA-injected fish 
were carried out overnight and the digested DNAs were electrophoresed in a 0.8% 
agarose gel. The DNA samples were transferred to nytran membranes (Shleicher and 
Shuell) according to the manufacturer's recommendations. The 1.9 kb luciferase gene 
was labeled with 32P-dCTP (3000 Ci/mmole) to 1-2 x 109 cpm/pg by random priming 
(Amersham ). Unincorporated nucleotides were removed by chromatographic 
separation in a G-50 spin column (Boehringer Mannheim). The membranes were 
prehybridized at 420 C in 5X SSPE (1X SSPE = 150mM NaC1, 10mM NaH2PO4, 
1mM EDTA, pH7.4), 1% SDS, 50% formamide and 1.5% DNA blocking reagent 
(Boehringer Mannheim) for 1 hr. The probe was then added and hybridization was 
carried out at 420 C overnight. The membrane was washed in buffer with the highest 
stringency for 30 minutes in 0.1X SSPE, 1.5% SDS, at 680 C. The membrane was 
wrapped in polyethylene film before exposure to radiographic film (Hyperfilm-MP, 
Amersham) at -700 C for 24-48 hours. 
Histochemistry 55 
Fish at 0.5- 1 gram were injected with 10 i.tg of pCMVI3gal. At 3-5 days post 
injection the fish were killed and immersed in 5% formalin, 1% glutaraldeyde for one 
hr. The fish were rinsed in distilled water for 10 min and then incubated in X-gal 
solution (0.2% X-gal chromagen, 10mM sodium phosphate, 150mM NaC1, 1mM 
MgC12, 3.3mM K4Fe(CN)6.3H20, and 3.3mM K3Fe(CN)6, pH7.0) at 370 C for 16 
hours. The fish were rinsed in water for several hours and processed as previously 
described (Drolet et.al., 1993). Sections of 6 gm were taken from the embedded fish, 
counterstained briefly in eosin, and examined microscopically for cells containing blue 
precipitate as an indicator of13-galactosidase expression. 
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Abstract 
Plasmid vectors encoding the infectious hematopoietic necrosis virus (IHNV) 
nucleoprotein gene or the glycoprotein gene were tested for their ability to immunize 
rainbow trout (Oncorhynchus mykiss) against IHNV. The plasmid DNA was injected 
into the skeletal muscle of 1 g rainbow trout and the specificity of virus-specific 
antibodies and protection against an IHNV challenge were measured. Fish injected 
with the glycoprotein encoding plasmid either alone or in combination with the 
nucleoprotein encoding plasmid generated a glycoprotein-specific antibody response 
and were protected from a subsequent IHNV challenge. Injection of fish with the 
nucleoprotein encoding plasmid did not promote a measurable virus-specific antibody 
response, nor did it immunize fish against IHNV. 
Introduction 
The rhabdovirus, IHNV, is a pathogen of salmon and trout that are native to 
the countries of the North Pacific Rim (reviewed in Wolff, 1988). The severity, 
prevalence, and ultimately, the economic cost of II-IN disease has prompted 
substantial efforts to develop an effective and safe IHNV vaccine (reviewed in Leong 
and Fryer, 1993). The effort has led to the development of attenuated (Fryer et al., 
1976; Tebbit, 1976), killed (Amend, 1976; Nishimura et al., 1985), and subunit IHNV 
vaccines (Gilmore et at, 1988; Oberg et al., 1991). These vaccines have all been 
successful under different immunization regimens in protecting fish against IHNV. 
Indeed, each vaccine has provided valuable information regarding the fish immune 
response and the replication and pathogenesis of IHNV. These successes, however, 
have not resulted in a commercially viable IHNV vaccine because questions have been 
raised regarding the safety and preparation costs in the case of the attenuated and 
killed vaccine, and consistent efficacy in the case of the subunit vaccine (Leong and 
Fryer, 1993) 
One of the newest approaches in vaccine design is the use of DNA vaccines. 
This approach, genetic immunization, is based upon the finding that naked plasmid 
DNA when injected into skeletal muscle cells is able to express its encoded protein(s) 
(Wolff et al., 1990). The protein antigen can stimulate a specific immune response 61 
composed of cytotoxic T cells, T-helper cells, and antibodies (Cox et al., 1993; Fynan 
et al., 1993; Ulmer et al., 1993; Yankauckas et al., 1993; Wang et al., 1993; Xiang et 
al., 1994; Raz et al., 1994; Segedah et al., 1994). These DNA vaccines have been 
successful in immunizing animals against influenza virus (Ulmer et al., 1993; Fynan et 
al., 1993; Montgomery et al., 1993; Raz et al., 1994), rabies virus (Xiang et al., 1993), 
bovine herpesvirus 1 (Cox et al., 1993), and malaria (Segedah et al., 1994). With the 
DNA vaccines as well, there is no longer a need to purify the pathogen or 
immunoprotective antigen for vaccination and there is no possibility of reversion to 
virulence since the DNA encodes a single viral protein. 
In this study, an effort was made to develop a DNA vaccine to IHNV. Initial 
experiments had shown that rainbow trout will express firefly luciferase and b­
galactosidase from naked DNA injected into the skeletal muscle cells (Anderson et al., 
submitted). The route of injection, the appropriate promoter, the optimal dose of 
DNA required for expression, and the duration of gene expression had been 
determined with plasmid DNA containing the firefly luciferase under the control of 
the cytomegalovirus immediate early promoter (CMV -IEP). The experiments 
described in this paper demonstrate that plasmid DNA containing the IHNV 
glycoprotein (G) gene downstream of the CMV-IEP will induce an immune response 
in fish. Fish injected with plasmid DNA encoding the IHNV G protein or with a 
combination of plasmid DNAs encoding G and N (nucleoprotein) protein, produced a 
strong protective immune response to subsequent challenge with a lethal dose of 
IHNV. 
Results 
Expression of the IHNV nucleoprotein and glycoprotein in transfected cells 
Expression of the IHNV G protein and N protein by the plasmids pCMV4-G 
or pCMV4-N, respectively, was confirmed by immunohistochemical staining of EPC 
cells transiently transfected with the plasmid DNA (Figure 4.1). The cells were 
probed 48 hr post transfection with an anti-IHNV G (3GH136J) or N (1NDW14D) 
specific monoclonal antibody and subsequently stained chemically. The pCMV4-G 
and pCMV4-N transfected cells reacted specifically with the G or N specific 62 
Figure 4.1	  Expression of the IHNV G and N protein in pCMV4-G and pCMV4­
N transfected cells. EPC cells were transfected with pCMV4-G (A) or 
pCMV4-N (B) and then probed with a G-specific (3GH136J) or N-
specific (1NDW14D) monoclonal antibody, respectively. The cells 
expressing the IHNV proteins were subsequently identified using 
alkaline phosphatase immunocytochemical staining which stains the 
cells black 63 
(A)
 
(B)
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antibody, respectively. Both the pCMV4-G and pCMV-N transfected cells were 
moderately to intensely stained throughout the cytoplasm. In addition, when the 
pCMV4-G transfected cells were briefly reacted with the color substrate, staining was 
primarily seen at the cell surface. Thus, both pCMV4-G and pCMV4-N are 
functional and should direct IHNV protein synthesis in fish skeletal muscle cells 
transfected by direct injection. 
Humoral immune response 
IHNV specific antibody activity in serum collected from fish injected with 
plasmid DNA was measured using an ELISA (Figure 4.2). Fish injected with a 
combination of pCMV4-G and pCMV4-N first produced measurable antibody 
activity 4 weeks post injection, the activity peaked at 8 weeks, and remained high 
throughout the 4-14 week test period. Fish injected with pCMV4-G followed a 
similar trend as the co-injected fish except that the first measurable anti-IHNV 
antibody activity was recovered 6 weeks post injection. At peak antibody activity, 8 
weeks post injection, the co-injected fish antisera contained 26-fold greater anti-IHNV 
antibody activity than did the pCMV4-G injected fish antisera. There was not any 
anti-IHNV antibodies at any point in the experiment when antisera from pCMV4-N 
injected fish was tested using the ELISA 
To obtain enough antisera to perform the ELISA, antiserum was pooled from 
five vaccinated fish. Thus, it is possible that the time of appearance and intensity of 
the antibody response was proportional to the number of fish which had 
seroconverted or, alternatively, that the results were a reflection of the humoral 
response of individual fish. Whichever is the case, the fish co-injected with pCMV4­
N and pCMV4-G plasmids produced measurable anti-IHNV antibodies earlier and 
more abundantly than the fish injected with pCMV4-G alone.  This indicates that 
pCMV4-N was involved in enhancing the anti-IHNV antibody activity in co-injected 
fish or, alternatively that the results were due to the limited sample population. 
However, the enhancing effect of pCMV4-N plasmid was also observed when 350 g 
rainbow trout were co-injected with pCMV4-G and pCMV4-N (unpublished results). 
The specificity of the immune response was measured by Western blot 
analysis (Figure 4.3) A 1/ 100 dilution of the antiserum collected from the fish co­
injected with pCMV4-N and pCMV4-G or with a single injection with pCMV4-G 65 
Figure 4.2	  Analysis of anti-IHNV antibody activity recovered from fish injected 
with plasmid DNA by an ELISA. The IHNV specific antibody 
response in fish injected with PBS, pCMV4-Luc, pCMV4-G, 
pCMV4-N, and pCMV4-G + pCMV4-N was determined 4, 6, 8, 12 
and 14 weeks post injection. The antibody activity is expressed as the 
log of realative units (RU) of antibody activity. The RU was 
calculated by comparison of antiserum collected from a mature fish 
which had survived a non-lethal experimental infection with IHNV 
Figure 4.3	  Specificity of anti -IHNV antibody activity recovered from fish injected 
with plasmid DNA by Western blotting. IHNV (20 peg/lane) was 
probed with a 1/100 dilution of antiserum recovered from fish injected 
with: lane 1, pCMV4-G (8 weeks); lane 2, pCMV4-G and pCMV4-N 
(6 weeks); lane 3, pCMV4-G and pCMV4-N (8 weeks); lane 4, 
positive control rainbow trout antisera; lane 5, molecular weight 
markers; lane 6, pCMV4-N (8 weeks); lane 7, pCMV4-Luc (8 weeks); 
lane 8, PBS (8 weeks). The molecular weight for the purified IHNV is: 
G 67 kd; N 42 kd; M1 25 kd; M2 21 kd. 66 
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was specific to the IHNV G (20 Ile lane of purified IHNV). There was no detectable 
anti-N antibodies in serum collected from pCMV4-N or from the co-injected fish. 
Immunization of fish with DNA against IHNV 
Fish immunized with the pCMV4-N and pCMV4-G together or pCMV4-G 
alone were significantly protected against a subsequent challenge with 108 PFU / 2L 
(Ranger isolate) (Figure 4.4 and Table 4.1). This dose of virus killed 65-75% of the 
pCMV4-N, pCMV4EAL, and PBS injected or unhandled fish during the 30 day assay 
period (Fig. 4.4). The survival of fish injected with pCMV4-G or pCMV4-N + 
pCMV4-G was 86% (Table 4.1). 
Discussion 
In this study we developed an IHNV DNA vaccines composed of either the 
IHNV G gene or the N gene. The vaccines were tested for their ability to immunize 
rainbow trout against the virus and produce an antibody response in vaccinated 
rainbow trout. The design of the pCMV4-G vaccine was based upon the finding that 
the purified IHNV glycoprotein is the only viral protein capable of neutralizing IHNV 
( Engelking and Leong, 1989). In addition, vaccination with the glycoprotein can 
immunize fish against all five IHNV electropherotypes (Engelking et al., 1991). The 
pCMV4-N vaccine was included because it has been shown to augment the efficacy of 
a subunit G vaccine (Oberg et al., 1991). Further, the rabies virus (RV) N protein is 
able to immunize mice and dogs against RV, though it is not as effective as the RV G 
protein (Fu et al., 1991; Sumner et al., 1991; Fekadu et al., 1992). While side by side 
trials were not performed in this study, the efficacy of the pCMV4-G vaccine 
administered alone or in conjunction with the pCMV4-N vaccine compares favorably 
with the attenuated, killed, and subunit IHNV vaccines previously reported 
(reviewed in Leong et al., 1988). 
Fish injected with pCMV4-G vaccine generated both anti-G specific 
antibodies and were protected from a subsequent challenge with IHNV. This is 
further confirmation that the IHNV glycoprotein alone can confer significant 69 
Table 4.1	  Survival of fish injected with plasmid DNA and subsequently 
challenged with IHNV. Fish of 1 g size were injected or unhandled as 
indicated. Six weeks post-injection the fish were challenged with 104 
PFU/L of IHNV (Rangen isolate). The challenge was conducted for 30 
days. 
Number of  Total number  Percent 
Treatment  fish/group  of deaths  Survival 
Unhand led  60  39  35 
PBS 60 40  33 
pCMV4-Luc  60  42  30 
pCMV4-N  40  30  25 
pCMV4-G  60  10  83 
pCMV4-N +  60  9  85 
pCMV4-G 70 
Figure 4.4	  Mortality rate of fish injected with plasmid DNA. Rainbow trout at 
an average weight of 1 g were exposed to IHNV (104 PFU/L, Rangen 
isolate) six weeks after injection with PBS, pCMV4-Luc, pCMV4-N, 
pCMV4-G, or pCMV4-N + pCMV4. In addition an unhandled (not 
injected) was included. 71 
pCMV4-N 
pCMV4-Luc 
PBS 
Unhand led 
pCMV4 -G 
a pCMV4-G 
+ pCMV4-N 
10  15 20  25  30 
Days post challenge 
Figure 4.4 72 
immunity to vaccinated fish against IHNV as has been previously reported (Engelking 
et al., 1991). These results are similar to those of Xiang et al. (1994) using a DNA 
vaccine composed of the RV G protein, pSG5rab.gp, to vaccinate mice. The 
pSG5rab.gp vaccine also produced a strong G-specific T-cytotoxic cell response and 
lymphokine secretion from T (H1) cells which was both dose and booster dependent. 
Additional studies have shown that the route and site of administration of DNA 
vaccination is important in determining the type of immune response generated (Raz 
et al., 1994; Fynan et al., 1993). Thus, it is clearly possible that further study of the 
vaccination regimens and delivery methods will improve the efficacy of the pCMV4­
G vaccine. 
The pCMV4-N vaccine did not protect rainbow trout against IHNV, nor did it 
evoke a measurable antibody response. It is possible that the N protein is a poor 
protective immunogen in fish, or is not accessible to immune surveillance, with the 
strategy employed in our study. However, it has been reported that the N protein 
subunit vaccine did not immunize fish against IHNV (Oberg et al., 1992). In addition, 
within a population of IHNV infected fish, only a small proportion contain anti-N 
antibodies, the majority contain anti-G and M-1 antibodies (Ristow et al;.1993, 
Lapatra et al., 1993). The possibility that the N protein was aberrantly expressed in 
fish muscle cells and therefore not available for immune recognition cannot be 
excluded. Yet, in this study (and unpublished results) it was found that fish co­
injected with the N and G DNA vaccines had an earlier and stronger antibody 
response to G. While the results are tentative, it does suggest that the pCMV4-N 
vaccine is functional and capable of augmenting the immune response. That pCMV4­
N is functional is further supported by the fmding that the N protein is synthesized 
in transfected fish cells. It could be speculated that the augmentation occurs via T-cell 
activation. The N protein of rabies virus is a major target for T-helper cells (Ertl et al., 
1989) and the IHNV N protein contains a number of putative T-helper cell epitopes 
(Oberg et al., 1991). Activation of T-cells could increase the activity of the B-cells 
producing anti-G antibodies. This type of cooperation has been observed for both 
influenza virus (Russell and Liew, 1979) and hepatitis B virus (Milich et al., 1987). 
Though fish injected with a combination of pCMV4-N and pCMV4 -G had a 
stronger anti-G specific antibody response than pCMV4-G injected fish, there was 
not a relative increase in survival following IHNV challenge. Thus, the level of 
antibody production by DNA vaccinated fish was not a good indication of the degree 
of protection against IHNV. Zhuang et al. (1992) also found that there was not a 
relationship between anti-IHNV antibody titer and protection. There are many 73 
explanations for this. It is possible that once a threshold level of antibodies have been 
reached, increasing the antibody concentration does not enhance the relative degree of 
protection. It is also probable that the antibody response is not the only immune 
function conferring protection following genetic immunization. 
In summary, the results presented in this report show that fish can be included 
among the organisms which can be immunized against a viral pathogen using DNA 
vaccines. Because the DNA vaccines can be delivered simply, the proteins are 
synthesized indepent of the whole pathogen, and can potentially generate a broad 
spectrum immune response, genetic immunization should prove to be a powerful tool 
to study the fish immune repetoire. 
Material/Methods 
Cells and Virus 
The chinook salmon embryo cell line CHSE-214 (Lannan et al., 1984) was 
used for the propagation of IHNV as previously described (Engelking and Leong, 
1981). The cells were grown as monolayers in RPMI-1640 medium (GIBCO 
Laboratories) supplemented with 10% fetal calf serum (Intergen), penicillin 100 
I.U./ml, streptomycin 100 gg/m1 and 2mM L-glutamine (all from GIBCO 
Laboratories). The type-2 IHNV isolate used in this study was isolated in 1983 from 
a juvenile rainbow trout at the Rangen Research Laboratories, Idaho, USA (Hsu et al., 
1986). The virus was propagated in fish cells at a multiplicity of infection of 0.001 at 
150 C. The cell-free supernatant contained 108 plaque forming units (PFU) as 
determined by a plaque assay (Burke and Mulcahy, 1980). 
Fish immunization and challenge 
Rainbow trout (Shasta strain) with no previous history of IHNV were 
provided by the Food Toxicology and Nutrition Laboratory at Oregon State 
University. Fish were held at the Oregon State University Fish Disease Laboratory in 74 
120 C fish-pathogen-free well water where subsequent immunization and challenge 
experiments were conducted. The fish were anesthetized in 50 ppm 3-aminobenzoic 
acid ethyl ester (Benzocaine; Sigma) followed by intramusclular injection of 10 ug of 
plasmid DNA as previously described (Anderson et al., submitted). Six weeks post 
DNA injection, fish were challenged by immersion in 2L of water containing  104 
plaque forming units/L of live, infectious type-2 IHNV (Rangen). Dead fish were 
collected daily for 30 days. 
Plasmid Construction 
The N and G gene from IFINV were placed down stream of the 
cytomegalovirus immediate early enhancer/promoter (CMV-IEP) in the plasmid 
pCMV4 (Andersson et al., 1989) .  All of the DNA restriction enzymes used were 
obtained from Promega. The plasmid pGEM-N which contains the complete cDNA 
of the IHNV N (Gilmore and Leong, 1988a ) was digested with Hind 111 and the N 
gene fragment from nucleotides 444-1400 was gel purified using glass beads according 
to the suppliers protocol (Bio 101 Inc.). The Hind 111 N gene fragment was inserted 
into the Hind 111 multiple cloning site of plasmid pCMV4 to create 
pCMV4EAH3N. The plasmid pGEM-N was then digested with Kpnl and Nar 1 
and the N gene sequences from nucleotides 0-841 was gel purified using glass beads. 
The plasmid pCMV4EAH3N was digested with Kpnl and Nar 1 and the 6.2 Kb 
DNA fragment was gel purified using glass beads. The N gene Kpnl/Narl fragment 
was then inserted into pCMV4EAH3N Kpnl/Nar 1 fragment to create a full length N 
gene plasmid construct named pCMV4-N. The plasmid pG8 containing the complete 
cDNA of the IHNV G gene (Koener et al., 1987) was digested with Kpn 1 and Hind 
111 and the 1600 base pair G gene was gel purified using glass beads. The plasmid 
pCMV4 was digested with KPN1 and Hind 111 and the gel purified G gene was 
inserted into the compatible site in the multiple cloning region of pCMV4 to create 
pCMV4-G. The plasmid pCMV4EAL contains the firefly luciferase gene 
downstream of the CMV -IEP promoter. The construction of pCMV4 EAL has been 
previously described (Anderson et al., submitted) 75 
Confirmation of protein synthesis 
Protein synthesis from the plasmids pCMV4-N and pCMV4-G was 
confirmed by transfection of fish cells epithelioma papulosum cyprini (EPC; Fijian et 
al., 1983) .  Fish cells were seeded in a 6 well plate (Corning, 9.4 cm2/ well) at a 50­
60% confluencey. The following day the cells at 90% confluencey, were transfected 
with 1 p.g of the appropriate DNA vector using lipofectamine according to the 
suppliers protocol (GIBCO). The DNA lipid complex was incubated with the cells 
for 24 hours. Following transfection the lipid DNA complex was rinsed from the cells 
using RPMI-1640 medium without fetal bovine serum or antibiotics. The cells were 
incubated throughout the experiments at 200 C in a incubator culture chamber (C.B.S. 
Scientific Co.: model no. M-624) perfused with a blood gas mixture containing 9.9% 
mol/mol carbon dioxide, 10.2% mol/mol oxygen and 79.9% mol/mol nitrogen (Airco 
medical gases BOC). Five days post transfection expression of the N and the G in 
fish cells was confirmed, using the monoclonal antibody (MAb) 1NDW14D and 
3GH136J respectively (Ristow and Arnzen de Avila, 1991), as previously described 
(Drolet et al., 1993). 
Immunization 
DNA was prepared using qiagen affinity chromatographic columns (Qiagen, 
Inc.). Ten ug of the appropriate plasmid DNA was suspended in 200 ills of 
phosphate buffered saline solution (PBS, 0.14 M NaC1, 10mM Na2HPO4.7H20, pH 
7.4). The plasmid DNA was injected into anesthetized fish (50 ppm Benzocaine) as 
described elsewhere (Manuscript submitted). 
Determination of IHNV Ab titers and specificity 
Pools of fish blood from five fish was collected 4, 6, 8, 12, and 14 weeks post 
DNA injection. The blood was obtained by cutting off the caudal fm of anesthetized 
fish and pressing a heparinized capillary tube to the site. The capillary tubes were 76 
then centrifuged at 5 X g for 15 min and the serum was collected. The activity of anti-
IHNV fish antibodies in the collected serum was determined using an enzyme-linked 
immunosorbent assay (ELISA) .  Purified IHNV was prepared as previously 
described (Engelking and Leong, 1989). Purified IHNV (3ug/m1) in carbonate buffer 
(15mM Na2CO3, 35mM NaHCO3, NaN3, pH 9.6) was coated onto a 96 well 
microtiter plates (Costar E.I.A/R.I.A. certified surface chemistry, Cambridge, MA) 
overnight at 40 C. The plates were washed with TBS containing 0.5% Tween-20 
(TBTS). Serial dilutions of the collected fish antiserum were added and incubated 
overnight at 170 C .  The plates were washed in Tris-buffered saline (TBS, 20mM 
Tris base, 500mM NaCI, pH 7.5) containing 0.5% Tween-20 (TBTT) followed by a 1 
hr in a blocking solution containing 3% bovine serum albumin (Sigma). The plates 
were then washed in TBTT and MAb 1/14 specific for trout immunoglobulin (Deluca 
et al., 1983) was added, and incubated for 2 hours at 170 C. The plates were washed 
in TBTT and then incubated with strepavidin-horseradish peroxidase (Sigma) for 1 
hour. The plates were washed again with TBTS and 2,2-azino-di(3­
ethylbenzthiazoline sulfonate (ABTS; Boehringer Mannheim) in 0.2% citrate with 
0.03% hydrogen peroxide was added as the color development reagent. The color 
reaction was measured at an optical density of 405 nm using a Titertek Multiscan 
Plus plate reader (Flow Laboratories). Each plate contained a standard anti-IHNV 
hyper immune serum titration used for normalization of the data. The antibody 
activity was determined by a comparison to the dilution of hyperimmune anti-IHNV 
fish sera which resulted in half maximal activity. The antibody activity was assigned 
a numeric value accordingly and the data is presented as the log relative units (RU) of 
ant-IHNV antibody activity. 
The specificity of the antibodies produced in response to the expression of 
plasmids encoding the N or G genes when injected into fish was determined by 
western blotting. Purified IHNV (20 pg/ lane) was separated on a 12% 
polyacrylamide gel and transferred to nitrocellulose membranes (Shleicher and Shuell) 
as previously described (Engelking and Leong, 1989a). Following transfer the 
membranes were blocked for 1 hr in TBS containing 5% non-fat milk (TBSM). DNA 
injected fish antisera was incubated with virus at a 1:100 dilution in TBSM at 170C 
for 17 hrs. The membranes were washed in TBSM and then incubated for 2 hrs with 
biotinylated MAb 1/14 in TBSM. The blot was washed in TBSM and then incubated 
for 30 min with avidin-alkaline phosphatase (Vector Laboratories) in TBSM . The 
membrane was washed in TBS and developed with a one component developer 
(Kirkegard and Perry) in the dark for 30 min. 77 
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Abstract 
An inducible expression plasmid pMMTV-neo containing the infectious 
hematopoietic necrosis (IHNV) nucleoprotein (N) gene in the sense or antisense 
orientation was tested for their ability to interfere with the IHNV life cycle. Fish cells 
transfected with the plasmids were resistant to IHNV plaque formation and produced 
fewer infectious IHNV than control cells. The antisense plasmids conferred a higher 
degree of cellular viral resistance than the sense plasmids.  The degree of viral 
resistance of the transfected cells decreased with cell passage. This temporal change 
was observed for both the sense and antisense transfected cell lines. 
Introduction 
Intracellular immunity to viruses mediated by cellular expression ofviral 
transgenes has been reported for both plants and animals (for a review, see van der 
Krol et al., 1988; Beachy, 1993). The interfering transgenes can disrupt the life cycle 
of the virus at numerous steps during infection. One level of viral interference by the 
transgene is duplex formation with a viral RNA target sequence resulting in 
degradation of the duplex, inhibition of viral mRNA translation, or inhibition of 
mRNA processing (for a review, see Inouye, 1988; Takayama and Inouye, 1990; 
Helene and Toulme, 1990). Interference can also be achieved by expression of 
positive polarity viral transgenes. The expressed proteins can disrupt the virus life 
cycle by receptor interference (Federspiel et al., 1989), blockage of virion uncoating 
(reviewed in Reimann-Philipp and Beachy, 1993), limiting the systemic spread of the 
virus (Wisniewski et al., 1990), or functioning as trans dominant repressors (Mermer 
et al., 1990; Bevec et al., 1992; Malim et al., 1992; Balmer et al., 1993). Intracellular 
immunity has also been attained using viral specific ribozymes (Weerasinghe et al., 
1991), RNA decoys (Sullenger et al., 1991; Lisziewicz et al., 1993; Bevec et al., 
1994), and oligonucleotides (reviewed in Stein and Cheng, 1993). In this report the 
cellular expression of viral transgenes of IHNV was investigated fortheir ability to 
disrupt the viruses replicative cycle. 
IHNV is a rhabdovirus which causes a severe disease in a number of species of 
salmonid fish native to the Pacific Rim (Wolf, 1988). The virus establishes a rapid 85 
systemic viremia in infected fish (Drolet et al., 1994), causes extensive necrosis of the 
hematopoietic tissues (Yasutake, 1970), and in some instances can result in greater 
than 90% mortalities within a population (Amend, 1969). In cell culture IHNV 
inhibits both cellular transcription and translation which results in cell death 48-72 hrs 
post infection. In infected cells the viral nucleoprotein (N) can be detected 2-3 hrs 
post infection (p.i.), the matrix proteins (M1 and M2) 6-7 hrs p.i., the glycoprotein 
(G) 9-10 brs p.i., and the low abundance polymerase (L) 30 hrs p.i (Hsu et al., 1985). 
The time of appearance of the viral proteins is believed to be a result of sequential 
transcription of the genome by the viral polymerase complex starting at the 3' end of 
the negative stranded genome. The IHNV genome gene order been determined to be 3' 
N-M1-M2-G-NV-L 5' (Kurath et al., 1985). 
The N protein of IHNV, by analogy with the rhabdovirus vesicular stomatitis 
virus (VSV), is thought to be involved in modulating the switch from viral 
transcription to replication (Banerjee, 1987). Thus, because the N protein is the first 
and most abundant viral protein synthesized in infected cells, and plays an important 
role in the regulation of viral synthesis, transgenes targeted to the IHNV N gene may 
be an effective strategy for disrupting the viruses life cycle. Indeed, antisense 
oligonucleotides targeted to the N mRNA of vesicular stomatitis virus (VSV) have 
been shown to interfere with VSV synthesis (Agris et al., 1986; Lemaitre et al., 1987; 
Leonetti et al., 1988). 
In this study, a hormone-inducible, mouse mammary tumor virus plasmid was 
constructed that contained the IHNV nucleoprotein gene in the sense or antisense 
orientation. These vectors were used to transfect fish cells and tested for their ability 
to inhibit IHNV synthesis. 
Materials and Methods 
Plasmid DNA construction. 
Standard cloning protocols were used as described by Sambrook et al. (1989). 
The IHNV N gene cDNA (Gilmore and Leong, 1988) was inserted in the sense or 
antisense orientation downstream of the mouse mammary tumor virus promoter 86 
contained in the plasmid pMMTV-neo (Clontech). The pMMTV-neo plasmid was 
digested with Sal 1 (Promega) in the multiple cloning site, and blunt ended with the 
DNA polymerase 1 ldenow fragment (Promega). The 1359 base pair IHNV N cDNA 
contained in pGEM-3Z (Gilmore and Leong, 1988) was released with Pst 1 
(Promega), separated from the plasmid DNA by agarose gel electrophoresis, and 
purified from the gel using glass beads (Bio 101 Inc.). The purified N Pst 1 fragment 
was blunted using T4 DNA polymerase (GIBCO BRL) and ligated (T4 DNA ligase; 
GIBCO BRL) to the pMMTV-neo Sal 1 digested and blunted plasmid. Two 
pMMTV-N vectors were produced, one in the antisense orientation termed pN(-), 
and the other in the sense orientation termed pN(+).  Additionally, plasmid 
pMMTV-Luc (Clontech) which contains the luciferase gene downstream of the 
MMTV promoter, and pMMTV-Neo (blank parent plasmid) were used in the 
experiments. 
Transfections of cells 
All the plasmids were transfected into the fish cells, epithelioma papulosum 
cyprini (EPC) (Fijian et al., 1983). The fish cells were grown in RPMI-1640 medium 
(GIBCO BRL) supplemented with 10% fetal bovine serum (Intergen), antibiotics and 
L-glutamine (penicillin, 100 IU/ml; streptomycin, 100 ug/ml; and L-glutamine, 2mM; 
all from GIBCO BRL), and rainbow trout embryo extract. The cells were maintained 
in a incubator culture chamber (C.B.S. Scientific) perfused with a blood-gas mixture 
composed of 9.9% mol/mol CO2, 10.2% mol/mol 02, and 79.9% mol/mol N2. 
Transfections were performed on cells in a 6-well plates (Nunc), at 20-220 C. The 
cells were transfected at a density of 2 x 106 cells/cm2 All of the cell lines were 
maintained by a 1:4 passage every 14-17 days. 
Two methods were used to transfect the fish cells. The first method was 
conducted using DNA calcium phosphate precipitation as described by Araki et al. 
(1991). The second transfection method was performed by incubating cell 
monolayers for 24 hrs with a solution of 1 ml of opti-MEM (GIBCO BRL) 
containing 6 ul of lipofectamine (GIBCO BRL) and 1 ug of DNA. Transfected cells 
were selected using geneticin (0418, .3 mg,/m1) supplemented medium. After selection 
in G418 medium for approximately one month, G418 resistant colonies were pooled 
to facilitate cell growth. 87 
Viral assays 
The IHNV isolate, RB-1, used in this study was isolated from a juvenile 
rainbow trout in 1976, from Round Butte Hatchery, Oregon, USA. The virus was 
propagated in EPC cells at a multiplicity of infection of 0.001 at 16° C. The IHNV 
titer in cell free supernatants taken 5-7 days post infection was determined by a 
plaque assay (Burke and Mulcahy, 1980). 
Viral plaque assays were conducted using transfected and control cell 
monolayers (2.5 x 106 cells/cm2). Prior to IHNV infection, 1.0 uM water-soluble 
dexamethasone (dex, Sigma) in RPMI -1640 supplemented medium was  incubated for 
36 hours with a portion of the cells to induce the MMTV promoter.  Following dex 
induction, ten-fold dilutions of IHNV RB-1 suspended in 100 ul of RPMI-1640 
(without FBS or antibiotics) was incubated with the cells for five minutes.  The cells 
were washed briefly three times with medium, and then overlaid with complete 
medium containing 0.75% methylcellulose (Fischer Scientific) and 1.0 uM dex (in the 
dex induced cells only). The cells were held at 16° C for 10-14 days, and then fixed 
and stained with crystal violet in formalin (25% formalin, 10% ethanol, 5% acetic 
acid, 1% w/v crystal violet). The number of viral plaques were enumerated 
macroscopically and microscopically and standardized to PFU/ml (plaque forming 
units). 
Viral growth was also measured on transfected and control cell monolayers. 
The appropriate wells were induced with dex as above, and then infected with a 
multiplicity of infection of one. Infection was allowed to proceed for four days 
(100% lysis of control cells), the virus in the cell free supernatants was then measured 
by a plaque assay (Burke and Mulcahy, 1980). 
Immunohistochemistry 
Transfected and control cells which had been fixed and stained following viral 
plaque assays were subsequently stained immunohistochemically with an IHNV 
glycoprotein-specific monoclonal antibody, 3GH136J (Ristow and Arnzen de Avila, 
1991). The assay was performed exactly as described by Drolet et al. (1994). 88 
Nucleic acid analysis 
Southern analysis of genomic DNA and Northern analysis of cellular RNA 
extracted from transfected and control cells was performed as described by Sambrook 
et al. (1989). Prior to southern analysis, the genomic DNA was digested with the 
restriction enzymes Eco RI or Hind 111 (Promega). Total cellular RNA was isolated 
using RNAzoI according to the suppliers protocol (TM Cinna Scientific, Inc.). The 
RNA was electrophoretically separated on a formaldehyde-agarose gel (Sambrook et 
al. 1989). The southern and northern blots were hybridized with a  32P-labeled N-
specific probe (approximately 109 cpmlug) which was prepared using a random-
primed DNA labeling system (Amersham) according to the suppliers protocol. 
Following hybridization, the Northern and Southern blots were washed; the highest 
stringency wash was performed using 0.1 X SSPE (SSPE: NaCI, 149 mM; Na2HPO4­
H20, 10mM; EDTA, 0.99 mM) containing 1% SDS (sodium dodecyl sulfate), for 30 
min at 680 C. The blots were wrapped in Reynolds film and exposed to hyperfilm 
(Kodak) at -700 C. 
Results 
Transfected cell analysis 
The plasmids plvIMTV-neo, pMMTV -Luc, pN(+), and pN(-), were 
transfected into the EPC fish cells. Transfected cells were selected using the antibiotic 
G418; all of the pMMTV plasmid derivatives contain the neomycin resistance gene 
downstream of the SV40 promoter allowing G418 selection. 
The calcium phosphate precipitation (CPP) method of transfection resulted in 
a low efficiency of transfection compared to the liposome (L) transfection method. 
The CPP transfected cells yielded 16-20 individual G418 resistant colonies per 2x 107 
cells after one month of G418 selection. It required 2 months of propagation to reach 
confluency in a 9.4 cm2 dish. There were greater than 500 G418 resistant colonies 
per 2 X 107 cells using the L transfection method and the cells grew back to complete 
confluency after one month of G418 selection. For each method of transfection, 89 
isolated G418 resistant colonies could not be expanded. However, pooling of 6-10 
G418 resistant colonies and addition of rainbow trout embryo extract to the medium 
facilitated cell growth. Because the cells were pooled they were likely heterogeneous 
with regards to the number of copies of plasmid integrations per cell and the level of 
transgene expression. 
Southern blots were performed on high molecular weight DNA extracted from 
pN(+), and pN(-) CPP transfected G418 resistant cells approximately 5 months post 
transfection (Figure 5.1 a, b, and c). The DNA was digested with Eco RI and Hind 
111 restriction enzymes. The 7180 base pair Eco R1 fragment contains the pMMTV 
promoter, the N gene, the SV40 promoter, and the neomycinresistance gene for both 
plasmids pN(+) and pN(-) (Figure 5.1 a) . Thus, the EcoRl fragment contains 
plasmid sequences essential for conferring G418 resistance and expression of the 
sense and antisense N c D N A . The D N A digested w i t h Hind 1 1 1 reveals the positive 
sense orientation, 2090 and 1907 base pair fragments, and antisense orientation, 2419 
and 1578 base pair fragments, of the N gene in the plasmids pN(+) and pN(-).  The 
southern blots also revealed that the plasmid DNA had integrated into multiple sites 
and/or had integrated as concatamers in the cells genome as evidenced by numerous N 
probe hybridizing bands of higher and lower molecular weight than predicted by the 
plasmid restriction map. 
Northern blots were performed on RNA extracted from pN(+) and pN(-) CPP 
transfected G418 resistant cells approximately five months after transfection (Figure 
5.2). A portion of the transfected cells were treated with 1.0 uM dex to increase the 
synthesis of the transgene mRNA by the MMTV promoter (Lee et al., 1981). 
Hormone induction resulted in a 2-3 fold increase in N mRNA expression (Figure 5.2; 
lanes 1 and 3) compared to uninduced cells (Figure 5.2; lanes 2 and 4). 
Viral assays 
Viral plaque assays were performed on pN(+) and pN(-) transfected cells and 
non-transfected EPC or pMMTV-Neo ( blank plasmid) transfected cells as negative 
controls. In the first series of experiments the CPP transfection method was 
employed to generate cells containing the pN(+), pN(-), of pMMTV-Neo plasmids. 
Approximately 3 months (5 cell passages) after transfection there were a sufficient 
number of G418 resistant cells to perform a viral plaque assay. The viral plaque 90 
assays were conducted on transfected and control cells (pMMTV-Neo transfected 
and non-transfected EPC cells) grown in multi-well plates containing approximately 
2.5 X 106 cells/cm2. Prior to infection with IHNV, the appropriate cells were 
induced with 1 uM dex. The results of the first experiment are presented in Table 5.1. 
Macroscopic viral plaques appeared only on the control cell lines; there were not any 
macroscopic IHNV plaques on the uninduced or dex induced pN(+) or pN(-) 
transfected cells (Figure 5.3). However, at 10 X magnification there were minute 
plaques visible on the dex uninduced pN(+) and pN(-) transfected cells; there were 
also foci of infection on the dex induced cells (rounded cells) but there were not any 
cleared zones indicative of plaque formation. 
The viral resistance appeared to be dependent upon the expression of the N 
transgene. This is supported by the fmding that number of plaques formed and free 
virus particles released using control, dex induced or uninduced pMMTV-Neo or 
pMMTV-Luc transfected cells, were the same as non-transfected cells. Further, at 
the time of the assays all the cells lines were growing at similar rates and assayed at 
the same density. This discounts the possibility that viral resistance of the pN(+) and 
pN(-) transfected cells was due to the cells' growth characteristics or cell densities as 
previously described by Mulcahy et al. (1984). Finally, in a separate series of 
experiments, cell free supernatants taken from the pN(+) and pN(-) cell lines 
following an IHNV plaque assay tested negative for interferon production (data not 
shown). 
Following the viral plaque assays, the same tissue culture plates were probed 
with an IHNV glycoprotein specific monoclonal antibody, 3GH136J (Figure 5.4). 
The microscopic plaques found on the uninduced pN(+) and pN(-) transfected cells 
reacted with the G-specific antibody as did the viral plaques on the control cells. 
There were also individual rounded cells which reacted with the G-specific 
monoclonal antibody on the dex induced pN(+) and pN(-) transfected cells. 
The same cells used in the first plaque assay experiment were expanded to 
provide enough cells to repeat the viral assay (5 months post transfection, 12 
passages), and perform southern and northern blots. The viral plaque assay were 
performed the same as in the first experiment, the results are presented in Table 5.2 
(indicated as 2A). The pN(+) and pN(-) transfected cells were less resistant to IHNV 
plaguing than they were in the initial 3 month assay. In addition, the plaques formed 
on the pN(+) and pN(-) transfected cells were macroscopically visible (Figure 5.5). 
We investigated the possibility that the reduction of viral resistance of the 
pN(+) and pN(-) transfected cells was the result of a suppression of transgene 91 
Figure 5.1	  Southern blot analysis of pN(+) and pN(-) transfected cells. (A) 
shematic diagram of the pN(+) and pN(-) plasmids and predicted 
fragments released by EcoR1 or Hind 111 digestion. (B) EcoR1 
digested DNA (10 kg), lanes: 1, control pN(+) plasmid (10 pg); 2, 
pN(-); 3, pN(+). (B).Hind 111 digested DNA (20 kg), 
lanes: 1, control (EPC-DNA), 2, PN(-); 3, empty; 4, pN(+). 
Figure 5.2	  Northern blot analysis of pN(+) and pN(-) transfected cells. 
For the pN(+) and pN(-) transfected cells 3014 of total RNA was 
loaded/ well; for the IHNV infected cells 0.5 kg of total RNA was 
loaded/well. Lanes: 1 and 2, dex. induced and uninduced 
pN(+) transfected cells, respectively; 2 and 4 , dex induced and 
uninduced pN(-) transfected cells , respectively; 5, positive control 
IHNV  . The label 1400 is the approximate size, in nucleotides, of the 
band hybridizing with the labelled N cDNA. 92 
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assays were conducted on transfected and control cells (pMMTV-Neo transfected 
and non-transfected EPC cells) grown in multi-well plates containing approximately 
2.5 X 106 cells/cm2. Prior to infection with IHNV, the appropriate cells were 
induced with 1 uM dex. The results of the first experiment are presented in Table 5.1. 
Macroscopic viral plaques appeared only on the control cell lines; there were not any 
macroscopic IHNV plaques on the uninduced or dex induced pN(+) or pN(-) 
transfected cells (Figure 5.3). However, at 10 X magnification there were minute 
plaques visible on the dex uninduced pN(+) and pN(-) transfected cells; there were 
also foci of infection on the dex induced cells (rounded cells) but there were not any 
cleared zones indicative of plaque formation. 
The viral resistance appeared to be dependent upon the expression of the N 
transgene. This is supported by the fmding that number of plaques formed and free 
virus particles released using control, dex induced or uninduced pMMTV-Neo or 
pMMTV-Luc transfected cells, were the same as non-transfected cells. Further, at 
the time of the assays all the cells lines were growing at similar rates and assayed at 
the same density. This discounts the possibility that viral resistance of the pN(+) and 
pN(-) transfected cells was due to the cells' growth characteristics or cell densities as 
previously described by Mulcahy et al. (1984). Finally, in a separate series of 
experiments, cell free supernatants taken from the pN(+) and pN(-) cell lines 
following an IHNV plaque assay tested negative for interferon production (data not 
shown). 
Following the viral plaque assays, the same tissue culture plates were probed 
with an IHNV glycoprotein specific monoclonal antibody, 3GH136J (Figure 5.4). 
The microscopic plaques found on the uninduced pN(+) and pN(-) transfected cells 
reacted with the G-specific antibody as did the viral plaques on the control cells. 
There were also individual rounded cells which reacted with the 0-specific 
monoclonal antibody on the dex induced pN(+) and pN(-) transfected cells. 
The same cells used in the first plaque assay experiment were expanded to 
provide enough cells to repeat the viral assay (5 months post transfection, 12 
passages), and perform southern and northern blots. The viral plaque assay were 
performed the same as in the first experiment, the results are presented in Table 5.2 
(indicated as 2A). The pN(+) and pN(-) transfected cells were less resistant to IHNV 
plaguing than they were in the initial 3 month assay. In addition, the plaques formed 
on the pN(+) and pN(-) transfected cells were macroscopically visible (Figure 5.5). 
We investigated the possibility that the reduction of viral resistance of the 
pN(+) and pN(-) transfected cells was the result of a suppression of transgene 95 
Table 5.1.  IHNV plaque assays on control non-transfected EPC, and pMeaN(+) 
and pMeaN(-) transfected EPC cells ( 5 cell passages). 
PFU/m1 X 106  Reduction of PFU/m1 
Cell line  (+) dex  () dex  (+) dex  (-) dex 
Control  24  25 
pN(+)  0  25.3  100%  0% 
pN(-)  0  28.6  100%  0% 
The reduction of PFU/ml was calculated as percentage of control values. 
Each test was performed in triplicate, the average PFU/ml is presented. 
The standard deviation was less than 7 for all measurements. 96 
Figure 5.3  IHNV plaque formation following infection of control pMMTV-Luc, 
pN(+) or pN(-) transfected cells ( 5 cell passages). Each well 
(duplicates are shown) were infected with roughly 250 PFU IHNV. 
Figure 5.4  Immunohistochemical analysis of control pMMTV-Luc or p(N-) 
transfected cells following viral infection (see Table 1 and figure 5.3). 
The cells were stained with an IHNV G-specific monoclonal 
antibody; the red stained cells indicate viral infection. (A) control 
cells, (B) pN(-) transfected cells without dex, (C) pN(-) transfected 
cells with dex. 97 
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Table 5.2.	  IHNV plaque assays on control pMMTV-luc transfected cells, and 
pMeaN(+) and pMeaN(-) transfected EPC cells. The assay was 
conducted using CPP-transfected cells indicated as IA (12 cell 
passages), or L-transfected cells indicated as 2A following 
(3 passages). 
PFU /ml X 106	  Reduction of PFU/ml 
Cell line  (+) dex  (-) dex  (+) dex  (-) dex 
Control
 
IA  55.5  51.5
 
2A  17.7  16.1
 
pN(+) 
1A  38.1  28.5*  31%  45% 
2A  11.3  11.9  36%  26% 
pN(-) 
IA  1  23  99% 54% 
2A  8.4  11.1  52%  31% 
The reduction of PFU/ml was calculated as percentage of control values. Each 
test was done in triplicate, the average PFU/ml is shown. The standard deviation 
was less than 7 for all measurements except *which was 13. 100 
Figure 5.5	  IHNV plaque formation following infection of control pMMTV -Luc, 
pN(+) or pN(-) transfected cells (12 cell passages). Each well 
(duplicates are shown) were infected with roughly 450 PFU IIiNV. 101 
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Figure 5.5 102 
expression due to reduced activity of the MMTV promoter by methylation. 
However, treatment of the pN(+) and pN(-) transfected cells (6 months post 
transfection, 15 passages) with 5-aza-2'-deoxycytidine which causes 
hypomethylation, Friedman et al., 1989), at different concentrations for different 
lengths of time did not increase the viral resistance of the cells (data not shown). 
Because the degree of viral resistance of the pN(+) and pN(-) transfected cells 
changed with time we generated another series of cell lines using lipofection mediated 
transfection. During the course of this study we found that this technique enhanced 
the number of transfected cells and reduced the time required to generate enough cells 
to perform the plaque assays. The results of the plaque assay performed on L 
transfected pN(+) and pN(-) positive cells (2 months post transfection, 3 cell 
passages) are also presented in Table 5.2 (indicated as 2B). The experiments 
conducted with the L transfected cells included as a negative control cells transfected 
with pMMTV -Luc. The L transfected cells were less resistant to IIINV plaguing 
than the CPP pN(+) and pN(-) transfected cells assayed at 3 and 5 months. 
However, both the CPP and L transfected pN(+) and pN(-) cells inhibited IHNV 
plaguing. Additionally, the CPP and L generated pN(-) cells were more resistant than 
the CPP and L generated pN(+) cells to IHNV plaguing. Though the degree of 
resistance was not identical for CPP and L transfected cells, the results demonstrated 
that pN(+) and pN(-) cells were IHNV resistant. 
The growth of IHNV in L transfected pMMTV-Luc control cells, and pN(+) 
and pN(-) transfected cells was measured. The cells were infected with IHNV at an 
m.o.i of 1. The cell free supernatants were collected four days post infection (100% 
lysis of the control cells), and the number of free viral particles was enumerated by a 
plaque assay. The results of the experiment are presented in Table 5.3. Consistent 
with the plaque assay, the pN(-) transfected cells produced less infectious virus than 
the pN(+) cells both of which produced less virus than the pMMTV-Luc transfected 
cells. There was little difference in the reduction of viral titers between the dex 
induced and uninduced pN(+) and pN(-) transfected cells. Infection of pN(+) and 
pN(-) transfected cells eventually resulted in 100% lysis. However, the time required 
for 100% lysis of pN(+) and pN(-) transfected cells was delayed approximately 24­
36 hrs compared to the pMMTV-Luc transfected cells (data not shown). 103 
Table 5.3.  Viral growth on control pMMTV-luc transfected cells, 
and pMeaN(+) and pMeaN(-) transfected cells 
(12 cell passages) 
Viral titre (PFU/ml X 106)  Reduction of viral titre 
Cell line  (+) dex  (-) dex  (+) dex  (-) dex 
Control  13.1  9.4 
pMeaN(+)  4  3.1  69%  66% 
pMeaN(-)  2.8  3.3  78%  64% 
The reduction of viral titres was calculated as percentage of control values. 
Each test was performed in triplicate, the average PFU/ml is shown. The standard 
deviation for each measurement was less than 7 
Discussion 
In this report IHNV N transgenes in the sense and antisense orientation were 
tested for their ability to interfere with IHNV replication. Two methods were used to 
measure viral interference; a plaque assay, and directproduction of free viral particles. 
In each case, the presence of pN(+) and pN(-) plasmids in transfected cells correlated 
with a significant reduction in the number of viral plaques or free virus particles 
caused by IHNV infection. 
While the pN(+) and pN(-) cell lines were resistant to IHNV plaque 
formation, the degree of resistance changed with cell passage. Several explanations 
could account for the temporal change. It is possible that cellular expression of the 
viral transgenes decreased with increasing cell passage. It has been reported that 
methylation of the MMTV promoter in stably transfected cells occurs with cell 
passage resulting in reduced gene expression from the promoter (Friedman et al., 1989; 
Darbe and King, 1987). However, treatment of the pN(+) and pN(-) transfected cells 
with 5'-aza-2'-deoxycytidine, which has been found to partially reverse the effects of 
methylation (Friedman et al., 1987; Midgeon et al., 1988), did not increase the viral 
resistance of the pN(+) or pN(-) transfected cells. It is also possible that during 104 
passage some of the pN(+) and pN(-) transfected cells lost their ability to express the 
virus inhibiting molecule. Uniform expression of viral interfering molecule by a cell 
population has previously been shown to be a requirement for successful intracellular 
immunity to reticuloedotheliosis virus (REV) (Federspiel et al., 1990). However, 
since the temporal change in the degree of immunity was unexpected, and all the cells 
were used for expansion (to repeat the plaque assay), appropriate experiments could 
not be conducted to test the second hypothesis and will be pursued in the future. 
Despite the discrepancy in the degree of viral resistance observed over time, 
the pN(+) and pN(-) were nevertheless viral resistant. Similar results have been 
reported using oligodeoxyriboducleoside methylphosphonates (oligoMP) (Agris et al., 
1986) and poly(L-lysine)-conjugated oligodeoxyribonucleotides (PLO) (Lemaitre et 
al., 1987; Leonetti et al., 1988) complementary to the N mRNA of the rhabdovirus 
VSV. In each case the interfering oligonucleotide inhibited the titers of VSV by 
roughly one to two logs. In addition, Lemaitre et al. (1987) reported that a PLO 
(positive sense) complementary to the VSV genome intergenic region reduced viral 
titers by two logs. 
Thus, there is precedent evidence for both sense and antisense mediated 
inhibition of rhabdoviral replication. However, as is the case for many studies, it is 
difficult to ascribe a mechanism of viral interference since a biological assay was used. 
Still, several observations can be made which will be useful in giving direction to 
future experiments. First, antisense mediated viral inhibition is consistently more 
effective than sense inhibition. This has also been observed previously using a similar 
strategy with HIV (Sczakiel et al., 1990; Joshi et al., 1991; Junker et al., 1994). It will 
be important to determine if this is due to differences in the ability of the interfering 
molecule to block a critical step in the IHNV life-cycle or , as Sczakiel et al. (1990) 
pointed out, due to differences in the accessibility of the interfering molecule or its 
viral target. Second, interference is not absolute. This was particularly evident when 
the number of free infectious IHNV particles released from pN(+) and pN(-) 
transfected cells was measured. In addition, even when no IHNV plaques were 
present on pN(+) and pN(-) transfected cells, IHNV could be detected in scattered 
cells by immunohistochemistry. It will be important to determine if this viral 
"breakthrough" was due to the virus overwhelming the interfering molecule as has 
previously been suggested (Rhodes and James, 1990; Joshi et al., 1991; Sczakiel et al., 
1992;) or rather due to a lack of uniformly expressed interfering molecules. 
In summary, the study presented here demonstrates that IHNV infection can 
be interrupted by expression of the antisense N cDNA in the sense or antisense 105 
orientation. This should provide a basis for future worked aimed at understanding the 
intracellular life-cycle of IHNV. Further, this strategy may be valuable in gaining 
further insight of the role and importance of IHNV proteins and RNA needed for viral 
replication. 
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Abstract 
Infectious hematopoietic necrosis virus (IENV) mRNA was detected in 
steelhead fry using nucleic acid in situ hybridization. Digoxigenin-labeled 
oligonucleotide probes specific for the IHNV nucleocapsid mRNA were used. 
Asymptomatic, moribund, and dead fish were taken from an experimentally induced 
IHNV epizootic and prepared for in situ hybridization. The optimal conditions for 
probe concentration, hybridization stringency, washing stringency and color 
development were determined. IHNV was detected in many organs and tissues as has 
been found by the isolation of virus in organ extracts. In addition, this technique has 
led to the identification of the specific cell types which were susceptible to infection 
in each organ. 
Introduction 
IHNV is a rhabdovirus that infects certain species of salmonid fish and is 
found endemically on the Pacific Coast of the North American continent and Japan. 
The route of transmission of IHNV in nature is unknown. However, experimental 
studies suggest that the virus can be transmitted both vertically and horizontally. The 
strongest evidence for vertical transmission comes from the association made between 
the appearance of the disease and the shipment of infected eggs into new geographical 
areas (Holway and Smith, 1973; Wolf et al., 1973). Horizontal water-borne 
transmission of IHNV has also been demonstrated by a number of investigators 
(Amend, 1975; Wingfield and Chan, 1970; Mulcahy et al., 1983) In these studies, 
susceptible fish held in the effluent water from infected fish subsequently became 
infected with IHNV. The relative importance of the different transmission routes in 
the maintenance of the virus in nature has been the subject of considerable 
controversy. 
One reason for the continued discussion on the role of vertical or horizontal 
transmission in the life cycle of IHNV is that a carrier state for IHNV may exist 
(Amend, 1975). After a typical IHNV epizootic, survivors continue to release virus 
for approximately one month, at which time they become virus negative by virus 
isolation assays. However, these survivors may return to the hatchery during 
spawning and release large quantities of virus in the milt or ovarian fluids. It is unclear 112 
whether these returning adults were IHNV carriers or if they were reinfected with 
IHNV when they returned for spawning. The work that is reported here was carried 
out to determine whether sensitive techniques like in situ hybridizationmight be used 
to detect the virus in "carrier" fish. 
Materials and Methods 
Virus and cells 
The Round Butte (RBI.) strain of IHNV was isolated in 1975 from adult 
steelhead trout at Round Butte Hatchery in Oregon. The tissue culture studies were 
conducted on chinook salmon embryo cells (CHSE-214) which were obtained 
originally from J. L. Fryer, Oregon State University, Corvallis, Oregon. The cells 
were grown as monolayers in Dulbecco's MEM supplemented with 10% fetal bovine 
serum, 100 'Wml penicillin, and 100 ug/ml streptomyocin (all from GIBCO) For the 
infected cell cultures used in these experiments, the cells were infected at a 
multiplicity of infection (MOI) of 0.5. 
Labeling of the N gene probe 
The nucleocapsid (N) gene specific oligonucleotide, 5'­
CTTGGTGAGCTTCTGTCCA-3', and the non-homologous Lactococcus 16 S rRNA 
specific oligonucleotide 5'- CTTTGAGTGATGCAATTGCATC -3', were prepared 
by the Central Service Facility of the Center for Gene Research and Biotechnology, 
Oregon State University. The N gene probe has been found to be specific for IHNV 
and also conserved in a wide variety of HMV isolates (Arakawa et al., 1990). The 16 
S rRNA probe will specifically detect Lactococcus lactis subsp. cremoris (Salama et 
al., 1991). The 3' end of each probe was enzymatically labeled with digoxigenin with 
digoxigenin-11-dUTP by terminal deoxynucleotidyl transferase as directed by 
Boehringer Mannheim. The digoxigenin-labeled probe was able to detect 3 pg of 113 
IHNV cDNA in a dot blot. This was equivalent to approximately 105 copies of viral 
RNA. 
Eisla 
Steelhead trout (Oncorhynchus mykiss) were obtained through the Oregon 
Department of Fish and Wildlife. The fish, in two groups of 2,000 were infected by 
water-borne challenge with 103 plaque forming units (PFU) /nal IHNV as described by 
Engelking and Leong (1989). After 80 days, the total cumulative mortality in the 
population was 42%. Fish were taken at three day intervals until the onset of 
mortality, when moribund fish were taken at daily intervals for fixation and 
subsequent examination by in situ hybridization. 
Preparation of sections for in situ hybridization 
Fish that died of an IHNV infection and uninfected control fish were fixed in 4 
% paraformaldehyde (prepared in PBS, 0.14M NaCl, 10mM sodium phosphate, pH 
7.4), 0.005M MgC12, for at least 24 h. The fish were then decalcified in Calex 
Decalcifier (Fisher Scientific) for 24 h. After this, the fish were dehydrated and 
embedded in paraffin. Sagittal sections were cut with a microtome to 6 p.m thickness 
and the sections were stored for up to two weeks at room temperature. 
For in situ hybridization, thin sections of fish were deparaffmized in xylene 
followed by rehydration in ethanol and then equilibrated in 2 X SSC (1 X SSC is 0.15 
M NaCl, 0.015M sodium citrate, pH 7.4) for 5 min. The samples were then treated 
with 0.25% (V/V) acetic anhydride in 0.1 M triethanolamine, pH 8.0, for 10 min and 
then equilibrated in 5 X SSC. 
All samples were prepared for hybridization by soaking in a solution of 5 X 
SSC, 0.5 mg/ml salmon sperm DNA (Sigma), and 0.25 mg/ml yeast tRNA (Sigma) for 
1 h. Thirty nanograms of the digoxigenin-labeled probe were mixed in 35 41 of 
hybridization solution and added to each slide. The hybridization and subsequent 
washing conditions were determined experimentally. After washing, the slides were 
equilibrated briefly in Buffer 1 (0.1 M Tris-OH, 0.15 M NaCI, pH 7.5) and then 114 
blocked for 30 min in Buffer 1 containing 2% sheep serum and 0.03% Triton X-100. 
The slides were rinsed in Buffer 1 and then incubated with a 1:500 dilution of sheep 
anti-digoxigenin (Boehringer Mannheim) for 1 h in the blocking solution, containing 1 
% instead of 2% normal sheep serum. The slides were then washed two times in 
Buffer 1 and then soaked in Buffer 2 (0.1 M Tris-OH, pH 8.0) for 5 min. 
Color Development 
Vector color substrate kit 3 (Vector Laboratories) was made in Buffer 2 
according to the manufacturer's instruction and 500 µl was applied to the slides. The 
slides were stored in a light-tight moist chamber and viewed periodically until a 
suitable color reaction was observed. The slides were rinsed in distilled water and 
mounted in crystal/mount (Biomeda). 
Results and Discussion 
An understanding of the pathogenesis of IHNV at the cellular level has been 
greatly improved by the development of techniques and specific probes to detect 
IHNV directly in tissues (Yamamoto et al., 1990; Arakawa et al., 1990). Analysis of 
nucleic acid extracted from tissue specimens by the polymerase chain reaction has also 
proven to be very sensitive for detecting low copy numbers of viruses in these 
materials. However, identification of the specific cell types that were infected is not 
possible with this procedure. Nucleic acid in situ hybridization and 
immunocytochemistry remain valuable techniques for localizing viruses and viral gene 
products in individual cells. We report here a method for detecting the IHNV N gene 
mRNA in infected cells and fish tissue. 
In the initial series of experiments, hybridization stringency was investigated 
to determine the hybridization temperature at which cross-reactivity of the IHNV N 
mRNA specific probe with uninfected tissues was eliminated. The stringency was 
controlled either by increasing concentrations of formamide in the hybridization fluid 
at 420 C or by increasing the temperature of hybridization. When concentrations of 
formamide above 15 % were used, it was clear that hybridization of the 115 
Table 6.1  Serial sections of IHNV (RBI) infected or control fry were 
hybridized at 42° C in increasing concentrations of formamide to 
determine the optimum hybridization stringency 
Percent  Hybridization 
Fish section  formamide  Control  Infected 
1  0  +  + 
2  1  ND  + 
3  5  ND  + 
4  10  ND  + 
5  15  ND  +/­
6  20  +1­ +1­
7  30  ND 
8  50  +/­
ND, not done. 
oligonucleotide probe was reduced gable 6.1) The disruption of stable duplexes in 
the presence of formamide was similar in both infected and uninfected fish. In 
contrast, there was a clear difference in the temperature at which the duplexes were 
disrupted when the formamide was omitted from the buffer and the temperature was 
varied. Hybridization of the non-homologous probe was reduced at 480 C and 
completely disrupted at 50° C. The IHNV specific probe formed stable duplexes 
with the IHNV N mRNA at 48° C. 
The optimal washing temperature was also determined to ensure that the 
IHNV N gene probe did not bind nonspecifically to cellular nucleic acid. After several 
washes in SSC as described in figure 6.1, serial sections of an infected fry were 
subjected to a wash in 0.1 X SSC at different temperatures for 1 h. Hybridization 
with the non-homologous probe was decrease at temperatures above 480 C and 
completely eliminated at 52° C. In contrast, the homologous probe did not exhibit 
reduced hybridization until the wash was performed at 55° C and there was complete 
loss of hybridization at 60° C. 116 
Fish 
Fix in 4% paraformaldehyde, 5mM MgC12 at least 24 hr 
Decalcify for 24 hr in calex 
Dehydrate and embed 
Cut 6 uM sections and place on gelatin-coated slides 
Fish sections 
Deparaffinize in x-ylene and rehydrate in graded ethanol washes 
Treat with acetic anhydride and triethanolamine 
Prehybridize at room temperature for 1 hr 
Hybridization 
Hybridize 16-24 hr at 48 °C in a moist chamber 
Washes 
1 hr at room temperature in 2 x SSC, then 1 hr in lx SSC 
Stringency wash at 55 °C, 30 min 
1 hr in 0.1 x SSC, room temperature 
Antibody 
Block sections for 30 min in Buffed + 2% normal sheep serum 
Incubate with anti-digoxigenin for 1 hr 
Wash two times in Buffer 1 for 10 min 
Color Reaction 
Equilibrate slides for 5 min in color reaction buffer 
Apply color reagents and incubate in the dark until color develops 
Figure 6.1. Outline of procedure for in situ hybridization 117 
Table 6.2  Serial sections of IHNV (RB 1) infected fry were hybridized with a 
non-homologous Lactococcus 16 S rRNA specific probe or an IHNV 
N mRNA specific probe to determine the optimum temperature of 
hybridization. The hybridization buffer contained no formamide. 
Hybridization 
Section  Temp., 0C  Lactococcus  IHNV N 
1  42  + + 
2  48  +/- + 
3  50  +/- + 
4 52  + 
5  55  +/­
6  60 
Table 6.3	  Serial sections of IHNV (RB1) infected fry were washed at increasing 
temperatures in 0.1 x SSC to determine the optimum stringency needed 
to eliminate non-specific probe hybridization. 
Hybridization 
Section  Temp., 0C  Lactococcus  IHNV N 
1  42  + + 
2  48 + + 
3  50  +/- + 
4  52  +/- + 
5  55  - +/­
6	  60 118 
Figure 6.2	  Localization of IHNV in fish sections by in situ hybridization. 
Histological section of the cerebellum and medulla oblongata of a 
steelhead fry which died 10 d after an IHNV challenge. The non­
homologous probe (A) did not hybridize with the brain tissue. The 
IHNV specific probe (B) hybridized to N mRNA strongly in the 
molecular layer (upper arrow) of the cerebellum with a weak reaction 
in the granular layer immediately under the molecular layer. There is 
also a weak hybridization in the medulla oblongata which is indicated 
by the lower arrow 119 
(A)
 
(B)
 
Figure 6.2 120 
These results led to the development of a procedure for detecting the IHNV N 
mRNA in situ by hybridization with an oligonucleotide probe. This procedure is 
outlined in figure 6.1. The specificity of the reaction was determined by the washing 
conditions used to disrupt nonspecific hybridization (Table 6.3) The method calls for 
hybridization of a digoxigenin-labeled oligonucleotide probe to fish sections at 480 C 
without formamide for 24 h which is followed by a stringency wash at 55° C. 
The pathogenesis of IHNV infection were examined by in situ hybridization in 
10 infected fish taken at the height of an IHNV epizootic. IHNV was located in the 
brain, gills, eyes, kidney, heart, liver, spleen, pyloric caeca, pancreas, stomach, 
intestine, skin, and muscle. Reactions were particularly strong inthe anterior kidney 
tubules and hematopoietic tissues. The parenchymal tissue of the liver was positive 
and the epithelial cells near the surface of the skin were also positive.  The most 
conspicuously positive hematopoietic cells were neutrophils, unidentified 
lymphocytes and, rarely, erythrocytes. In the brain, the cerebellum was heavily 
infected in the molecular layer with diffuse infection in the granular layer (Figure 6.2). 
The brain infection may be one reason for the erratic swimming pattern observed in 
infected fish. In addition, preliminary results suggest that the medulla oblongata and 
the spinal cord are also sites of infection. These sites may account for the 
development of scoliosis which is often associated with survivors of an IHNV 
epizootic (Busch, 1983) 
The fish examined in this study were taken at the height of an IHNV 
epizootic, and it was possible to discern sites of infection and cell types susceptible 
to IHNV infection. However, it was not possible to determine the initial sites of 
infection or the course taken in the spread of the infection in the animal. Those 
studies are in progress. We are also determining whether survivors of an IHNV 
epizootic can become lifelong carriers of the virus. 
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CHAPTER 7
 
THESIS SUMMARY
 
In this thesis a molecular study of the cytopathic mechanisms of infectious 
hematopoietic necrosis virus (IHNV) in vivo and in vitro was reported. The approach 
was to develop and use methods that interfered with IHNV, or localized IHNV in 
vivo, to better understand the cytopathicity of IHNV. Several new pieces of 
information regarding IHNV cytopathicity were discovered. In addition, several 
techniques were developed which should be useful to future scientific endeavors. 
Genetic immunization 
The finding that naked plasmid DNA can be easily delivered to somatic cells in 
vivo, and is capable of synthesizing its encoded proteins (Wolff et al., 1990), has led 
to the use of naked DNA for vaccination. In this thesis the feasibility of using such 
an approach was investigated. The ultimate goal was to determine if plasmid DNA 
encoding the IHNV glycoprotein (G) or nucleoprotein (N) could immunize fish 
against IHNV and if so, determine the importance and interaction of these proteins in 
evoking an immune response. 
In Chapter 4, it was demonstrated that naked DNA delivered by a simple 
injection protocol could be taken up and efficiently expressed by a number of tissues. 
It was found that gene expression was of prolonged duration. In addition, it was 
found that the DNA did not integrate into the genome nor was it replicated. Taken 
together, these results suggest that in a number of instances, including promoter 
analysis and functional analysis of protein synthesis, the direct injection of naked 
DNA could replace or complement the development of transgenic fish. This 
technique could also be used as an approach toward gene therapy, for instance using 
cytokines or growth enhancing genes . 
Future research on somatic cell delivery of DNA should include the following: 
1) Determination of the mechanism(s) of DNA uptake by cells in vivo. 2) 
Determination of the impact of the plasmid DNA on the health of the transfected 
organism. 3) Development of new DNA delivery systems. 3) Development of 124 
plasmids capable of integrating in a site specific manner. 4) Identifying promoters 
which express the transgenes in a tissue specific manner. 
In Chapter 5, it was reported that the DNA vaccine pCMV4-G injected into 
fish either alone or in combination with pCMV4-N promoted both a G-specific 
immune response and immunized fish against IHNV. This work confirms that the 
IHNV G protein is capable of inducing a protective immune response in fish. The 
plasmid pCMV4-N did not induce an antibody response nor did it protect fish against 
IHNV. However, pCMV4-N did appear to augment the humoral immune response 
against the IHNV G protein in fish injected with a combination of the two DNA 
vaccines. 
Future work on the DNA vaccines should include the following:  1) 
Determining the role of the N protein in the immune response of fish. 2)  Determining 
whether other vaccination protocols (quantity of DNA, boosters, method of delivery) 
alter the type of immune response 3) Determine the duration of the immune 
response. 4) Develop practical methods for the mass vaccination of fish. 
Intracellular immunization 
Izant and Weintraub (1984) were the first to show that endogenously 
synthesized, artificially introduced, expression of antisense RNA could interfere with 
its complementary RNA in eukaryotic cells. Since this initial report, antisense and 
sense suppression of viral genes has been successfully employed using both plant and 
animal model systems. 
In Chapter 5, this technology was used to interfere with the life cycle of 
IHNV. Both sense and antisense expression of the IHNV N gene in transfected fish 
cells produced a state of intracellular immunity. The immunity was temporal 
decreasing with cell passage. Cellular antisense expression of N was more efficient 
than sense expression in providing immunity to IHNV. Taken together these results 
suggest that viral synthesis of the N mRNA or protein is an integral part of the 
replication cycle of IHNV. 
Areas of future research should include: 1) Comparative study of the other 
IHNV genes ability to interfere with IHNV replication. 2) A structural analysis of 
the portion(s) of the antisense and sense N RNA responsible for mediating the 125 
resistance. 3) Development of transient assays allowing the circumvention of the 
tedious and time consuming process of selecting IHNV resistant cell lines. 
In Chapter 5, several techniques were developed which were not available 
previously to those using fish cell culture. Specifically, a highly efficient transfection 
protocol was established. Using lipofection , transient transfection efficiency 
approaching 30% were achieved. by optimizing both cell culture conditions and ratios 
of lipid (Lipofectamine, Gibco) and DNA. Prior to this technology, transfection 
efficiencies of 1% or less were common. In addition , protocols for the maintenance 
and long term culture of transfected, antibiotic resistant cells, was established. 
Localization of IHNV In Vivo 
It is unclear whether fish surviving an IHNV infection become life long carriers 
or recover and thereafter are virus free. There has been only one report showing that 
fish could become life long carriers of IHNV (Amend et al. 1976) However, numerous 
reports have demonstrated that infectious virus can not be isolated from fry surviving 
an IHNV epizootic after 40-50 days. Nevertheless, there is a possibility that IHNV 
persist at levels below that detectable by tissue culture assays. 
Thus, the development of in situ hybridization, reported in Chapter 6, should 
provide an important tool for the study of the IHNV life cycle. The technique is 
sensitive and can be used to determine which cell types are infected with IHNV. Using 
a similar technique, in situ immunohistochemistry, Drolet etal. (1995) have shown that 
IHNV can persist in fish. It is still uncertain in which tissues IHNV is replicated 
during a persistent infection. This question could likely be answered using in situ 
hybridization since it allows identification of both viral genome RNA and mRNA. 126 
BIBLIOGRAPHY
 
Agris, C. H., B. K. R. Blake, P. S. Miller, M. P. Reddy and P. O. P. Ts'O (1986). 
Inhibition of vesicular stomatitis virus protein synthesis and infection by 
sequence-specific oligodeoxynucleotide methylphosphonates. Biochemistry 
25: 6268-6275. 
Amend, D. F. (1970). Control of infectious hematopoietic necrosis virus desease by 
elevating the water temperature. J. Fish. Res. Board Can. 27: 265-270. 
Amend, D. F. (1975). Detection and transmission of infectious hematopoietic necrosis 
virus in rainbow trout. J. Wildl. Dis. 11: 471-478. 
Amend, D. F. (1976). Prevention and control of viral disease of salmonids. J. Fish. 
Res. Bd. Canada 33: 1059-1066. 
Amend, D. F. and V. C. Chambers (1970). Morphology of certain viruses of salmonid 
fishes.  1. In vitro studies of some viruses causing hematopoietic necrosis. J. 
Fish. Res. Bd. Canada 27: 1285-1293. 
Amend, D. F. and V. C. Chambers (1970). Morphology of certainviruses of salmonid 
fishes. 11. In vivo studies of infectious hematopoietic virus. J. Fish. Res. Bd. 
Canada 27: 1385-1388. 
Amend, D. F. and J. P. Pietsch (1972). Virucidal activity of two iodophores to 
salmonid viruses. J. Fish. Res. Board. Can. 29: 61-65. 
Amend, D. F., W. T. Yasutake and R. W. Mead (1969). A hematopoietic virus disease 
of rainbow trout and sockeye salmon. Trans. Am. Fish. Soc. 98: 796-804. 
Andersson, S., S. Davis, D. N. Dahlback, H. H. Jomvall and D. W. Russell (1989). 
Cloning, structure, and expression of the mitochondrial cytochrome P-450 
sterol 26-hydroxylase, a bile acid biosynthetic enzyme. J. Bio. Chem. 264: 
8222-8229. 127 
Arakawa, C. K., R. E. Deering, K. H. Higman, K. H. Oshima, P J. Ohara and J. R. 
Winton (1990). Polymerase chain reaction (PCR) amplification of a 
nucleoprotein gene sequence of infectious hematopoietic necrosis virus. Dis. 
Aqua. Org. 8: 165-170. 
Araki, K., N. Hiroyuki and 0. Hiroshi (1991). Transfection of the dominant selective 
marker, pSV2neo, into a fish cell line epithelioma papulosum cyprini (EPC). 
Bull. Natl. Res. Inst. Aquaculture 20: 1-9. 
Ascadi, G., G. Dickson, D. R. Love, A. Jani, F. S. Walsh, A. Gurusinghe, J. A. Wolff 
and K. E. Davies (1991). Human dystrophin expression in mdx mice after 
intramuscular infection of DNA constructs. Nature 352: 815-818. 
Balmer, I., C. Thou, X.-J. Yu, Q.-L. Hao, J. C. Guatelli and D. B. Kohn (1993). 
Comparison of trans-dominant inhibitory mutant human immunodeficiency 
virus type 1 genes expressed by retroviral vectors in human T lymphoctes. J. 
Virol. 67: 3199-3207. 
Banerjee, A. K. (1987). Transcription and Replication of Rhabdoviruses. Microbiol. 
Rev. 51(1): 66-87. 
Batts, W. N., M. L. Landolt and J. R. Winton (1991). Inactivation of infectious 
hematopoietic necrosis virus (IHNV) by low levels of iodine. Appl. Environ. 
Microbiol. 57: 1379-1385. 
Baxby, D. and E. Paoletti (1992). Potential use of non-replicating vectors as 
recombinant vaccines. Vaccine 10: 8-9. 
Bayever, E., P. Iversen, L. Smith, J. Spinolo and G. Zon (19992). Guest editorial: 
systemic human antisense therapy begins. Antisense Res. Dev. 2: 109-110. 
Benvenisty, N. and L. Reshef (1986). Direct introduction of genes into rats and 
expression of the genes. Proc. Natl. Acad. Sci. USA 83: 9551-9555. 128 
Bevec, D. M., J. Drobovnic, J. Hauber and E. Bohniein (1992). Inhibition of human 
immunodeficiency virus type 1 replication in human T cells by retroviral 
mediated gene transfer of a dominant -negative Rev trans-activator. Proc. Natl. 
Acad. Sci. 89: 9870-9874. 
Bovo, G., G. Giorgetti, P. E. V. Jorgensen and N. J. Nelson (1987). Infectious 
hematopoietic necrosis: first detection in Italy. Bull. Eur. Ass. Fish Pathol. 7: 
124. 
Brem, G., B. Brenig, G. Horstgen-Schwark and E. L. Winnacker (1988). Gene transfer 
in tilapia (Oreochromis niloticus). Aquaculture 68: 209-219. 
Brown, D. W., Y. Kawaoka, R. G. Webster and H. L. Robinson (1992). Assesment of 
retrovirus-expressed nucleoprotein as a vaccine against lethal influenza virus 
infections of chickens. Avian Dis. 36: 515-520. 
Burke, J. and D. Mulcahy (1980). Plaguing procedure for infectious haematopoietic 
necrosis virus. Appl. Env. Microbiol. 39: 872-876. 
Burke, J. A. and R. S. Grischkowsky (1984). An epizootic caused by infectious 
hematopoietic necrosis virus in an enhanced population of sockeye salmon 
Oncorhynchus nerka (Walbaum) smolts at Hidden Creek, Alaska. J. Fish Dis. 
7: 421-429. 
Busch, It (1983). J.C. Leong and T. Y. Barila, ed. In: Proceedings of a workshop on 
viral diseases of salmonid fishes in the columbia river basin, Oct. 7-8, 1982, 
Portland, Oregon. Special Publication, Bonneville Power Administration, 173. 
Castric, J. and J. Jeffory (1991). Experimentally induced diseases in marine fish with 
IHNV and a rhabdovirus of eel, pp. 55-54 In: N De Pauw and J. Joyce (eds.), 
Aquaculture and the environment. EAS Special Publication No. 14. Dublin, 
Ireland. 
Chang, L.-J. and C. M. Stoltzfus (1985). Gene expression from both intronless and 
intron-containing rous sarcoma virus clones is specifically inhibited by anit­
sense RNA. Mol. Cell. Biol. 5: 2341-2348. 129 
Chaterjee, S., P. it Johnson and K. K. J. Wong (1992). Dual-target inhibition of HIV­
1 in vitro by means of an adeno-associated virus antisense vector. Science 258: 
1485-1488. 
Chen, M. F. (1984). Comparative susceptibility of salmonid fish and salmonid fish 
cell lines to five isolates of infectious hematopoietic necrosis virus and 
biological properties of two plaque variants. Ph.D. Thesis, Oregon State 
University, Corvallis Oregon, pp. 124. 
Cheng, L., P. it Ziegelhaffer and N.-S. Yang (1993). In vivo promoter activity and 
transgene expression in mammalian somatic tissues evaluated by usingparticle 
bombardment. Proc. Natl. Acad. Sci. USA 90: 4455-4459. 
Chourrout, D., R. Guyomard and L.-M. Houdebine (1986). High efficiency gene 
transfer in rainbow trout ( Salmo Gairdneri Rich.) by microinjection into egg 
cytoplasm. Aquaculture 51: 143-150. 
Colwell, it it (1983). Biotechnology in the marine sciences. Science 222: 19-24. 
Cox, G. J. M., T. J. Zamb and L. A. Babiuk (1993). Bovine herpesvirus 1: Immune 
responses in mice and cattle injected with plasmid DNS. J. Virol. 67: 5664­
5667. 
Crowley, T. E., W. Nellen, It H. Gomer and R. A. Firtel (1985). Phenocopy of 
discoidin I-minus mutants by antisense transformation in dictyostelium. Cell 
43: 633-641. 
Culp, P., C. Nusslein-Volhard and N. Hopkins (1991). High-frequency germ-line 
transmissio of plasmid DNA sequences injected into fertilized zebrafish eggs. 
Proc. Natl. Acad. Sci. USA 88: 7953-7957. 
Cuozzo, M., K. M. O'Connel, W. Kaniewski, R.-X. Fang, N.-H. Chua and N. E. 
Turner (1988). Viral protection in transgenic tobacco plants expressing the 
cucumber mosaic virus coat protein or its anisense RNA. Biotechnol. 6: 549­
556. 130 
Darbe, P. D. and R. J. B. King (1987). Progression to steroid insensitivity can occur 
irrespective of the presence of functional steroid receptors. Cell 51: 521-528. 
Davidson, G. A., A. E. Ellis and C. J. Secombes (1993). Route ofimmunizatio 
influences the generation of antibody secreting cells in the gut of rainbow trout 
(Oncorhynchus mykiss). Devel. Comp. Immunol 17: 373-376. 
Davis, H. L., R. G. Whalen and B. A. Demeneix (1993).  Direct gene transfer into 
skeletal muscle in vivo: factors affecting efficiency of transfer and stability of 
expression. Hum. gene therp. 9: 151-159. 
Deluca, D., M. Wilson and G. W. Warr (1983). Lymphocyte heterogeneity in the 
trout (Salmo gairdneri), defined with monoclonal antibodies to IgM. Eur. J. 
Immunol 13: 546-551. 
DeWet, J. R., K. V. Wood, M. DeLuca, D. R. Helinski and S. Subramani Firefly 
luciferase gene: structure and expression in mammalian cells. Mol. Cell. Biol. 7: 
725-737. 
Drolet, B. S., P. P. Chiou, J. Heidel and J. C. Leong (1995). Persistance of an RNA 
infection by defective interfering particles. (Submitted) 
Drolet, B. S., J. S. Rohovec and J. C. Leong (1993). Serological identification of 
infectious hematopoietic necrosis virus in fixed tissue culture cells by alkaline 
phosphatase immunocytochemistry. J. Aquat. Anim Health 5: 265-269. 
Drolet, B. S., J. S. Rohovec and J. C. Leong (1994). The route of entry and 
progression of infectious haematopoietic necrosis virus in Onchorhynchus 
mykiss (Walbaum): a sequential immunohistochemical studies. J. Fish Dis. 17: 
337-347. 
Dropulic, B. and K.-T. Jeang (1994). Intracullular susceptibility to ribozymes in a 
tethered substrate-ribozyme provirus model is not predicted by secondary 
structures of human immunodeficiency virus type 1 RNAs in vitro. Antisense 
Res. Devel. 4: 217-221. 131 
Dunham, R. A., J. Eash, J. Askins and T. M. Townes (1987). Transfer of the 
metallothionein-human growth hormone fusion gene into channel catfish. 
Trans. Am. Fish. Soc. 116: 87-91. 
Eisenbraun, M. D., D. H. Fuller and J. R. Haynes (1993). Examination of parameters 
affecting the elicitation of humoral immune responses by particle 
bombardment-mediated genetic immiini7Ation. DNA Cell. Biol. 12: 791-797. 
Engelking, H. M., J. Harry and J. C. Leong (1991). Comparison of representative 
strains of infectious hematopoietic necrosis virus by serological neutralization 
and cross-protection assays. Appl. Environ. Microbiol. 57(5): 1372-1378. 
Engelking, H. M. and J. Kaufman (1994). Infectious hematopoietic necrosis virus 
(IHNV) found in four geographically distinct feral populations of salmonids in 
Oregon. FHS/AFS Newsletter 22: 10-12. 
Engelking, H. M. and J. C. Leong (1981). IHNV persistently infects chinook salmon 
embryo cells. Virology 109: 47-58. 
Engelking, H. M. and J. C. Leong (1989). Glycoprotein from infectious hematopoietic 
necrosis virus (IHNV) induces protective immunity against five IHNV types. 
J. Aquat. Anim. Health 1: 291-300. 
Engelking, H. M. and J. C. Leong (1989). The glycoprotein of infectious 
hematopoietic necrosis virus elicits neutralizing antibody and protective 
responses. Virus Res. 13: 213-230. 
Ertl, H. C. J., B. Dietzchold, M. Gore, L. Otvos, J. K. Larson, W. H. Wunner and H. 
Koprowski (1989). Induction of rabies virus-specific T-helper cells by 
synthetic peptides that carry dominant T-helper cell epitopes of the viral 
ribonucleoprotein. J. Virol. 63: 2885-2892. 
Etkin, L. D. and B. Pearman (1987). Distribution, expression and germ line 
transmission of exogenous DNS sequences following microinjection into 
Xenopus laevis eggs. Development 99: 15-23. 132 
Federspiel, M. J., L. B. Crittenden and S. H. Hughes (1989). Expression of avian 
reticuloendotheliosis virus envelope confers host resistance. Virology 173: 
167-177. 
Fekadu, M., J. W. Sumner, J. H. Shaddock, D. W. Sanderlin and G. M. Baer (1992). 
Sickness and recovery of dogs challenged with a street virus after vaccination 
with a vaccinia virus recombinant expressing rabies virus N protein. J. Virol. 
66: 2601-2604. 
Feigner, P. L., T. R. Gadek, M. Holm, it Roman, H. W. Chan, M. Wenz, J. P. 
Northrop, G. M. Ringold and M. Danielsen (1987). Lipofection: A highly 
efficient, lipid-mediated DNA-transfection procedure. Proc. Natl. Acad. Sci. 
USA 84: 7413-7417. 
Fendrick, J. L., W. J. Groberg and J. C. Leong (1982). Comparative sensitivity of five 
fish cell lines to wild tyupe infectious hematopoietic necrosis virus from two 
Oregon sources. J. Fish Dis. 5: 87-95. 
Fijan, N., D. Sulmanovic, M. Bearzotti, D. Miizinie, L. D. Zwillengerg, S. 
Chilmonczyck, J. F. Vantherot and P. d. Kinkelin (1983). Some properties of 
the Epithelioma papulosum cyprini (EPC) cell line from carp Cyprinus carpio. 
Ann. Virol. 134: 207-220. 
Fletcher, G. L. and P. L. Davies (1991). Transgenic fish for aquaculture. Genetic Eng. 
13: 331-371. 
Fletcher, G. L., M. A. Shears, M. J. King, P. L. Davies and C. L. Hew (1988). 
Evidence for antifreeze protein gene transfer in atlantic salmon(Salmo salar). 
Can. J. Fish Aquat. Sci. 45: 352-357. 
Friedman, H. M., A. Yee, H. Diggelmann, J C Hastings, R. Tal-Stinger, C. A. Seidel-
Dugan, R. J. Eisenberg and G. H. Cohen (1989). Use of a glucocorticoid­
inducible promoter for expression of herpes simplex virus type 1 glycoprotein 
gC1, a cytotoxic protein in mammalian cells. Mol. Cell. Biol. 9: 2303-2314. 
Fryer, J. L., J. S. Rohovec, G. L. Tebbit, J. S. McMichael and K. S. Pilcher (1976). 
Vaccination for control of infectious diseases in pacific salmon. Fish Pathol. 
10(2): 155-164. 133 
Fu, Z. F., B. Dietzschold, C. L. Schumacher, W. H. Wunner, H. C. J. Ertl and H. 
Koprowski (1991). Rabies virus nucleoprotein expressed in and purified from 
insect cells is efficacious as a vaccine. Proc. Natl. Acad. Sci. USA 88: 2001­
2005. 
Fukuda, H., N. Kato, H. Y. Chou, Y. Yasuda and T. Sano (1989). Virulency of an 
attenuated IHNV clone AF71-1 multiplied by CL3 to rainbow fry. Jap. Soc. 
Sci. Fish 55: 267-271. 
Fynan, E. F., H. L. Robinson and R. G. Webster (1993). Use of DNA encoding 
influenza hemagglutinin as an avian influenza vaccine. DNA. Cell. Biol. 12: 
785-789. 
Fynan, E. F., R. G. Webster, D. H. Fuller, J. R. Haynes, J. C. Santoro and H. L. 
Robinson (1993). DNA vaccines: Protective immunizations by parenteral, 
mucosal, and gene-gun inoculations. Proc. Natl. Acad. Sci. USA 90:  11478­
11482. 
Germain, R. N. and D. H. Margulies (1993). The biochemistry and cell biology of 
antigen processing and presentation. Annu. Rev. Immunol. 11: 403-450. 
Gibbs, P. D. L. (. I., expression and screening of reporter genes in transgenic zebrafish. 
Ph.D. Thesis, Washington State University, Pullman, Washington USA pp. 
63-65. : 
Gilmore, R. D., H. M. Engelking, D. S. Manning and J. Leong (1988). Expression in 
Escherichia coli of an epitope of the glycoprotein of infectious hematopoietic 
necrosis virus ptrotects against viral challenge. Biotechnol. 6: 295-300. 
Gilmore, R. D. and J. C. Leong (1988). The nucleocapsid gene of infectious
 
hematopoieitc necrosis virus, a fish rhabdovirus. Virology 167: 644-648.
 
Gong, Z., C. L. Hew and J. R. Viellcind (1991). Functional analysis and temporal 
expression of promoter regions from fish antifreeze protein genes in transgenic 
Japanese medaka embryos. Mol. Mar. Biol. Biotech. 1:64 -72. 134 
Graham, F. L. and L. Prevec (1992). Adenovirus-based expression vectors and 
recombinant vaccines. Biotechnology 20: 363-390. 
Guenther, R. W., S. W. Watson and R. R. Rucker (1959). Etiology ofsockeye salmon 
"virus" disease. U.S. Fish Wildl. Serv. Spec. Sci. Rep. Fish. 296: 
Gupta, K. C. (1987). Antisense oligodeoxynucleotides ptrovide insight into 
mechanism of translation initiation of two sendai birus mRNAs. J. Biol. Chem. 
262: 7492-7496. 
Guyomard, R., D. Chourrout, C. Leroux, L. M. Houdebine and F. Pourrain (1989). 
Integration and germ line transmission of foreign genes microinjected into 
fertilized trout eggs. Biochimie. 71: 857-863. 
Hansen, E., K. Fernandes, G. Goldspink, P. Butterworth, P. K. Umeda and IC-C. 
Chang (1991). Strong expression of foreign genes following direct injection into 
fish muscle. FEBS 190: 73-76. 
Hart, S., A. B. Wratmell, J. E. Harris and T. H. Grayson (1988). Gut immunology in 
fish: A review. Devel. Comp. Imm. 12: 453-480. 
Hasobe, M. and M. Saneyoshi (1985). On the approach to viral chemotherapy against 
infecitous hematopoietic necrosis virus (I NV) in vitro and in vivo in 
salmonid fishes. Fish. Pathol. 20: 343-351. 
Helene, C. and J.-J. Toulme (1990). Specific regulation of gene expression by 
antisense, sense and antigen nucleic acids. Biochim. Biophys. Acta. 1049: 99­
125. 
Helmrich, A., G. S. Bailey and D. W. Barnes (1988). Transfection of cultured fish 
cells with exogenous DNA. Cytotechnology 1: 215-221. 
Hetrick, F. M., J. L. Fryer and M. D. Knittle (1979). Effect of water temperature on 
the infection of rainbow trout Salmo gairdneri (Richardson) with infectious 
hematopoietic necrosis virus. J. Fish Dis. 2: 253-257. 135 
Hill, B. J. (1992). Impact of viral diseases off salmonid fish in the European 
community, pp. 48-59. In: T. Kimura (ed.), Proceedings of the Oil 
International Symposium on Salmonid Diseases, Hokkaido University Press, 
Sapporo, Japan : 
Hill, B. J., B. 0. Underwood, C. J. Smale and F. Brown (1975). Physiochemical and 
seological characterization of five rhabdovirusis infecting fish. J. Gen. Virol. 
27: 369-378. 
Holmgren, J., C. Czerkinsky, N. Lycke and A.-M. Svennerholm (1992). Mucosal 
immunity: Implications for vaccine development. Immunobiol. 184: 157-179. 
Holoway, J. E. and C. E. Smith (1973). Infectious hematopoietic necrosis of rainbow 
trout in Montana: a case report. J. Wildl. Dis. 9: 287-290. 
Holt, J. T. (1991). Cutting the chain of command: specific inhibitors of transcription. 
Antisense Res. Devel. 1: 365-369. 
Hruby, D. E. (1993). Vaccinia virus: A novel approach for molecular engineering of 
peptide vaccines. Sem. Hematol. 30: 35-44. 
Hsu, Y.-L., H. M. Engelking and J. C. Leong (1985). Analysis of the quanity and 
synthesis of the virion proteins of infectious hematopoietic necrosis virus. 
Fish Pathol. 20: 331-338. 
Hsu, Y. L., H. M. Engelking and J. C. Leong (1986). Occurrence of different types of 
infectious hematopoietic necrosis virus in fish. Appl. Environ. Microbiol. 52: 
1353-1361. 
Hunt, L. A., D. W. Brown, H. L. Robinson, C. W. Naeve and R. G. Webster (1988). 
Retrovirus- expressed hemagglutinin protects against lethal influenza virus 
infections. J. Virol. 62(8): 3014-3019. 
Hunt, L. A., D. W. Brown, H. L. Robinson, C. W. Naeve and R. G. Webster (1989). 
Avian-retrovirus-expressed hemagglutinin protects against lethal influenza 
infection. Vaccines : 1-5. 136 
Hynes, N., A. J. J. v. Ooyen, N. Kennedy, P. Herrlich, H. Ponta and B. Groener 
(1983). Subfragments of the large terminal repeat cause glucocorticoid­
responsive expression of mouse mammaryu tumor virus and of an adjacent 
gene. Proc. Natl. Acad. Sci. USA 80: 3637-3641. 
Inoue, K., S. Yamashita, J.-i. Hata, S. Kabeno, S. Asada, E. Nagahisa and T. Fujita 
(1990). Electroporation as a new technique for producing transgenic fish. Cell 
Diff. Devel. 29: 123-128. 
Inouye, M. (1988). Antisense RNA: its functions and applications in gene regulation-
a review. Gene 72: 25-34. 
Irwin, M. J., L. S. Laube, V. Lee, M. Austin, S. Chanda, C. G. Anderson, K. 
Townsend, D. J. Jolly and J. F. warner (1994). Direct injection of a 
recombinant retroviral vector induces human immunodeficiencyvirus-specific 
immune responses in mice and nonhuman primates. J. Virol. 68: 5036-5044. 
Izant, J. G. and H. Weintraub (1984). Inhibition ofthymidine kinase gene expression 
by anti-sense RNA: A molecular approach to genetic analysis. Cell 36: 1007­
1015. 
Izant, J. G. and H. Weintraub (1985). Constitutive and conditional suppression of 
exogenous and endogenous genes by antis-sense RNA. Science 229: 345-352. 
Joshi, S., A. V. Brunshot, S. Mad, I. V. D. Elst, S. E. Read and A. Bernstein (1991). 
Inhibition of human immunodeficiency virus type 1 multiplication by 
antisense and sense RNA expression. J. Virol. 65: 5524-5530. 
Juliano, R. L. and S. Akhtar (1992). Liposomes as a drug delivery system for
 
antisense oligonucleotides. Antisense Res. Devel. 2: 165-176.
 
Junker, U., K. Rittner, M. Homann, D. Bevec, E. Bohnlein and G. Sczakiel (1994). 
Reduction in replication of the human immunodeficiency virus type 1 in 
human T cell lines by polymerase 111-driven transcription of chimeric tRNA­
antisense RNA genes. Antisense Res. Devel. 4: 165-172. 137 
Kaneda, Y., K. Iwai and T. Uchida (1989). Introduction and expression of the human 
insulin gene in adult rat liver. J. Biol. Chem. 264(21): 12126-12129. 
Kasid, U., A. Pfeifer, B. M. Beckett, R. R. Weichselbaum, A. Dritschilo and G. E. 
Mark (1989). Effect of antisense c-raf-1 on tumorigenicity and radiation 
sensitivity of a human squamous carcinoma. Science 243: 1354-1356. 
Kim, S. K. and B. J. Wold (1985). Stable reduction of thymidine kinase activity in 
cells expressing high levels of anti-sense RNA. Cell 42: 129-138. 
Kitis, R. N., P. M. Buttrick, E. M. McNally, M. L. Kaplan and L. A. Leinwand 
(1991). Hormonal modulation of a gene injected into rat heart in vivo. Proc. 
Natl. Acad. Sci. USA 88: 4138-4142. 
Klein, T. M., E. D. Wolf, R. Wu and J. C. Sanford (1987). High-velocity 
microprojectiles for delivering nucleic acids into living cells. Nature 327: 70-73. 
Koener, J. F. and J. C. Leong (1990). Expression of the glycoprotein gene from a fish 
rhabdovirus by using baculavirus vectors. J. Virol. 64: 428-430. 
Koener, J. F., C. W. Passavant, G. Kurath and J. Leong (1987). Nucleotide sequence 
of a cDNA clone carrying the glycoprotein gene of infectious hematopoietic 
necrosis virus, a fish rhabdovirus. J. Virol. 61: 1342-1349. 
Kurath, G., K. G. Ahern, G. D. Pearson and J. C. Leong (1985). Molecular cloning of 
the six mRNA species of infectious hematopoietic necrosis virus, a fish 
rhabdovirus, and gene order determination by R-loop mapping. J. Virol. 53: 
469-476. 
Kurath, G. and J. C. Leong (1985). Characterization of infectious hematopoietic 
necrosis virus mRNA species reveals a nonvirion rhabdovirus protein. J. Virol. 
53: 462-468. 
Kurath, G. and J. C. Leong (1987). Transcription in vitro of infectious haematopoietic 
necrosis virus, a fish rhabdovirus. J. Gen. Virol. 68: 1767-1771. 138 
Lannan, C. N., J. R. Winton and J. L. Fryer (1984). Fish cell lines: establishment and 
characterization of nine cell lines from salmonids. In Vitro 20: 671-676. 
LaPatra, S. E., J. L. Fryer, W. H. wingfield and R. P. Hedrick (1987). Transmission of 
infectious hematopoietic necrosis virus (IHNV) between adult species of 
salmon: management strategies for anadromous broodstock. Am. Fish. Soc. 
Fish Health Sec. News. 15: 7. 
LaPatra, S. E., J. M. Groff, J. L. Fryer and R. P. Hedrick (1990). Comparative 
pathogenisis of three strains of infectious hematopoietic necrosis virus in 
rainbow trout Oncorhynchus mykiss. Dis. Aquat. Org. 8: 105-112. 
LaPatra, S. E., J. Parsons, G. R. Jones and W. 0. McRoberts (1992).  Susceptibility of 
brook trout and rainbow trout x brook trout hybrids to infectious 
hematopoietic necrosis. J. Aquat. Anim. Health 1: 29-36. 
LaPatra, S. E., T. Turner, K. A. Lauda, G. R. Jones and S. Walker (1993). 
Characterization of the humoral response of rainbow trout to infectious 
hematopoietic necrosis virus. J. Aquat. Anim. Health 5: 165-171. 
Laurencin, F. B. (1987). IHN in France. Bull. Eur. Ass. Fish Pathol. 7: 104. 
Lavignon, M., N. Tounekti, B. Rayner, J.-L. Imbach, G. Keith, J. Paoletti and C. 
Malvy (1992). Inhibition of murine leukemia viruses by nuclease-resistant a-
oligonucleotides. Antisense Res. Devel. 2: 315-324. 
Lavitrano, M., A. Camaioni, V. M. Fazio, S. Dolci, M. G. Farace and C. Spandafora 
(1989). Sperm cells as vectors for introducing foreign DNA into eggs: Genetic 
transformation of mice. Cell 57: 717-723. 
Lee, F., Mulligan, R., Berg, P., and Ringold, G. (1981). Glucocorticoids regulate 
expression of dihydrofolate reductase cDNA in mouse mammary tumour virus 
chiameric plasmids. Nature 294:228-232. : 
Lee, F., R. Mulligan, P. Berg and G. Ringold (1981). Glucocorticoids regulate 
expression of dihydrofolate reductase cDNA in mouse mammary tumour virus 
chimaeric plasmids. Nature 294: 228-232. 139 
Lemaitre, M., B. Baynard and B. Lebleu (1987). Specific antiviral activity of a 
poly(L-lysine)-conjugated oligodeoxyribonucleotide sequence complementary 
to vesicular stomatitis virus N protein mRNA initiation site. Proc. Natl. Acad. 
Sci. USA 84: 648-652. 
Leonetti, J. P., B. Rayner, M. Lemaitre, C. Gagnor, P. G. Milhoud, J. L. Imbach and 
B. Lebleu (1988). Antiviral activity of conjugates between poly(L-lysine) and 
synthetic oligodeoxyribonucleotides. Gene 72: 323-332. 
Leong, J. (1993). Molecular and biotechnological approaches to fish vaccines. Curr. 
Biotechnol. 4: 286-293. 
Leong, J. C. and J. L. Fryer (1993). Viral vaccines for aquaculture. Ann. Rev. Fish 
Dis. 93: 225-240. 
Lisziewicz, J., D. Sun, M. Klotman, S. Agrawal, P. Zamecnik and R. Gallo (1992). 
Specific inhibition of human immunodeficiency virus type 1 replication by 
antisense oligonucleotides: An in vitro model for treatment. Proc. Natl. Acad. 
Sci. USA 89: 11209-11213. 
Lisziewicz, J., D. Sun, J. Smythe, P. Lusso, F. Lori, A. Louie, P. Markham, J. Rossi, 
M. Reitz and R. C. Gallo (1993). Inhibition of human immunodeficencyvirus 
type 1 replication by regulated expression of a polymeric Tat activation 
response RNA decoy as a strategy for gene therapy in AIDS. Proc. Natl. 
Acad. Sci. USA 90: 8000-8004. 
Liu, Z., Moav, B., Faras, A.J., Guise, K.S., Kapuscinski, A.R., and Hackett, P.B. 
(1990). Development of expression vectors for transgenic fish. Biotechnology 
8:1268-1272. : 
Liu, Z., B. Moav, A. J. Faras, K. S. Guise, A. R. Kapuscinski and P. B. Hackett 
(1990). Development of expression vectors for transgenic fish. Biotechnology 
8: 1268-1272. 
Liu, Z., B. Moav, A. J. Faras, K. S. Guise, A. R. Kaupuscinski and P. B. Hackett 
(1990). Functional analysis of elements affecting expression of the B-actin 
gene of carp. Mol. Cell. Biol. 10(7): 3432-3440. 140 
Liu, Z., Z. Zhu, K. Roberg, A. Faras, K. Guise, A. R. Kapuscinski and P. Hackett 
(1990). Isolation and characteriqation of B-actin gene of carp (Cyprinus 
carpio). J. DNA Mapp. Seq. 1: 1-11. 
Maclean, N., D. Penman and Z. Zhu (1987). Introduction of novel genes into fish. 
Biotechnol. 5: 257-261. 
Majors, J. and V. H. E (1983). A small region of the mouse mammary tumor virus 
long terminal repeat confers glucocorticoid hormone regulation on a linked 
heterologous gene. Proc. Natl. Acad. Sci. USA 80: 5866-5870. 
Malim, M. H., W. W. Freimuth, J. Liu, T. J. Boyle, R. K. Lyerly, B. R.  Cullen and G. 
J. Nabel (1992). Stable expression of transdominant Revprotein in human T 
cells inhibits human immunodeficiency virus replication. J Exp. Med. 186: 
1197-1201. 
Maniatis, T., Fritsch, E.F., and Sambrock, J. (1982). Molecular Cloning: A 
Laboratory Manual. Cold Springs Harbor, N.Y.: Cold Spring Harbor 
Laboratory. 
McAllister, P. E., J. L. Fryer and K. S. Pilcher (1974). Further characterization of 
infectious hematopoietic necrosis virus of salmonid fish (Oregon strain). Arch. 
Gesmte. Virusforsch. 44: 270-279. 
McCain, B. B., J. L. Fryer and K. S. Pilcher (1974). Physiochemical properties of 
RNA of salmonid hematopoietic necrosis virus (Oregon strain). Proc. Soc. 
Exp. Biol. Med. 3164: 630-634. 
McCain, B. B., J. L. Fryer and K. S. Pilcher (1974). Physiochemical properties of 
RNA of salmonid hematopoietic necrosis virus (Oregon strain). Proc. Soc. 
Exp. Biol. Med. 3146: 630-634. 
McClean, E. and E. M. Donaldson (1990). Absorption of bioactive proteins by the 
gastrointestinal tract of fish: A review. J. Aquat. Anim Health 2(1): 1-11. 141 
Mermer, B., B. K. Felber, M. Campbell and G. N. Pavlakis (1990). Identification of 
trans-dominant HIV-1 rev protein mutants by direct transfer of bvacterially 
produced proteins into human cells. Nuc. Acid Res. 18: 20372044-. 
Michard-Vanhee, C., D. Chourrout, S. Stromberg, A. Thuvander and L. Pilstrom 
(1994). Lymphocyte expression in transgenic trout by mouse immunoglovulin 
promoter/enhancer. Immunogenetics 40: 1-8. 
Midgeon, B. R., J. Axelman and A. H. Beggs (1988). Effect of ageing on reactivation 
of the human X-linked HPRT locus. Nature 335: 93-96. 
Milich, H. R., A. McLachlan, G. B. Thorton and J. L. Hughes (1987). Antibody 
production to the nucleocapsid and envelope of the hepatitis B virus primed 
by a single synthetic T cell site. Nature 329: 547-549. 
Montgomery, D. L., J. H. Shiver, K. R. Leander, H. C. Perry, A. Friedman, D. 
Martinez, J. B. Ulmer, J. J. Donnelly and M. A. Liu (1993). Heterologous and 
homologous protection against influenza A by DNA vaccination: 
Optimization of DNA Vectors. DNA Cell. Biol. 12: 777-783. 
Mulcahy, D. and W. N. Batts (1987). Infectious hematopoietic necrosis virus 
detected by separation and incubation of cells from salmonid cavity fluid. Can. 
J. Fish Aquat. Sci. 44: 1071-1075. 
Mulcahy, D., D. Klaybor and W. N. Batts (1990). Isolation of infectious 
hematopoietic necrosis virus from leech (Piscicola salmositica) and a copepod 
(Salmincola sp.), ectoparasites of sockeye salmon, Oncorhynchus nerka. Dis. 
Aquat. Org. 8: 29-34. 
Mulcahy, D., R. Pascho and C. K. Jenes (1983). Detection of infectious 
hematopoietic necrosis virus in riverwater and demonstration of waterborne 
transmission. J. Fish Dis. 6: 321-330. 
Mulcahy, D., R. Pascho and C. K. Jenes (1984). Comparison of in vitro growth 
characheristics of ten isolates of infectious haematopoietic necrosis virus. J. 
Gen. Virol. 65: 2199-2207. 142 
Mulcahy, D., R. Pascho and C. K. Jenes (1984). Comparison of in vitro growth 
characteristics of ten isolates of infectious hematopoieitic necrosis virus. J. 
Gen. Virol. 64: 2199-2207. 
Mulcahy, D. and R. J. Pascho (1984). Adsorption to fish sperm of vertically 
transmitted virus. Science 225: 333-335. 
Mulcahy, D. M. and R. J. Pascho (1985). Vertical transmission of infectious 
hematopoietic necrosis virus in sockeye salmon (Oncorhynchus nerka): 
isolation of virus from dead eggs and fry. J. Fish Dis. 8: 393-396. 
Muzyczka, N. (1992). Use of adeno-associated virus as a general transduction vector 
for mammalian cells. Curr. Top. Microbiol. Immunol. 158: 97-129. 
Nabel, E. G., G. Plautz and G. J. Nabel (1990). Site-specific gene expression in vivo 
by direct gene transfer into the arterial wall. Science 249: 1285-1288. 
Naganawa, S., 0. Nakamura, T. Nishimura, K. Fukada and T. Sano (1993). 
Nonspecific viral resistance revealed in rainbow trout (Oncorhynchus mykiss) 
fry inoculated intraperitoneally with formalin-killed infectious hematopoietic 
necrosis virus (FKHV). J. Tokyo Univ. Fish. 80: 155-161. 
Nguyen, V. T., M. Morange and 0. Bensaude (1988). Firefly luciferase luminescence 
assays using scintillation counters for quantitation in transfected mammalian 
cells. Anal. Biochem. 171: 404-408. 
Nishimura, T., Y. Ishada, S. Yamamoto, H. Fekuda, N. Okamato and T. Sano (1985). 
Infectious hematopoietic necrosis: Virus titer in the fish bodies, rearing water 
and feces of artificially infected rainbow trout fry. Fish Pathol. 23: 13-17. 
Nishimura, T., H. Sasaki, M. Ushiyama, K. Inouye, Y. Suzuki, M. Kohara, M. Arai, 
M. Slaima and T. Sano (1985). A trial of vaccination against rainbow trout fry 
with formalin killed IHN virus. Fish Path. 20: 435-443. 
Norton, P. A. and J. M. Coffin (1985). Bacterial 13-galactosidase as a marker of tons 
sarcoma virus gene expression and replication. Mol. Cell. Biol. 5(2): 281-290. 143 
Oberg, L. A., J. Wirkkula, D. Mourich and J. C. Leong (1991). Bacterially expressed 
nucleoprotein of infectious hematopoietic necrosis virus virus augments 
protective immunity induced by the glycoprotein vaccine in fish. J. Virol. 
65(8): 4486-4489. 
O'Hagan, D. T. (1992). Oral delivery of vaccines. Clin. Pharm. 22(1): 1-10. 
Ojawang, J. 0., A. Hampel, D. J. Looney, F. Wong-Staal and J. Rappaport (1992). 
Inhibition of human immunodeficiency virus type 1 expression by a hairpin 
ribozyme. Proc. Natl. Acad. Sci. USA 89: 10802-10806. 
Ozato, K., H. Kondoh, H. Inohara, T. Iwamatsu, Y. Wakamatsue and T. S. Okada 
(1986). Production of trangenic fish: introduction and expression of chicken 
delta-crystallin gene in medaka embryos. Cell Diff. 19: 237-244. 
Park, M. A., S. G. Sohn, S. D. Lee, S. K. Chun, J. W. Park, J. L. Fryer and Y. C. Yah 
(1993). Infectious hematopoietic necrosis virus from salmonids cultured in 
Korea. J. Fish Dis. 16: 471-478. 
Penmann, D. J., A. J. Beeching, S. Penn and N. Maclean (1990). Factors affecting 
survival and integration following microinjection of novel DNA into rainbow 
trout eggs. Aquaculture 85: 35-50. 
Pilcher, K. S. and J. L. Fryer (1980). The viral diseases of fish: A review through 
1978. Part 1: Diseases of proven etiology. CRC Rev. Microbiol. 7: 287-364. 
Plumb, J. A. (1972). A virus-caused epizootic of rainbow trout (Salmo gairdneri) in 
Minnesota. Trans. Am. Fish. Soc. 101: 121-123. 
Poddevin, B., S. Meguenni, I. Elias, M. Vasseur and M. Blumenfeld (1994). Improved 
anti-herpes simplex virus type 1 activity of a phosphodiester antisense 
oligonucleotide containing a 3'-terminal hairpin-like structure. Antisense Res. 
Devel. 4: 147-154. 
Powers, D. (1989). Fish as Model Systems. Science 246: 352-358. 144 
Prevec, L., B. S. Christie, K. E. Laurie, M. M. Bailey and F. L. Graham (1991). 
Immune response to HIV-1 gag antyigenes induced by recombinant adenovirus 
vectors in mice and rhesus macaque monkeys. J. Acq. Imm. Def. Syn. 4: 568­
576. 
Rahman, A. and N. Maclean (1992). Fish transgene expression by direct injection into 
fish muscle. Mol. Mar. Biol. Biotechnol. 1: 286-289. 
Raz, E., D. A. Carson, S. E. Parker, T. B. Parr, A. M. Abai, G. Aichinger, S. H. 
Gromkowski, M. Singh, D. Lew, M. A. Yankauckas, S. M. Baird and G. H. 
Rhodes (1994). Intradermal gene immunization: The possible role of DNA 
uptake in the induction of cellular immunity to viruses. Proc. Natl. Acad. Sci. 
USA 91: 9519-9523. 
Raz, E., A. Watanabe, S. M. Baird, R. A. Eisenberg, T. B. Parr, M. Lotz, T. J. Kipps 
and D. A. Carson (1993). Systemic immunological effects of cytokine genes 
injected into skeletal muscle. Proc. Natl. Acad. Sci. USA 90: 4523-4527. 
Reimann-Philipp, U. and R. N. Beachy (1993). The mechanism(s) of coat protein-
mediated resistance against tobacco mosaic virus. Sem. Virol. 4: 349-356. 
Reimann-Phillip, U. and R. N. Beachy (1993). The mechanism(s) of coatprotein­
mediated protection. Sem. Virol. 4: 349-356. 
Renneisen, K., L. Leserman, E. Matthes, H. C. Schroder and W. E. G. Muller (1990). 
Inhibition of expression of human immunodeficiency virus-1 in vitro by 
antibody-targeted liposomes containing antisense RNA to the env region. J. 
Biol. Chem. 265: 1633716342. 
Rhodes, A. and W. James (1990) Inhibition of human immunodeficiency virus 
replication in cell culture by endogenously synthesized antisense RNA. J. 
Gen. Virol. 71: 1965-1974. 
Ristow, S. R. and J. A. deAvila (1991). Monoclonal antibodies to the glycoprotein 
and nucleoprotein of infectious hematopoietic necrosis virus (IHNV) reveal 
differences among isolates of the virus by fluorescence, neutralization and 
electrophoresis. Dis. Aquat. Org. 11:105-115. 145 
Ristow, S. S., J. d. Avila, S. E. LaPatra and K. Lauda (1993). Detection and 
characterization of rainbow trout antibody against infectious hematopoietic 
necrosis virus. Dis. Aquat. Org. 15: 109-114. 
Rittner, K., C. Burmester and G. Sczakiel (1993). In vitro selection of fast-hybridizing 
and effective antisense RNAs directed against the human immunodeficiency 
virus type 1. Nuc. Acid Res. 21: 1381-1387. 
Rittner, K. and G. Sczakiel (1991). Identification and analysis of antisense RNA 
target regions of the human immunodeficiency virus type 1. Nuc. Acid Res. 
19: 1421-1428. 
Rokkones, E., P. Alestrom, H. Skjervold and K. M. Gautvik (1989). Microinjection 
and expression of a mouse mettalothionein human growth hormone fusion gene 
in fertilized salmonid eggs. J. Comp. Physiol. 158: 751-758. 
Rombout, J. H. W. M., A. A. V. D. Berg, C. T. G. A. V. D. Berg, P. Witte and E. 
Egberts (1989) Immunological importance of the second gut segment of 
carp.111. Systemic and/or mucosal immune responses after immunization with 
soluble or particulate antigen. J. Fish Biol. 35: 179-186. 
Rombout, J. H. W. M., N. Taverne, M. v. d. Kamp and A. J. Taveme-Thiele (1993). 
Differences in mucus and serum immunoglobulin of carp (Cyprinus carpio L.). 
Developmental and comparative immunology 17: 309-317. 
Rombout, J. H. W. M., A. J. Taveme-Thiele and M. I. Villena (1993). The gut-
associated lymphoid tissue (GALT) of carp (Cyprinus carpio L.): An 
immunocytochemical analysis. Devel. Comp. Immunol. 17: 55-66. 
Ross, A. J., J. Pelnar and R. R. Rucker (1960). A virus-like disease of chinook salmon. 
Trans. Am. Fish Soc. 89: 160-163. 
Rucker, R. R., W. J. Whipple, J. R. Parvin and C. A. Evans (1953). A contagious 
disease of salmon possibly of virus origin. US Fish and Wildl. Serv. Fish Bull. 
54: 35-46. 146 
Russell, S. M. and F. Y. Liew (1979). T cells primed by influenza virion internal 
components can cooperate in the antibody response to haemagglutinin. Nature 
280: 147-148. 
Salama, M., W. Sandine and S. Giovannoni (1991). Development and application of 
oligonucleotide probes for identification of Lactococcus lactis subsp. cremoris. 
Appl. Environ. Microbiol 57: 1313-1318. 
Sambrook, J., E. F. Fritsch and T. Maniatias (1989). Molecular cloning: A laboratory 
manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY : 
Sano, T., T. Nishimura, N. Okamoto, T. Yamazald, H. Hanada and Y. Watanabe 
(1977). Studies on viral diseases of Japanese fishes. Infectious hematopoietic 
necrosis (IHN) of salmonids in the mainland of Japan. J. Tokyo. Univ. Fish. 
63: 81-85. 
Scherczinger, C. A. and D. A. Knecht (1993). Systemic analysis of antisense RNA 
inhibition of myosin 11 heavy-chain gene expression in Dictyostelium 
discoideum. Antisense Res. Devel. 3: 191-205. 
Scott, J. L., J. L. Fendrick and J. C. Leong (1980). Growth of infectious hematopoietic 
necrosis virus in mosquito and fish cell lines. Wassman J. Biol. 38: 21-29. 
Sczakiel, G., M. Oppenlander, K. Rittner and M. Pawlita (1992). Tat-and Rev-
directed antisense RNA expression inhibits and abolishes replication of human 
immunodeficiency virus type 1: a temporal analysis. J. Virol. 66: 5576-5581. 
Sczakiel, G. and M. Pawlita (1991) Inhibition of human immunodeficiency virus type 
1 replication in human T cells stably expressing antisense RNA. J. Virol. 65: 
468-472. 
Sczakiel, G., M. Pawlita and A. Kleinheinz (1990). Specific inhibition of human 
immunodeficiency virus type 1 replication by RNA transcribed in sense and 
antisense orientation from the 5'leader /gag region. Biochem. Biophys. Res. 
Comm. 169: 643-651. 147 
Sedegah, M., R. Hedstrom, P. Hobart and S. L. Hoffman (1994). Protection against 
malaria by immunization with plasmid DNA encoding circumsporozoite 
protein. Proc. Natl. Acad. Sci. USA 91: 9866-9870. 
Sharps, A., K. Nishiyama, P. Collodi and D. Barnes (1992). Comparison of activities 
of mammalian viral promoters directing gene expression in vitro in zebrafish 
and other fish cell lines. Mol. Mar. Biol. Biotechnol. 1(6): 426-431. 
Shears, M. A., G. L. Fletcher, C. L. Hew, S. Gauthier and P. L. Davies (1991). 
Transfer, expression, and stable inheritance of antifreeze protein genes in 
atlantic salmon (Salmo salar). Mol. Mar. Biol. Biotechnol. 1(1): 58-63. 
Shors, S. and V. Winston (1989). Detection of infectious hematopoietic necrosis virus 
in an invertebrate (Callibaetis sp.). Am. J. Vet. Res. 50: 1307-1309. 
Stein, C. A. and Y. C. Cheng (1993). Therapeutic applications of oligonucleotides. 
Science 261: 1004-1012. 
Stephenson, M. L. and P. C. Zamecnik (1978) Inhibition of rous sarcoma viral RNA 
translation by a specific oligodeoxyribonucleotide. Proc. Natl. Acad. Sci. USA 
75: 285-288. 
Stribling, R., E. Brunette, D. Liggitt, K. Gaensler and R. Debs (1992). Aerosol gene 
delivery in vivo. Proc. Natl. Acad. Sci. USA 89: 11277-11281. 
Stuart, G. W., J. V. McMurray and M. Westerfield (1988). Replication, integration, 
and stable germ-line transmission of foreign sequences injected into early 
zebrafish embryos. Development 10: 
Sullenger, B. A., H. F. Gallardo, G. E. Ungers and E. Gilboa (1991). Analysis of trans­
acting response decoy RNA-mediated inhibition of human immunodeficiency 
virus type 1 transactivation. J. Virol. 65: 6811-6816. 148 
Sullivan, S. M., R. K. H. Giese ler, S. Lenzner, J. Ruppert, T. G. Gabrysiak, J. H. 
Peters, G. Cox, R. Leroy, W. J. Martin and M. J. Scolaro (1992). Inhibition of 
human immunodeficiency virus-1 proliferation by liposome-encapsulated 
sense DNA to the 5' tat splice acceptor site. Antisense Res. Devel. 2: 187­
197. 
Sumner, J. W., M. Fekadu, J. H. Shaddock, J. J. Esposito and W. J. Bellini (1991). 
Protection of Mice with Vaccinia Virus Recombinants That Express the 
Rabies Nucleoprotein. Virology 183: 703-710. 
Symonds, J. E., S. P. Walker, F. Y. T. Sin and I. Sin (1994). Development of mass 
gene transfer mehtod in chinook salmon: optimization of a gene transfer by 
electroporated sperm. Mol. Mar. Biol. Biotechnol. 3(2): 104-111. 
Takayama, K. M. and M. Inouye (1990). Antisense RNA. Crit. Rev. Biochem. Mol. 
Biol. 25: 155-185. 
Tang, D.-c., M. DeVit and S. A. Jonston (1992). Genetic immunization is a simple 
method for eliciting an immune response. Nature 356: 152-154. 
Tebbit, G. L. (1976). Viruses infecting salmonid fishes from Oregon, A. The 
occurence and distribution ofinfectious pancreatic necrosis virus, B. The 
development of an attenuated strain of infectious hematopoietic necrosis virus 
(IHNV) for the immunization of salmonids. Ph.D. Thesis, Oregon State 
University, Corvallis, Oregon : 81. 
Traxler, G. S. (1986). An epizootic of infectious hematopoietic necrosis in 2 year-old 
kokanee, Oncorhynchus nerka (Walbaum) at Lake Cowichan, British 
Columbia. J. Fish. Dis. 9: 545-549. 
Ulmer, J. B., J. J. Donnely, S. E. Parker, G. H. Rhodes, P. L. Feigner, V. J. Dwarki, S. 
H. Gromkowski, R. R. Deck, C. M. DeWitt, A. Friedman, L. A. Hawe, K. T. 
Leander, D. Martinez, H. C. Perry, J. W. Shiver, et al. (1993). Heterologous 
protection against influenza by injection of DNA encoding a viral protein. 
Science 259: 1745-1749. 
Wakita, T. and J. R. Wanda (1994). Specific inhibition of hepatitis C virus expression 
by antisense oligodeoxynucleotides. J. Biol. Chem. 269: 1420514210. 149 
Wang, B., K. E. Ugden, V. Srikantan, M. G. Agadjanyan, K. Dang, Y. Refaeli, A. I. 
Sato, J. Boyer, W. V. Williams and D. B. Weiner (1993). Gene inoculation 
generates immune responses against human immunodeficiency virus type 1. 
Proc. Natl. Acad. Sci. USA 90: 4156-4160. 
Watson, S. W. (1954). Virus diseases of fish. Trans. Am. Fish. Soc. 83: 331-341. 
Wedemeyer, G. A., N. C. Nelson and C. A. Smith (1978). Survival of the salmonid 
viruses infectious hematopoietic necrosis (IHNV) and infectious pancreatic 
necrosis (IPNV) in ozonated, chlorinated, and untreated waters. J. Fish. Res. 
Bd. Canada 35: 875-879. 
Weeransinghe, M., S. E. Liem, S. Asad, S. E. Read and S. Joshi (1991). Resistance to 
human immunodeficiency virus type 1 (HIV-1) ifection in human CD4+ 
lymphocyte-derived cell lines conferred by using retroviral vectors expressing 
an HIV-1 RNA-specific ribozyme. J. Virol. 65: 5531-5534. 
Wet, J. R. D., K. V. Wood, M. DeLuca, D. R. Helinski and S. Subramani (1987). 
Firefly luciferase gene: structure and expression in mammalian cells. Mol. Cell. 
Biol. 7: 725-737. 
Wiktor, T. J., R. I. MacFarlan, K. J. Reagen, B. Dietzschold, P. J. Curtis, W. H. 
Wmmer, M.-P. Kieny, R. Lathe, J.-P. Lecocq, M. Mackett, B. Moss and H. 
Koprowski (1984). Protection from rabies by a vaccinia virus recombinant 
containing the rabies virus glycoprotein gene. Proc. Natl. Acad. Sci. USA 81: 
7194-7198. 
Williams, I. V. and D. Amend (1976). A natural epizootic of infectious hematopoietic 
necrosis in fry of sockeye salmon (Oncorhynchus nerka) at Chillco Lake, 
British Columbia. J. Fish. Res. Board Can. 33: 1564-1567. 
Wingfield, W. H., J. L. Fryer and K. S. Pilcher (1969). Properties of the sockeye 
salmon virus (Oregon Strain). Proc. Soc. Exp. Biol. Med. 130: 1055-1059. 
Wisniewski, L. A., P. A. Powell, R. S. Nelson and R. N. Beachy (1990). Local and 
systemic spread of tobacco mosaic virus in transgenic tobacco plants. Plant. 
Cell. 2: 559-567. 150 
Wolf, K. (1988). Fish Viruses and fish viral diseases. Cornell University Press, Ithaca, 
New York : 
Wolf, K. and J. A. Mann (1980). Pokilotherm vertebrate cell lines and viruses: a 
current listing. In Vitro 16: 168-179. 
Wolf, K., M. C. Quimby, L. L. Pettijohn and M. L. Landoll (1973). Fish viruses: 
isolation and identification of infectious hematopoietic necrosis in eastern 
North America. J. Fish. Res. Board Can. 30: 1625-1627. 
Wolff, J. A., R. W. Malone, P. Williams, W. Chong, G. Ascadi, A. Jani and P. L. 
Feigner (1990). Direct gene transfer into mouse muscle in vivo. Science 247: 
1465. 
Wolff, J. A., P. Williams, G. Ascadi, S. Jiao, A. Jani and W. Chong (1991). Conditions 
affecting direct gene transfer into rodent muscle in vivo. BioTechniques 4: 474­
485. 
Xiang, Z. Q., S. Spitalnik, M. Tran, W. H. Wunner, J. Cheng and H. C. J. Ertl (1994). 
Vaccination with a Plasmid Vector Carrying the Rabies Virus Glycoprotein 
Gene Induces Protective Immunity against Rabies Virus. Virology 199: 132­
140. 
Yamamoto, T. and T. J. Clermont (1990). Multiplication ofinfectious hematopoietic 
necrosis virus in rainbow trout following immersion infection: Organ assay and 
electron microscopy. J. Aquat. Anim. Health 2: 261-270. 
Yang, N.-S., J. Burkholder, B. Roberts, B. Martinelli and D. McCabe (1990). In vivo 
and in vitro gene transfer to mammalian somatic cells by particle 
bombardment. Proc. Natl. Acad. Sci. USA 87: 9568-9572. 
Yankauckas, M. A., J. E. Morrow, S. E. Parker, A. Abai, G. H. Rhodes, V. J. Dwarki 
and S. H. Gromkowski (1993). Long-term anti-nucleoprotein cellular and 
humoral immunity is induced by intramuscular injection of plasmidDNA 
containing NP gene. DNA Cell. Biol. 12: 771-776. 151 
Yasutake, W. T. (1970). Comparative histopathology ofepizootic salmonid virus 
diseases. In: S. F. Snieszko (ed.), A symposium on Diseases ofFish and 
Shellfishes. Special Publication No. 5, Am. Fish. Soc., Washington, D. C. : 
341-350. 
Yasutake, W. T. (1983). Histopathology of yearling sockeye salmon (Oncorynchus 
nerka) infected with infectious hematopoietic necrosis (MN). Fish Pathol. 4: 
59-64. 
Yoon, S. J., E. M. Hallerman, M. L. Gross, Z. Liu, J. F. Schneider, A. J. Faras, P. B. 
Hackett, A. R. Kapuscinski and K. S. Guise (1990). Transfer of the gene for 
neomycin tesistance into golfish, carassius auratus. Aquaculture 85: 21-33. 
Yoshimizu, M., M. Sami and T. Kimura (1989). Survivability of infectious 
hematopoietic necrosis virus in fertilized eggs of masu and chum salmon. J. 
Aqut. Anim. Health 1: 13-20. 
Yoshimizu, M., M. Sami, M. Kohara, T. Yamazaki and T. Kimura (1991). Detection 
of LEINV in hatchery water by molecular filtration method and effectiveness of 
UV irradiation on IHNV infectivity. Nippon Suisan Gakkaishi 57: 555-560. 
Zhang, P., M. Hayat, C. Joyce, L. L Gonzalez-Villasenor, C. M. Lin, R. A. Dunham, 
T. T. Chen and D. A. Powers (1990). Gene transfer, expression and 
inheritance of pRSV-rainbow trout-GH cDNA in the common carp, Cyprinus 
cario (Linnaeus). Mol. Reprod. Devel. 25: 3-13. 
Zhu, N., D. Liggitt, Y. Liu and R. Debs (1993). Systemic gene expression after 
intravenous DNA delivery into adult mice. Science 261: 209-211. 
Zhuang, W., Z. M. Hattori, M. Onuma and h. Kodama (1992). Sensitive method for 
the detection of antibodies to infectious hematopoietic necrosis virus. J. Med. 
Vet. Science 54: 371-373. 